UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021
OR
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
FOR THE TRANSITION PERIOD FROM TO
COMMISSION FILE NUMBER: 814-00849
SLR SENIOR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
Maryland | 27-4288022 | |
(State of Incorporation) | (I.R.S. Employer Identification Number) | |
500 Park Avenue New York, N.Y. |
10022 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (212) 993-1670
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbol |
Name of Each Exchange on Which Registered | ||
Common Stock, par value $0.01 per share | SUNS | The NASDAQ Global Select Market |
Securities registered pursuant to Section 12(g) of the Act: None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☐ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☒ | |||
Non-accelerated filer | ☐ | Smaller Reporting Company | ☐ | |||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its managements assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes ☐ No ☒
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes ☐ No ☒
The aggregate market value of common stock held by non-affiliates of the Registrant on June 30, 2021 based on the closing price on that date of $15.19 on the NASDAQ Global Select Market was approximately $229.3 million. For the purposes of calculating this amount only, all directors and executive officers of the Registrant have been treated as affiliates. There were 16,049,034 shares of the Registrants common stock outstanding as of February 25, 2022.
SLR SENIOR INVESTMENT CORP.
FORM 10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021
Page | ||||||
PART I | ||||||
Item 1. | 1 | |||||
Item 1A. | 28 | |||||
Item 1B. | 70 | |||||
Item 2. | 70 | |||||
Item 3. | 70 | |||||
Item 4. | 71 | |||||
PART II | ||||||
Item 5. | 72 | |||||
Item 6. | 77 | |||||
Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
77 | ||||
Item 7A. | 96 | |||||
Item 8. | 96 | |||||
Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure |
128 | ||||
Item 9A. | 128 | |||||
Item 9B. | 128 | |||||
Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections |
128 | ||||
PART III | ||||||
Item 10. | 129 | |||||
Item 11. | 134 | |||||
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
136 | ||||
Item 13. | Certain Relationships and Related Transactions, and Director Independence |
137 | ||||
Item 14. | 140 | |||||
PART IV | ||||||
Item 15. | 142 | |||||
Item 16. | 144 | |||||
Signatures | 145 |
PART I
Item 1. | Business |
SLR Senior Investment Corp. (SLR Senior, the Company, SUNS, we, us or our) (f/k/a Solar Senior Capital Ltd.), a Maryland corporation formed in December 2010, is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940, as amended (the 1940 Act). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standard Board (FASB) Accounting Standards Codification (ASC) Topic 946. In addition, for U.S federal income tax purposes, we have elected, and intend to qualify annually, to be treated as a regulated investment company (RIC) under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code).
On February 24, 2011, we priced our initial public offering, selling 9.0 million shares of our common stock, including the underwriters over-allotment, raising approximately $168 million in net proceeds. Concurrent with this offering, Solar Senior Capital Investors LLC, an entity controlled by Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, and Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, purchased an additional 500,000 shares of our common stock through a private placement transaction exempt from registration under the Securities Act of 1933, as amended, or the Securities Act (the Concurrent Private Placement), raising another $10 million.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. We define middle market to refer to companies with annual revenues typically between $50 million and $1 billion. Our investment objective is to seek to maximize current income consistent with the preservation of capital. We seek to achieve our investment objective by directly and indirectly investing primarily in senior loans, including first lien, and second lien debt instruments, made to private middle-market companies whose debt is rated below investment grade, which we refer to collectively as senior loans. We may also invest directly in the debt and equity securities of public companies that are thinly traded or in other equity and equity related securities and such investments may not be limited to any minimum or maximum market capitalization. In addition, we may invest in foreign markets, including emerging markets. Under normal market conditions, at least 80% of the value of our net assets (including the amount of any borrowings for investment purposes) will be invested directly or indirectly in senior loans. Senior loans typically pay interest at rates which are determined periodically on the basis of a floating base lending rate, primarily LIBOR, plus a premium. Senior loans in which we invest are typically made to U.S. and, to a limited extent, non-U.S. corporations, partnerships and other business entities which operate in various industries and geographical regions. Senior loans typically are rated below investment grade. In addition, some of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may write-off such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize in a loss or a substantial amount of unpaid principal and interest due upon maturity. Securities rated below investment grade are speculative and are often referred to as leveraged loans, high yield or junk securities, and may be considered high risk compared to debt instruments that are rated investment grade. While the Company does not typically seek to invest in traditional equity securities as part of its investment objective, the Company may occasionally acquire some equity securities in connection with senior loan investments and in certain other unique circumstances, such as the Companys equity investments in SLR Healthcare ABL (SLR Healthcare) and SLR Business Credit.
We invest in senior loans made primarily to private, leveraged middle-market companies with approximately $20 million to $100 million of earnings before income taxes, depreciation and amortization (EBITDA). Our business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our direct investments in individual securities generally range between $5 million and $30 million each, although we expect that this investment size will vary with the size of our capital base and/or strategic initiatives. In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to
1
enhance our overall returns. These opportunistic investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. We may invest up to 30% of our total assets in such opportunistic investments, including loans issued by non-U.S. issuers, subject to compliance with our regulatory obligations as a BDC under the 1940 Act. Our investment activities are managed by SLR Capital Partners, LLC (SLR Capital Partners or the Investment Adviser) and supervised by our board of directors (the Board or board of directors), a majority of whom are non-interested, as such term is defined in Section 2(a)(19) of the 1940 Act. SLR Capital Management, LLC (SLR Capital Management) provides the administrative services necessary for us to operate.
As of December 31, 2021, our investment portfolio totaled $403.1 million and our net asset value was $247.7 million. Our portfolio was comprised of debt and equity investments in 50 portfolio companies.
SLR Capital Partners
SLR Capital Partners, our investment adviser, is controlled and led by Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, and Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer. They are supported by a team of investment professionals. SLR Capital Partners investment team has extensive experience in leveraged lending and private equity, as well as significant contacts with financial sponsors.
In addition, at December 31, 2021, SLR Capital Partners serves as investment adviser to private funds and managed accounts as well as to SLR Investment Corp., another publicly traded BDC that primarily invests in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities, SCP Private Credit Income BDC LLC, an unlisted BDC that primarily invests in first lien loans to upper middle market private leveraged companies and SLR HC BDC LLC, an unlisted BDC that primarily invests in first lien healthcare cash flow loans and life science loans. Through December 31, 2021, the investment team led by Messrs. Gross and Spohler has invested approximately $12.5 billion in more than 450 different portfolio companies involving over 200 different financial sponsors. As of February 25, 2022, Mr. Gross and Mr. Spohler beneficially owned, either directly or indirectly, approximately 6.3% of our outstanding common stock.
Mr. Gross has over 25 years of experience in the private equity, distressed debt and mezzanine i.e., actually or structurally subordinated lending businesses and has been involved in originating, structuring, negotiating, consummating and managing private equity, distressed debt and mezzanine lending transactions. Prior to his current role as our Chairman, Co-Chief Executive Officer and President, Mr. Gross founded Apollo Investment Corporation, a publicly traded BDC. He served as its chairman from February 2004 to July 2006 and its chief executive officer from February 2004 to February 2006. Under his management, Apollo Investment Corporation raised approximately $930 million in gross proceeds in an initial public offering in April 2004, built a dedicated investment team and infrastructure and invested approximately $2.3 billion in over 65 companies in conjunction with 50 different private equity sponsors. Mr. Gross is also a founder and a former senior partner of Apollo Management, L.P., a leading private equity firm. During his tenure at Apollo Management, L.P., Mr. Gross was a member of the investment committee that was responsible for overseeing more than $13 billion of investments in over 150 companies.
Mr. Gross also has served on the boards of directors of more than 20 public and private companies. As a result, Mr. Gross has developed an extensive network of private equity sponsor relationships as well as relationships with management teams of public and private companies, investment bankers, attorneys and accountants that we believe should provide us with significant business opportunities.
We also rely on the over 25 years of experience of Mr. Spohler, who has served as our Chief Operating Officer and a partner of SLR Capital Partners since its inception and as Co-Chief Executive Officer since June 2019. Previously, Mr. Spohler was a managing director and a former co-head of U.S. Leveraged Finance for
2
CIBC World Markets. He held numerous senior roles at CIBC World Markets, including serving on the U.S. Management Committee, Global Executive Committee and the Deals Committee, which approves all of CIBC World Markets U.S. corporate finance debt capital decisions. During Mr. Spohlers tenure, he was responsible for senior loan, high yield and mezzanine origination and execution, as well as CIBC World Markets below investment grade loan portfolio in the United States. As a co-head of U.S. Leveraged Finance, Mr. Spohler oversaw over 300 capital raising and merger and acquisition transactions, comprising over $40 billion in market capitalization.
SLR Capital Partners senior investment professionals have been active participants in the primary and secondary leveraged credit markets throughout their careers. They have effectively managed portfolios of senior secured, distressed and mezzanine debt as well as other investment types. The depth of their prior experience and credit market expertise has led them through various stages of the economic cycle as well as several market disruptions.
SLR Capital Management
Pursuant to an administration agreement (the Administration Agreement), SLR Capital Management furnishes us with office facilities, equipment and clerical, bookkeeping and record keeping services at such facilities. Under the Administration Agreement, SLR Capital Management also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain and preparing reports to our stockholders. In addition, SLR Capital Management assists us in determining and publishing our net asset value, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. SLR Capital Management also provides managerial assistance, if any, on our behalf to those portfolio companies that request such assistance.
License Agreement
We have entered into a license agreement with SLR Capital Partners pursuant to which SLR Capital Partners has agreed to grant us a non-exclusive, royalty-free license to use the names SLR Senior and SOLAR Under this agreement, we have a right to use the SLR Senior and names for so long as the Investment Advisory and Management Agreement with our investment adviser is in effect. Other than with respect to this limited license, we will have no legal right to the SLR Senior or SOLAR names.
Market Opportunity
SLR Senior invests directly and indirectly in senior loans of private middle-market leveraged companies organized and located primarily in the United States. We believe that the size of this market, coupled with leveraged companies need for flexible sources of capital at attractive terms and rates, creates an attractive investment environment for us.
| Middle-market companies continue to face increasing difficulty in accessing the capital markets. While many middle-market companies were formerly able to raise funds by issuing high-yield bonds, we believe this approach to financing has become more difficult in recent years as institutional investors have sought to invest in larger, more liquid offerings. In addition, many private finance companies that historically financed their lending and investing activities through securitization transactions have lost that source of funding and reduced lending significantly. Moreover, consolidation of lenders and market participants and the illiquid nature of investments have resulted in fewer middle-market lenders and market participants. |
| There is a large pool of uninvested private equity capital likely to seek additional senior debt capital to support their investments. We believe there is more than $600 billion of uninvested private equity |
3
seeking debt financing to support acquisitions. We expect that middle-market private equity firms will continue to invest in middle-market companies and that those private equity firms will seek to support their investments with senior loans from other sources such as SLR Senior. |
| The significant amount of leveraged loans maturing through 2024 should provide additional demand for capital. A high volume of financings are expected to mature over the next few years. We believe that this supply of prospective lending opportunities coupled with a lack of available credit in the middle-market lending space may offer attractive risk-adjusted returns to investors. Risk-adjusted return compares returns against the amount of risk incurred. The term risk-adjusted return does not imply that an investment is no risk or low risk. |
| Investing in private middle-market senior secured debt provides an attractive risk reward profile. In general, terms for illiquid, middle-market subordinated debt have been more attractive than those for larger corporations which are typically more liquid. We believe this is because fewer institutions are able to invest in illiquid asset classes. |
Therefore, we believe that there is an opportunity to invest in senior loans of leveraged companies and that we are well positioned to serve this market.
Competitive Advantages and Strategy
We believe that we have the following competitive advantages over other providers of financing to leveraged companies.
Management Expertise
As managing partner, Mr. Gross has principal management responsibility for SLR Capital Partners, to which he currently dedicates substantially all of his time. Mr. Gross has over 25 years of experience in leveraged finance, private equity and distressed debt investing. Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and a partner of SLR Capital Partners, has over 25 years of experience in evaluating and executing leverage finance transactions.
Proprietary Sourcing and Origination
We believe that SLR Capital Partners senior investment professionals longstanding relationships with financial sponsors, commercial and investment banks, management teams and other financial intermediaries provide us with a strong pipeline of origination opportunities. We expect to continue leveraging the over 100 relationships with middle-market sponsors that SLR Capital Partners investment team established while sourcing and originating investments for SLR Senior, which gives us access to deals that are not available through large syndication processes.
Versatile Transaction Structuring and Flexibility of Capital
We believe SLR Capital Partners senior investment teams broad expertise and ability to draw upon its extensive experience enable us to identify, assess and structure investments successfully and to manage potential risk and return at all stages of the economic cycle. The attempt to manage risk does not imply low risk or no risk. While we are subject to significant regulation as a BDC, we are not subject to many of the regulatory limitations that govern traditional lending institutions such as banks. As a result, we believe that we can be more flexible than such lending institutions in selecting and structuring investments, adjusting investment criteria and building transaction structures.
Emphasis on Achieving Strong Risk-Adjusted Returns
SLR Capital Partners uses a structured investment and risk management process that emphasizes research and analysis. SLR Capital Partners seeks to build our portfolio on a bottom-up basis, choosing and sizing
4
individual positions based on their relative risk/reward profiles as a function of the associated downside risk, volatility, correlation with the existing portfolio and liquidity. At the same time, SLR Capital Partners takes into consideration a variety of factors in managing our portfolio and imposes portfolio-based risk constraints promoting a more diverse portfolio of investments and limiting issuer and industry concentration. We do not pursue short-term origination targets. We believe this approach enables us to build an attractive investment portfolio that meets our return and value criteria over the long term. We believe it is critical to conduct extensive due diligence on investment targets. In evaluating new investments we, through SLR Capital Partners, conduct a rigorous due diligence process.
Dedication of Resources to Industries with Substantial Information Flow
We dedicate our investing resources to industries characterized by strong cash flow and in which SLR Capital Partners investment professionals have deep investment experience. As a result of their investment experience, Messrs. Gross and Spohler, together with SLR Capital Partners other investment professionals, have long-term relationships with management consultants and management teams in the industries we target, as well as substantial information concerning those industries.
Longer Investment Horizon
Unlike private equity and venture capital funds, we are not subject to standard periodic capital return requirements. Such requirements typically stipulate that the capital of these funds, together with any capital gains on such invested funds, can only be invested once and must be returned to investors after a pre-agreed time period. We believe that our flexibility to make investments with a long-term view and without the capital return requirements of traditional private investment vehicles enables us to invest in private middle-market senior debt, which we believe provides a more attractive investment profile than the liquid senior debt market for larger companies. We also believe our longer investment horizon enables us to be a better long-term partner for our portfolio companies.
Investments
SLR Senior seeks to create a diverse portfolio of senior loans by investing approximately $5 million to $30 million of capital, on average, in the individual securities of leveraged companies, including private middle-market companies. We expect that this investment size will vary proportionately with the size of our capital base and/or strategic initiatives. We may also invest in the debt and equity of public companies that are thinly traded. Under normal market conditions, at least 80% of the value of our net assets (including the amount of any borrowings for investment purposes) will be invested directly or indirectly in senior loans.
Senior loans typically pay interest at rates which are determined periodically on the basis of a floating base lending rate, primarily LIBOR, plus a spread or premium. Senior loans in which we invest are typically made to U.S. and, to a limited extent, non-U.S. corporations, partnerships and other business entities which operate in various industries and geographical regions. Senior loans typically are rated below investment grade. Securities rated below investment grade are speculative and are often referred to as leveraged loans, high yield or junk securities, and may be considered high risk compared to debt instruments that are rated investment grade. Senior loans, however are generally less risky than subordinated debt, bearing lower leverage and higher recovery statistics. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may write-off such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
In addition to senior loans, we may invest a portion of our portfolio in opportunistic investments, which are not our primary focus, but are intended to enhance our returns to stockholders. These investments may include similar direct investments in public companies that are not thinly traded and securities of leveraged companies
5
located in select countries outside of the United States. We may invest up to 30% of our total assets in such opportunistic investments, including loans issued by non-U.S. issuers, subject to compliance with our regulatory obligations as a BDC under the 1940 Act.
We currently borrow funds under our credit facilities and may borrow additional funds to make investments. As a result, we are exposed to the risks of leverage, which may be considered a speculative investment technique. The use of leverage magnifies the potential for loss on amounts invested and therefore increases the risks associated with investing in our securities. In addition, the costs associated with our borrowings, including any increase in management fees payable to our investment adviser, SLR Capital Partners, will be borne by our common stockholders.
Additionally, we may in the future seek to securitize our loans to generate cash for funding new investments. To securitize loans, we may create a wholly owned subsidiary and contribute a pool of loans to the subsidiary. This could include the sale of interests in the subsidiary on a non-recourse basis to purchasers who we would expect to be willing to accept a lower interest rate to invest in investment grade loan pools, and we would retain a portion of the equity in the securitized pool of loans.
Moreover, we may acquire investments in the secondary market and, in analyzing such investments, we will employ a substantially similar analytical process as we use for our primary investments.
We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in non-U.S. currencies because the value of those securities is likely to fluctuate as a result of factors not entirely related to currency fluctuations.
Our principal focus is to provide senior loans, including first lien loans, to leveraged private middle-market companies in a variety of industries. We generally seek to target companies that generate positive cash flows and/or have substantiated assets that serve our loans. We generally seek to invest in companies from the broad variety of industries in which our investment adviser has direct expertise. The following is a representative list of the industries in which we may invest.
Aerospace & Defense |
Hotels, Restaurants & Leisure | |
Air Freight & Logistics |
Household & Personal Products | |
Airlines |
Industrial Conglomerates | |
Asset Management |
Insurance | |
Automobiles |
Internet & Catalog Retail | |
Auto Components |
Internet Services & Infrastructure | |
Auto Parts & Equipment |
IT Services | |
Biotechnology |
Leisure Equipment & Products | |
Building Products |
Life Sciences Tools & Services | |
Capital Markets |
Machinery | |
Chemicals |
Media |
6
Commercial Services & Supplies |
Metals & Mining | |
Communications Equipment |
Multiline Retail | |
Construction & Engineering |
Multi-Sector Holdings | |
Consumer Finance |
Oil, Gas & Consumable Fuels | |
Containers & Packaging |
Packaged Foods & Meats | |
Distributors |
Paper & Forest Products | |
Diversified Consumer Services |
Personal Products | |
Diversified Financial Services |
Pharmaceuticals | |
Diversified Real Estate Activities |
Professional Services | |
Diversified Telecommunications Services |
Research & Consulting Services | |
Education Services |
Road & Rail | |
Energy Equipment & Services |
Software | |
Food Products |
Specialty Retail | |
Footwear |
Textiles, Apparel & Luxury Goods | |
Health Care Equipment & Supplies |
Thrifts & Mortgage Finance | |
Health Care Facilities |
Trading Companies & Distributors | |
Health Care Providers & Services |
Utilities | |
Health Care Technology |
Wireless Telecommunications Services |
We may also invest in other industries if we are presented with attractive opportunities.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds. We may also participate in negotiated co-investment transactions with certain affiliates, each of whose investment adviser is SLR Capital Partners, or an investment adviser controlling, controlled by or under common control with SLR Capital Partners and is registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the Advisers Act), in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions of the most recent exemptive order obtained from the SEC on June 13, 2017 (the Exemptive Order). Pursuant to the Exemptive Order, we are permitted to co-invest with our affiliates if a required majority (as defined in Section 57(o) of the 1940 Act) of our independent directors make certain conclusions in connection with a co-investment transaction, including, but not limited to, that (1) the terms of the potential co-investment transaction, including the consideration to be paid, are reasonable and fair to us and our stockholders and do not involve overreaching in respect of us or our stockholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of our stockholders and is consistent with our then-current investment objective and strategies.
At December 31, 2021, our portfolio consisted of 50 portfolio companies and was invested 71.2% directly in senior secured loans and 28.8% in common equity/equity interests/warrants (of which 8.9% is SLR Healthcare ABL and 19.8% is SLR Business Credit, through which the Company indirectly invests in senior secured loans), in each case, measured at fair value. We expect that our portfolio will continue to primarily include senior secured loans.
While our primary investment objective is to maximize current income through direct and indirect investments in U.S. senior secured loans, and we may also invest a portion of the portfolio in opportunistic investments, including foreign securities.
7
Listed below are our top ten portfolio companies and industries based on their fair value and represented as a percentage of total assets as of December 31, 2021 and 2020:
TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2021
Portfolio Company |
% of Total Assets |
|||
SLR Business Credit* |
14.0 | % | ||
SLR Healthcare ABL*. |
6.3 | % | ||
World Insurance Associates, LLC |
2.6 | % | ||
Community Brands ParentCo, LLC. |
2.4 | % | ||
BayMark Health Services, Inc |
2.1 | % | ||
KORE Wireless Group, Inc |
2.1 | % | ||
Drilling Info Holdings, Inc |
2.0 | % | ||
GSM Acquisition Corp |
1.9 | % | ||
Foundation Consumer Brands, LLC. |
1.9 | % | ||
Logix Holding Company, LLC |
1.9 | % |
* | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. |
Industry |
% of Total Assets |
|||
Diversified Financial Services |
20.2 | % | ||
Health Care Providers & Services |
11.4 | % | ||
Insurance |
6.6 | % | ||
Building Products |
3.5 | % | ||
Trading Companies & Distributors |
2.8 | % | ||
Communications Equipment |
2.5 | % | ||
Software |
2.4 | % | ||
Pharmaceuticals |
2.3 | % | ||
Health Care Equipment & Supplies |
2.3 | % | ||
Diversified Consumer Services |
2.2 | % |
TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2020
Portfolio Company |
% of Total Assets |
|||
North Mill Holdco LLC* |
9.0 | % | ||
Gemino Healthcare Finance LLC*. |
5.5 | % | ||
Galway Partners Holdings, LLC (fka Edgewood) |
2.6 | % | ||
Confie Seguros Holding II Co. |
2.2 | % | ||
Ministry Brands, LLC. |
2.1 | % | ||
American Teleconferencing Services, Ltd |
2.0 | % | ||
KORE Wireless Group, Inc. |
1.8 | % | ||
Drilling Info Holdings, Inc |
1.7 | % | ||
Aegis Toxicology Sciences Corporation. |
1.6 | % | ||
Logix Holding Company, LLC |
1.6 | % |
* | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. |
8
Industry |
% of Total Assets |
|||
Diversified Financial Services |
14.5 | % | ||
Insurance |
8.2 | % |
Portfolio Company |
% of Total Assets |
|||
Health Care Providers & Services |
6.7 | % | ||
Software |
3.8 | % | ||
Communications Equipment |
3.5 | % | ||
Professional Services |
2.5 | % | ||
Wireless Telecommunication Services |
1.8 | % | ||
Pharmaceuticals |
1.8 | % | ||
IT Services |
1.7 | % | ||
Building Products |
1.6 | % |
Set forth below is a brief description of each portfolio company in which we have made an investment that represents greater than 5% of our total assets as of December 31, 2021.
SLR Business Credit
We acquired 100% of the equity interests of North Mill Capital LLC (NMC) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries. We invested approximately $51 million to effect the transaction. Subsequently, the Company contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, the Company and ESP SSC Corporation contributed their equity interests to North Mill LLC. On May 1, 2018, North Mill LLC merged with and into NMC, with NMC being the surviving company. The Company and ESP SSC Corporation own 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. NMC currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. On June 28, 2019, North Mill Holdco LLC (NM Holdco), a newly formed entity and ESP SSC Corporation acquired Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and medium-sized businesses. As part of this transaction, the Companys 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMCs credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from the Company of $19.0 million and borrowings on NMCs credit facility of $47.7 million.
SLR Healthcare ABL
SLR Healthcare (f/k/a Gemino Healthcare Finance LLC) is a commercial finance business focused on originating, underwriting, and managing financing solutions for small to mid-size companies operating in the healthcare industry. SLR Healthcares primary financing products today include revolving lines of credit secured by the borrowers accounts receivable, including receivables from Medicare, Medicaid, and private health insurance companies as well as senior cash flow term loans secured by all other assets, often with a pledge of equity or personal guarantee. The company has processes in place to source, underwrite and monitor portfolio companies. SLR Healthcare competes against an assortment of regional and local banks as well as specialized commercial finance companies. The companys performance is susceptible to changes in healthcare regulation and interest rates. The company is headquartered in Philadelphia, Pennsylvania and has a satellite office in Atlanta, Georgia.
9
Investment Selection Process
SLR Capital Partners is committed to and utilizes a value-oriented investment philosophy with a focus on the preservation of capital and a commitment to managing downside exposure.
Portfolio Company Characteristics
We have identified several criteria that we believe are important in identifying and investing in prospective portfolio companies. These criteria provide general guidelines for our investment decisions; however, not all of these criteria will be met by each prospective portfolio company in which we choose to invest.
Stable Earnings and Strong Free Cash Flow. We seek to invest in companies who have demonstrated stable earnings through economic cycles. We target companies that can de-lever through consistent generation of cash flows rather than relying solely on growth to service and repay our loans.
Value Orientation. Our investment philosophy places a premium on fundamental analysis from an investors perspective and has a distinct value orientation. We focus on companies in which we can invest at relatively low multiples of operating cash flow and that are profitable at the time of investment on an operating cash flow basis.
Value of Assets. The prospective value of the assets, if any, that collateralizes the loans in which we invest, is an important factor in our credit analysis. Our analysis emphasizes both tangible assets, such as accounts receivable, inventory, equipment and real estate, and intangible assets, such as intellectual property, customer lists, networks and databases. In some of our transactions, the companys fundings may be derived from a borrowing base determined by the value of the companys assets.
Strong Competitive Position in Industry. We seek to invest in target companies that have developed leading market positions within their respective markets and are well positioned to capitalize on growth opportunities. We seek companies that demonstrate significant competitive advantages versus their competitors, which we believe should help to protect their market position and profitability.
Diversified Customer and Supplier Base. We seek to invest in businesses that have a diversified customer and supplier base. We believe that companies with a diversified customer and supplier base are generally better able to endure economic downturns, industry consolidation, changing business preferences and other factors that may negatively impact their customers, suppliers and competitors.
Exit Strategy. We predominantly invest in companies which provide multiple alternatives for an eventual exit. We look for opportunities that provide an exit typically within three years of the initial capital commitment.
We generally seek companies that we believe have or will provide a steady stream of cash flow to repay our loans and reinvest in their respective businesses. We believe that such internally generated cash flow, leading to the payment of our interest, and the repayment of our principal represent a key means by which we will be able to exit from our investments over time.
In addition, we also seek to invest in companies whose business models and expected future cash flows or cash positions offer attractive exit possibilities. These companies include candidates for strategic acquisition by other industry participants and companies that may repay our investments through an initial public offering of common stock or another capital market transaction. We underwrite our investments on a held-to-maturity basis, but expensive capital is often repaid prior to stated maturity.
Experienced and Committed Management. We generally require that portfolio companies have an experienced management team. We also require portfolio companies have in place proper incentives to induce management to succeed and to act in concert with our interests as investors, including having significant equity interests.
10
Strong Sponsorship. We generally aim to invest alongside other sophisticated investors. We typically seek to partner with successful financial sponsors who have historically generated high returns. We believe that investing in these sponsors portfolio companies enables us to benefit from their direct involvement and due diligence.
SLR Seniors investment team works in concert with sponsors to proactively manage investment opportunities by acting as a partner throughout the investment process. We actively focus on the middle-market financial sponsor community, with a particular focus on the upper-end of the middle-market (sponsors with equity funds of $500 million to $5 billion). We favor such sponsors because they typically:
| buy larger companies with strong business franchises; |
| invest significant amounts of equity in their portfolio companies; |
| value flexibility and creativity in structuring their transactions; |
| possess longer track records over multiple investment funds; |
| have a deeper management bench; |
| have better ability to withstand downturns; and |
| possess the ability to support portfolio companies with additional capital. |
We divide our coverage of these sponsors among our more senior investment professionals, who are responsible for day-to-day interaction with financial sponsors. Our coverage approach aims to act proactively, consider all investments in the capital structure, provide quick feedback, deliver on commitments, and are constructive throughout the life cycle of an investment.
Due Diligence
Our private equity approach to credit investing typically incorporates extensive in-depth due diligence often alongside the private equity sponsor. In conducting due diligence, we will use publicly available information as well as information from relationships with former and current management teams, consultants, competitors and investment bankers. We believe that our due diligence methodology allows us to screen a high volume of potential investment opportunities on a consistent and thorough basis.
Our due diligence typically includes:
| review of historical and prospective financial information; |
| review and valuation of assets; |
| research relating to the companys management, industry, markets, products and services and competitors; |
| on-site visits; |
| discussions with management, employees, customers or vendors of the potential portfolio company; |
| review of senior loan documents; and |
| background investigations. |
We also expect to evaluate the private equity sponsor making the investment. Further, due to SLR Capital Partners considerable repeat business with sponsors, we have direct experience with the management teams of many sponsors. A private equity sponsor is typically the controlling stockholder upon completion of an investment and as such is considered critical to the success of the investment. The equity sponsor is evaluated along several key criteria, including:
| investment track record; |
11
| industry experience; |
| capacity and willingness to provide additional financial support to the company through additional capital contributions, if necessary; and |
| reference checks. |
Throughout the due diligence process, a deal team is in constant dialogue with the management team of the company in which we are considering to invest to ensure that any concerns are addressed as early as possible through the process and that unsuitable investments are filtered out before considerable time has been invested.
Upon the completion of due diligence and a decision to proceed with an investment in a company, the investment professionals leading the investment present the investment opportunity to SLR Capital Partners investment committee, which then determines whether to pursue the potential investment. Additional due diligence with respect to any investment may be conducted on our behalf by attorneys and independent accountants prior to the closing of the investment, as well as other outside advisers, as appropriate.
The Investment Committee
All new investments are required to be approved by a consensus of the investment committee of SLR Capital Partners, which is led by Messrs. Gross and Spohler. The members of SLR Capital Partners investment committee receive no compensation from us. Such members may be employees or partners of SLR Capital Partners and may receive compensation or profit distributions from SLR Capital Partners.
Investment Structure
Once we determine that a prospective portfolio company is suitable for investment, we will work with the management of that company and its other capital providers, including senior, junior and equity capital providers, to structure an investment. We negotiate among these parties to agree on how our investment is expected to perform relative to the other capital in the portfolio companys capital structure.
We seek to invest in portfolio companies primarily in the form of senior loans. These senior loans typically have current cash pay interest with some amortization of principal. Interest is typically paid on a floating rate basis, often with a floor on the LIBOR rate. We generally seek to obtain security interests in the assets of our portfolio companies that serve as collateral in support of the repayment of these loans. This collateral may take the form of first or second priority liens on the assets of a portfolio company.
Typically, we expect that our senior loans will have final maturities of four to seven years. However, we also expect that our portfolio companies often may repay these loans early, generally within three years from the date of initial investment. In some cases and when available, we seek to structure these loans with prepayment premiums to capture foregone interest.
In the case of our senior secured loan investments, we seek to tailor the terms of the investment to the facts and circumstances of the transaction and the prospective portfolio company, negotiating a structure that protects our rights and manages our risk while creating incentives for the portfolio company to achieve its business plan and improve its profitability. For example, in addition to seeking a senior position in the capital structure of our portfolio companies, we may be able to limit the downside potential of our investments by:
| requiring a total return on our investments (including both interest and potential capital appreciation) that compensates us for credit risk; |
| incorporating put rights and call protection into the investment structure; and |
| negotiating covenants in connection with our investments that afford our portfolio companies as much flexibility in managing their businesses as possible, consistent with preservation of our capital. Such |
12
restrictions may include affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights. |
Our investments may include equity features, such as warrants or options to buy a minority interest in the portfolio company. Any warrants we receive with our debt securities generally require only a nominal cost to exercise, and thus, as a portfolio company appreciates in value, we may achieve additional investment return from this equity interest. In addition, we may from time to time make direct equity investments in portfolio companies.
We generally seek to hold most of our investments to maturity or repayment, but believe we have the ability to sell our investments earlier, including if a liquidity event takes place such as the sale or recapitalization of a portfolio company.
Ongoing Relationships with Portfolio Companies
SLR Capital Partners monitors our portfolio companies on an ongoing basis. SLR Capital Partners monitors the financial trends of each portfolio company to determine if it is meeting its business plan and to assess the appropriate course of action for each company.
SLR Capital Partners has several methods of evaluating and monitoring the performance and fair value of our investments, which include the following:
| Assessment of success in adhering to each portfolio companys business plan and compliance with covenants; |
| Periodic and regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments; |
| Comparisons to other SLR Senior invested portfolio companies in the industry, if any; and |
| Review of monthly and quarterly financial statements, asset valuations, and financial projections for portfolio companies. |
In addition to various risk management and monitoring tools, SLR Capital Partners also uses an investment rating system to characterize and monitor our expected level of returns on each investment in our portfolio.
We use an investment rating scale of 1 to 4. The following is a description of the conditions associated with each investment rating:
Investment Rating |
Summary Description | |
1 | Involves the least amount of risk in our portfolio, the portfolio company is performing above expectations, and the trends and risk factors are generally favorable (including a potential exit) | |
2 | Risk that is similar to the risk at the time of origination, the portfolio company is performing as expected, and the risk factors are neutral to favorable; all new investments are initially assessed a grade of 2 | |
3 | The portfolio company is performing below expectations, may be out of compliance with debt covenants, and requires procedures for closer monitoring | |
4 | The investment is performing well below expectations and is not anticipated to be repaid in full |
SLR Capital Partners monitors and, when appropriate, changes the investment ratings assigned to each investment in our portfolio. As of December 31, 2021 and December 31, 2020, the weighted average investment rating on the fair market value of our portfolio was 2. In connection with our valuation process, SLR Capital Partners reviews these investment ratings on a quarterly basis.
13
Valuation Procedures
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with U.S. generally accepted accounting principles (GAAP), and the 1940 Act. Our valuation procedures are set forth in more detail below:
The Company conducts the valuation of its assets in accordance with GAAP and the 1940 Act. The Company generally values its assets on a quarterly basis, or more frequently if required. Investments for which market quotations are readily available on an exchange are valued at the closing price on the date of valuation. The Company may also obtain quotes with respect to certain of its investments from pricing services or brokers or dealers in order to value assets. When doing so, management determines whether the quote obtained is sufficient according to GAAP to determine the fair value of the investment. If determined adequate, the Company uses the quote obtained. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board.
Investments for which reliable market quotations are not readily available or for which the pricing sources do not provide a valuation or methodology or provide a valuation or methodology that, in the judgment of the Investment Adviser or the Board does not represent fair value, each shall be valued as follows: (i) each portfolio company or investment is initially valued by the investment professionals responsible for the portfolio investment; (ii) preliminary valuations are discussed with senior management of the Investment Adviser; (iii) independent valuation firms engaged by, or on behalf of, the Board will conduct independent appraisals and review the Investment Advisers preliminary valuations and make their own independent assessment for (a) each portfolio investment that, when taken together with all other investments in the same portfolio company, exceeds 10% of estimated total assets, plus available borrowings, as of the end of the most recently completed fiscal quarter, and (b) each portfolio investment that is presently in payment default and the Investment Adviser does not expect to reach an agreement with the portfolio company in the subsequent quarter; (iv) the Board will discuss the valuations and determine the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser and, where appropriate, the respective independent valuation firm.
The recommendation of fair value generally considers the following factors among others, as relevant: applicable market yields; the nature and realizable value of any collateral; the portfolio companys ability to make payments; the portfolio companys earnings and discounted cash flow; the markets in which the issuer does business; and comparisons to publicly traded securities, among others.
When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material.
Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio companys ability to make payments, its earnings and
14
discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2021, there has been no change to the Companys valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
Accounting Standards Codification (ASC) Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level 1: Quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level 3: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
Competition
Our primary competitors provide financing to middle-market companies and include other BDCs, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Additionally, alternative investment vehicles, such as hedge funds, frequently invest in middle-market companies. As a result, competition for investment opportunities at middle-market companies can be intense. While many middle-market companies were previously able to raise senior debt financing through traditional large financial institutions, we believe this approach to financing is more difficult as implementation of U.S. and international financial reforms limits the capacity of large financial institutions to hold non-investment grade leveraged loans on their balance sheets. We believe that many of these financial institutions have de-emphasized their service and product offerings to middle-market companies in particular.
Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a business development company. We use the industry information available to Messrs. Gross and Spohler and the other investment professionals of SLR Capital Partners to assess investment risks and determine appropriate pricing for our investments in portfolio companies. In addition, we believe that the relationships of Messrs. Gross and Spohler and the other senior investment professionals of our investment adviser enable us to learn about, and compete effectively for, financing opportunities with attractive leveraged companies in the industries in which we seek to invest.
15
Staffing
We do not currently have any employees. Mr. Gross, our Chairman and Co-Chief Executive Officer, and Mr. Spohler, our Co-Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for SLR Capital Partners. Guy Talarico, our Chief Compliance Officer, is a Senior Managing Director of Foreside Consulting Services, LLC, and performs his functions as our Chief Compliance Officer under the terms of an agreement between SLR Capital Management and Foreside Consulting Services, LLC. SLR Capital Management has retained Mr. Talarico and Foreside Consulting Services, LLC pursuant to its obligations under our Administration Agreement.
Our day-to-day investment operations are managed by SLR Capital Partners. Based upon its needs, SLR Capital Partners may hire additional investment professionals. In addition, we will reimburse SLR Capital Management for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of the Companys chief compliance officer and chief financial officer and their respective staffs.
Sarbanes-Oxley Act of 2002
The Sarbanes-Oxley Act of 2002 imposes a wide variety of regulatory requirements on publicly-held companies and their insiders. Many of these requirements affect us. For example:
| Pursuant to Rule 13a-14 of the Securities Exchange Act of 1934 (the 1934 Act), our Co-Chief Executive Officers and Chief Financial Officer must certify the accuracy of the consolidated financial statements contained in our periodic reports; |
| Pursuant to Item 307 of Regulation S-K, our periodic reports must disclose our conclusions about the effectiveness of our disclosure controls and procedures; |
| Pursuant to Rule 13a-15 of the 1934 Act, our management must prepare an annual report regarding its assessment of the effectiveness of internal controls over financial reporting and may be required to obtain an audit of the effectiveness of internal controls over financial reporting performed by our independent registered public accounting firm; and |
| Pursuant to Item 308 of Regulation S-K and Rule 13a-15 of the 1934 Act, our periodic reports must disclose whether there were significant changes in our internal controls or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. |
The Sarbanes-Oxley Act of 2002 requires us to review our current policies and procedures to determine whether we comply with the Sarbanes-Oxley Act of 2002 and the regulations promulgated thereunder. We will continue to monitor our compliance with all regulations that are adopted under the Sarbanes-Oxley Act of 2002 and will take actions necessary to ensure that we are in compliance therewith.
Business Development Company Regulations
A BDC is regulated by the 1940 Act. A BDC must be organized in the United States for the purpose of investing in or lending to primarily private companies and making significant managerial assistance available to them. A BDC may use capital provided by public stockholders and from other sources to make long-term, private investments in businesses. A BDC provides stockholders the ability to retain the liquidity of a publicly-traded stock while sharing in the possible benefits, if any, of investing in primarily privately owned companies.
We may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC unless authorized by vote of a majority of our outstanding voting securities, as required by the 1940 Act. A
16
majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (a) 67% or more of such companys voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented by proxy, or (b) more than 50% of the outstanding voting securities of such company. We do not anticipate any substantial change in the nature of our business.
As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. A majority of our directors must be persons who are not interested persons, as that term is defined in the 1940 Act. Additionally, we are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the BDC. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such persons office.
As a BDC, we are required to meet an asset coverage ratio, reflecting the value of our total assets to our total senior securities, which include all of our borrowings and any preferred stock we may issue in the future, of at least 150%. We may also be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our directors who are not interested persons and, in some cases, prior approval by the SEC.
We are generally not able to issue and sell our common stock at a price below net asset value per share without annual stockholder approval. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value of our common stock if the Board determines that such sale is in our best interests and the best interests of our stockholders, and our stockholders approve such sale. In addition, we may generally issue new shares of our common stock at a price below net asset value in rights offerings to existing stockholders, in payment of dividends and in certain other limited circumstances.
As a BDC, we were substantially limited in our ability to co-invest in privately negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the Exemptive Order), permits us to participate in negotiated co-investment transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entitys investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our investment adviser.
We will be periodically examined by the SEC for compliance with the federal securities laws, including the 1940 Act.
Qualifying Assets
Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDCs total assets. The principal categories of qualifying assets relevant to our business are the following:
(1) Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is,
17
or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:
(a) is organized under the laws of, and has its principal place of business in, the United States;
(b) is not an investment company (other than a small business investment company wholly owned by the BDC); and
(c) satisfies any of the following:
i. does not have any class of securities that is traded on a national securities exchange;
ii. has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and non-voting common equity of less than $250 million;
iii. is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company; or
iv. is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million.
(2) Securities of any eligible portfolio company which we control, which, as defined by the 1940 Act, is presumed to exist where a BDC beneficially owns more than 25% of the outstanding voting securities of the portfolio company.
(3) Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities, was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.
(4) Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own 60% of the outstanding equity of the eligible portfolio company.
(5) Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities.
(6) Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.
(7) Office furniture and equipment, interests in real estate and leasehold improvements and facilities maintained to conduct the business operations of the BDC, deferred organization and operating expenses, and other noninvestment assets necessary and appropriate to its operations as a BDC, including notes of indebtedness of directors, officers, employees, and general partners held by a BDC as payment for securities of such company issued in connection with an executive compensation plan described in Section 57(j) of the 1940 Act.
Under Section 55(b) of the 1940 Act, the value of a BDCs assets shall be determined as of the date of the most recent financial statements filed by such company with the SEC pursuant to Section 13 of the 1934 Act, and shall be determined no less frequently than annually.
Significant Managerial Assistance to Portfolio Companies
As a BDC, we offer, and must provide upon request, significant managerial assistance to our portfolio companies. This assistance could involve, among other things, monitoring the operations of our portfolio
18
companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance. We may also receive fees for these services. SLR Capital Management provides such managerial assistance, if any, on our behalf to portfolio companies that request this assistance.
Temporary Investments
Pending investment in other types of qualifying assets, as described above, our investments may consist of cash, cash equivalents, U.S. government securities or high-quality investment grade debt securities maturing in one year or less from the time of investment, which we refer to, collectively, as temporary investments, so that 70% of our assets are qualifying assets. Typically, we will invest in U.S. Treasury bills or in repurchase agreements, provided that such repurchase agreements are fully collateralized by cash or securities issued by the U.S. government or its agencies. A repurchase agreement involves the purchase by an investor, such as us, of a specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price which is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25% of our total assets constitute repurchase agreements from a single counterparty, we would not meet the diversification tests in order to qualify as a RIC for U.S. federal income tax purposes. Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. Our investment adviser will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement transactions.
Senior Securities
We are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after each such issuance. In addition, while certain senior securities remain outstanding, we may be required to make provisions to prohibit any distribution to our stockholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. We may also borrow amounts up to 5% of the value of our total assets for temporary purposes without regard to asset coverage. We may borrow money, which would magnify the potential for gain or loss on amounts invested and may increase the risk of investing in us.
Code of Ethics
We and SLR Capital Partners have each adopted a code of ethics pursuant to Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain transactions by our personnel. Our codes of ethics generally do not permit investments by our employees in securities that may be purchased or held by us. Each code of ethics is available on the EDGAR Database on the SECs Internet site at http://www.sec.gov. You may also obtain copies of the codes of ethics, after paying a duplicating fee, by electronic request at the following Email address: publicinfo@sec.gov.
Compliance Policies and Procedures
We and our investment adviser have adopted and implemented written policies and procedures reasonably designed to detect and prevent violation of the federal securities laws. We are required to review these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation and to designate a chief compliance officer to be responsible for their administration. Guy Talarico currently serves as our Chief Compliance Officer.
19
Proxy Voting Policies and Procedures
We have delegated our proxy voting responsibility to our investment adviser. A summary of the Proxy Voting Policies and Procedures of our adviser are set forth below. The guidelines are reviewed periodically by the adviser and our non-interested directors, and, accordingly, are subject to change.
As an investment adviser registered under the Advisers Act, SLR Capital Partners has a fiduciary duty to act solely in the best interests of its clients. As part of this duty, it recognizes that it must vote securities held by its clients in a timely manner free of conflicts of interest. These policies and procedures for voting proxies for investment advisory clients are intended to comply with Section 206 of, and Rule 206(4)-6 under, the Advisers Act.
Our investment adviser votes proxies relating to our portfolio securities in the best interest of our stockholders. SLR Capital Partners reviews on a case-by-case basis each proposal submitted for a proxy vote to determine its impact on our investments. Although it generally votes against proposals that may have a negative impact on our investments, it may vote for such a proposal if there exists compelling long-term reasons to do so. The proxy voting decisions of our investment adviser are made by the senior investment professionals who are responsible for monitoring each of our investments. To ensure that our vote is not the product of a conflict of interest, it requires that: (i) anyone involved in the decision making process disclose to a managing member of SLR Capital Partners any potential conflict that he or she is aware of and any contact that he or she has had with any interested party regarding a proxy vote; and (ii) employees involved in the decision making process or vote administration are prohibited from revealing how we intend to vote on a proposal in order to reduce any attempted influence from interested parties.
You may obtain information about how we voted proxies by making a written request for proxy voting information to: SLR Capital Partners, LLC, 500 Park Avenue, New York, NY 10022.
Privacy Principles
We are committed to maintaining the privacy of our stockholders and to safeguarding their non-public personal information. The following information is provided to help you understand what personal information we may have access to, how we protect that information and why, in certain cases, we may share such information with select other parties.
Generally, we do not receive any non-public personal information relating to our stockholders, although certain non-public personal information of our stockholders may become available to us. We do not disclose any non-public personal information about our stockholders or former stockholders to anyone, except as permitted by law or as is necessary in order to service stockholder accounts (for example, through a transfer agent or proxy solicitor).
We restrict access to non-public personal information about our stockholders to employees of our investment adviser and its affiliates with a legitimate business need for the information. We maintain physical, electronic and procedural safeguards designed to protect the non-public personal information of our stockholders.
Taxation as a Regulated Investment Company
As a BDC, we elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, we generally will not have to pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that we timely distribute to our stockholders as dividends. To continue to qualify as a RIC, we must, among other things, meet certain source-of-income and asset diversification requirements (as described below). In addition, to qualify for RIC tax treatment we must distribute to our stockholders, for each taxable year, at least 90% of our investment company taxable income, which generally is our ordinary income
20
plus the excess of our realized net short-term capital gains over our realized net long-term capital losses (the Annual Distribution Requirement). If we qualify as a RIC and satisfy the Annual Distribution Requirement, then we will not be subject to U.S. federal income tax on the portion of our investment company taxable income and net capital gain (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) we distribute (or are deemed to distribute) to stockholders. We will be subject to U.S. federal income tax at the regular corporate rates on any ordinary income or capital gain not distributed (or deemed not distributed) to our stockholders.
We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the one-year period ending October 31 in that calendar year and (3) any ordinary income and net capital gains that we recognized in preceding years, but were not distributed during such years, and on which we paid no U.S. federal income tax (the Excise Tax Avoidance Requirement).
In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:
| at all times during each taxable year, have in effect an election to be treated as a BDC under the 1940 Act; |
| derive in each taxable year at least 90% of our gross income from (a) dividends, interest, payments with respect to certain securities loans, gains from the sale of stock or other securities or currencies, or other income derived with respect to our business of investing in such stock, securities or currencies and (b) net income derived from an interest in a qualified publicly traded partnership; and |
| diversify our holdings so that at the end of each quarter of the taxable year: |
| at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and |
| no more than 25% of the value of our assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer, (ii) the securities of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of one or more qualified publicly traded partnerships. |
We may be required to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount (such as debt instruments with payment-in-kind (PIK) interest or, in certain cases, increasing interest rates or debt instruments issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. Because any original issue discount accrued will be included in our investment company taxable income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual Distribution Requirement, even though we will not have received any corresponding cash amount.
Because we may use debt financing, we will be subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources or are otherwise limited in our ability to make distributions, we could fail to qualify for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax.
21
Certain of our investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause us to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% gross income test described above. We will monitor our transactions and may make certain tax elections in order to mitigate the potential adverse effect of these provisions.
Gain or loss realized by us from the sale or exchange of warrants acquired by us as well as any loss attributable to the lapse of such warrants generally will be treated as capital gain or loss. The treatment of such gain or loss as long-term or short-term will depend on how long we held a particular warrant. Upon the exercise of a warrant acquired by us, our tax basis in the stock purchased under the warrant will equal the sum of the amount paid for the warrant plus the strike price paid on the exercise of the warrant.
Failure to Qualify as a Regulated Investment Company
If we were unable to qualify for treatment as a RIC, we would be subject to U.S. federal income tax on all of our taxable income at regular corporate rates. We would not be able to deduct distributions to stockholders, nor would they be required to be made. Such distributions would be taxable to our stockholders as dividends and, provided certain holding period and other requirements were met, could qualify for treatment as qualified dividend income in the hands of non-corporate stockholders (and thus eligible for the current 20% maximum rate) to the extent of our current and accumulated earnings and profits. Subject to certain limitations under the Code, corporate distributees would be eligible for the dividends received deduction. Distributions in excess of our current and accumulated earnings and profits would be treated first as a return of capital to the extent of the stockholders tax basis, and any remaining distributions would be treated as a capital gain. To requalify as a RIC in a subsequent taxable year, we would be required to satisfy the RIC qualification requirements for that year and dispose of any earnings and profits from any year in which we failed to qualify as a RIC. Subject to a limited exception applicable to RICs that qualified as such under Subchapter M of the Code for at least one year prior to disqualification and that requalify as a RIC no later than the second year following the non-qualifying year, we could be subject to tax on any unrealized net built-in gains in the assets held by us during the period in which we failed to qualify as a RIC that are recognized within the subsequent 5 years, unless we made a special election to pay corporate-level U.S. federal income tax on such built-in gain at the time of our requalification as a RIC.
Investment Advisory Fees
Pursuant to the Investment Advisory and Management Agreement, we have agreed to pay SLR Capital Partners a fee for investment advisory and management services consisting of two componentsa base management fee and a performance-based incentive fee.
The base management fee is calculated at an annual rate of 1.00% of our gross assets. For services rendered under the Investment Advisory and Management Agreement, the base management fee is payable quarterly in arrears. The base management fee is calculated based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Base management fees for any partial month or quarter will be appropriately pro-rated. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the immediately preceding calendar quarter. For
22
this purpose, pre-incentive fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement to SLR Capital Management, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). Pre-incentive fee net investment income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay in kind interest and zero coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains, computed net of all realized capital losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle of 1.75% per quarter (7.00% annualized). Our net investment income used to calculate this part of the performance-based incentive fee is also included in the amount of our gross assets used to calculate the 1.00% base management fee. We pay SLR Capital Partners a performance-based incentive fee with respect to our pre-incentive fee net investment income in each calendar quarter as follows:
| no performance-based incentive fee in any calendar quarter in which our pre-incentive fee net investment income does not exceed the hurdle of 1.75%; |
| 50% of our pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle but is less than 2.9167% in any calendar quarter (11.67% annualized). We refer to this portion of our pre-incentive fee net investment income (which exceeds the hurdle but is less than 2.9167%) as the catch-up. The catch-up is meant to provide our investment adviser with 20% of our pre-incentive fee net investment income as if a hurdle did not apply if this net investment income exceeds 2.9167% in any calendar quarter; and |
| 20% of the amount of our pre-incentive fee net investment income, if any, that exceeds 2.9167% in any calendar quarter (11.67% annualized) is payable to SLR Capital Partners (once the hurdle is reached and the catch-up is achieved, 20% of all pre-incentive fee investment income thereafter is allocated to SLR Capital Partners). |
The following is a graphical representation of the calculation of the income-related portion of the incentive fee:
Pre-incentive fee net investment income
(expressed as a percentage of the value of net assets)
Percentage of pre-incentive fee net investment income
allocated to SLR Capital Partners
These calculations are appropriately pro-rated for any period of less than three months. You should be aware that a rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our investment adviser with respect to pre-incentive fee net investment income.
The second part of the incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date), and
23
equals 20% of our realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees with respect to each of the investments in our portfolio.
Examples of Quarterly Incentive Fee Calculation
Example 1: Income Related Portion of Incentive Fee (*):
Alternative 1:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 1.25%
Hurdle rate (1) = 1.75%
Management fee (2) = 0.25%
Other expenses (legal, accounting, custodian, transfer agent, etc.) (3) = 0.20%
Pre-incentive fee net investment income
(investment income (management fee + other expenses)) = 0.80%
Pre-incentive net investment income does not exceed hurdle rate, therefore there is no incentive fee.
Alternative 2:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 2.70%
Hurdle rate (1) = 1.75%
Management fee (2) = 0.25%
Other expenses (legal, accounting, custodian, transfer agent, etc.) (3) = 0.20%
Pre-incentive fee net investment income
(investment income (management fee + other expenses)) = 2.25%
Incentive fee = 50% × pre-incentive fee net investment income, subject to the catch-up (4)
= 50% × (2.25% 1.75%)
= 0.25%
Alternative 3:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 4.00%
Hurdle rate (1) = 1.75%
Management fee (2) = 0.25%
Other expenses (legal, accounting, custodian, transfer agent, etc.) (3) = 0.20%
Pre-incentive fee net investment income
(investment income (management fee + other expenses)) = 3.55%
Incentive fee = 20% × pre-incentive fee net investment income, subject to catch-up (4)
Incentive fee = 50% × catch-up + (20% × (pre-incentive fee net investment income 2.9167%))
Catch-up = 2.9167% 1.75%
= 1.1667%
Incentive fee = (50% × 1.1667%) + (20% × (3.55% 2.9167%))
= 0.58334% + (20% × 0.6333%)
= 0.58334% + 0.12667%
= 0.71001%
(*) | The hypothetical amount of pre-incentive fee net investment income shown is based on a percentage of total net assets. |
24
(1) | Represents 7% annualized hurdle rate. |
(2) | Represents 1% annualized management fee. |
(3) | Excludes organizational and offering expenses. |
(4) | The catch-up provision is intended to provide our investment adviser with an incentive fee of approximately 20% on all of our pre-incentive fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.9167% in any calendar quarter. |
Example 2: Capital Gains Portion of Incentive Fee:
Alternative 1:
Assumptions
| Year 1: $20 million investment made in Company A (Investment A), and $30 million investment made in Company B (Investment B) |
| Year 2: Investment A sold for $50 million and fair market value (FMV) of Investment B determined to be $32 million |
| Year 3: FMV of Investment B determined to be $25 million |
| Year 4: Investment B sold for $31 million |
The capital gains portion of the incentive fee would be:
| Year 1: None |
| Year 2: Capital gains incentive fee of $6 million ($30 million realized capital gains on sale of Investment A multiplied by 20%) |
| Year 3: None |
$5 million cumulative fee (20% multiplied by $25 million ($30 million cumulative capital gains less $5 million cumulative capital depreciation)) less $6 million (previous capital gains fee paid in Year 2)
| Year 4: Capital gains incentive fee of $200,000 |
$6.2 million cumulative fee ($31 million cumulative realized capital gains multiplied by 20%) less $6 million (previous capital gains fee paid in Year 2)
Alternative 2:
Assumptions
| Year 1: $20 million investment made in Company A (Investment A), $30 million investment made in Company B (Investment B) and $25 million investment made in Company C (Investment C) |
| Year 2: Investment A sold for $50 million, FMV of Investment B determined to be $25 million and FMV of Investment C determined to be $25 million |
| Year 3: FMV of Investment B determined to be $27 million and Investment C sold for $30 million |
| Year 4: FMV of Investment B determined to be $24 million |
| Year 5: Investment B sold for $20 million |
The capital gains incentive fee, if any, would be:
| Year 1: None |
| Year 2: $5 million capital gains incentive fee |
25
20% multiplied by $25 million ($30 million realized capital gains on sale of Investment A less $5 million unrealized capital depreciation on Investment B)
| Year 3: $1.4 million capital gains incentive fee(1) |
$6.4 million cumulative fee (20% multiplied by $32 million ($35 million cumulative realized capital gains less $3 million unrealized capital depreciation)) less $5 million (previous capital gains fee paid in Year 2)
| Year 4: None |
| Year 5: None |
$5 million cumulative fee (20% multiplied by $25 million (cumulative realized capital gains of $35 million less realized capital losses of $10 million)) less $6.4 million (previous cumulative capital gains fee paid in Year 2 and Year 3)
(1) | As illustrated in Year 3 of Alternative 1 above, if SLR Senior were to be wound up on a date other than December 31 of any year, SLR Senior may have paid aggregate capital gain incentive fees that are more than the amount of such fees that would be payable if SLR Senior had been wound up on December 31 of such year. |
Payment of Our Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by SLR Capital Partners. We bear all other costs and expenses of our operations and transactions, including (without limitation):
| the cost of our organization and this offering; |
| the cost of calculating our net asset value, including the cost of any third-party valuation services; |
| the cost of effecting sales and repurchases of our shares and other securities; |
| interest payable on debt, if any, to finance our investments; |
| fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees; |
| transfer agent and custodial fees; |
| fees and expenses associated with marketing efforts; |
| federal and state registration fees, any stock exchange listing fees; |
| federal, state and local taxes; |
| independent directors fees and expenses; |
| brokerage commissions; |
| fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums; |
| direct costs and expenses of administration, including printing, mailing, long distance telephone and staff; |
| fees and expenses associated with independent audits and outside legal costs; |
| costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and |
26
| all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of the Companys chief compliance officer and chief financial officer and their respective staffs. |
Available Information
The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is http://www.sec.gov.
Our internet address is www.slrseniorinvestmentcorp.com. We make available free of charge on our website our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not incorporated by reference into this annual report on Form 10-K, and you should not consider information contained on our website to be part of this annual report on Form 10-K.
27
Item 1A. | Risk Factors |
Before you invest in our securities, you should be aware of various risks, including those described below. You should carefully consider these risk factors, together with all of the other information included in this annual report on Form 10-K, before you decide whether to make an investment in our securities. The risks described in this document and set out below are not the only risks we face. If any of the following events occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our net asset value and the trading price of our common stock could decline or the value of our preferred stock, debt securities, subscription rights, or warrants may decline, and you may lose all or part of your investment. Please refer also to those risk factors relating to our proposed merger with SLR Investment Corp. included under the caption Risk FactorsRisks Relating to the Mergers in pre-effective amendment no.1 to SLR Investment Corp.s registration statement on Form N-14 (333-261675) filed with the SEC on January 31, 2022, which are incorporated herein by reference.
SUMMARY RISK FACTORS
Risks Relating to Our Investments
| We operate in a highly competitive market for investment opportunities. |
| Our investments are very risky and highly speculative. |
| The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives. |
| Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry. |
| Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies. |
| If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely. |
| We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient. |
| Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity. |
| We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest. |
Risks Relating to an Investment in Our Securities
| Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term. |
| Our common stock price may be volatile and may decrease substantially. |
| Our business and operation could be negatively affected if we become subject to any securities litigation or shareholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price. |
| If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with |
28
historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital. |
| Due to the COVID-19 pandemic or other disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order preserve cash and maintain flexibility. |
| We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive. |
| Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock. |
| The net asset value per share of our common stock may be diluted if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock. |
| To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income. |
Risks Relating to Our Business and Structure
| We are dependent upon SLR Capital Partners key personnel for our future success. |
| Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business. |
| Our financial condition and results of operations will depend on SLR Capital Partners ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria. |
| We may need to raise additional capital to grow because we must distribute most of our income. |
| Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC. |
| Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage. |
| We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us. |
| It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business. |
| There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value. |
| There are significant potential conflicts of interest, including SLR Capital Partners management of other investment funds such as SLR Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC, which could impact our investment returns, and an investment in SLR Senior Investment Corp. is not an investment in SLR Investment Corp., SCP Private Credit Income BDC LLC, or SLR HC BDC LLC. |
| We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss. |
| Our incentive fee may induce SLR Capital Partners to pursue speculative investments. |
29
| We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code. |
| The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively. |
| Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results. |
| Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any. |
RISK FACTORS (CONTINUED)
Risks Relating to Our Investments
We operate in a highly competitive market for investment opportunities.
A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.
Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors pricing, terms and structure. However, if we match our competitors pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss.
Our investments are very risky and highly speculative.
We invest primarily in senior loans, including first lien and second lien debt instruments, made to private middle-market companies whose debt is rated below investment grade, which we refer to collectively as senior loans.
30
We may also invest in debt of public companies that are thinly traded or equity securities. Securities rated below investment grade are speculative and are often referred to as leveraged loans, high yield or junk securities, and may be considered high risk compared to debt instruments that are rated investment grade.
Senior Secured Loans. When we make a senior secured term loan investment, including a first lien or second lien debt investment, in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio companys financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loans terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies.
Equity Investments. When we invest in senior secured loans we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans, such as our investments in SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
In addition, investing in middle-market companies involves a number of significant risks, including:
| these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment; |
| they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors actions and market conditions, as well as general economic downturns; |
| they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us; |
| they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and |
| they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity. |
31
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we have material non-public information regarding such portfolio company.
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2021, our investments in SLR Business Credit and SLR Healthcare ABL comprised 14.0% and 6.3%, respectively, of our total assets and our investments in diversified financial services (which includes SLR Business Credit and SLR Healthcare ABL) and health care providers & services industries comprised 20.2% and 11.4%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.
Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates.
The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as leveraged loans, high yield or junk securities, and may be considered high risk compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuers capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable
32
to payoff its debt due to bankruptcy or other reasons and therefore we may write-off such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings.
As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio companys inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations.
There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
As a result of the November 2020 elections in the United States, the Democratic Party gained control of both the Presidency and the Senate from the Republican Party. Therefore, changes in federal policy, including tax policies, and at regulatory agencies are expected to occur over time through policy and personnel changes, which may lead to changes involving the level of oversight and focus on the financial services industry or the tax rates paid by corporate entities. The nature, timing and economic and political effects of potential changes to the current legal and regulatory framework affecting financial institutions remain highly uncertain. Uncertainty surrounding future changes may adversely affect our operating environment and therefore our business, financial condition, results of operations and growth prospects.
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasurys Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of services to, certain non-U.S. countries, territories, entities and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties.
The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an
33
issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations.
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all.
If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies.
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default and, as a result, the value of the collateral may be reduced by acts or omissions by owners or managers of the assets.
In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through standstill periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses.
If the value of collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or increasing interest rates may hinder a portfolio companys ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance.
34
The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business.
The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that the COVID-19 pandemic has imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could have non-performing assets or an increase in non-performing assets, and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations.
Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including the global COVID-19 pandemic), political unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses.
Our failure to make follow-on investments in our portfolio companies could impair the value of our portfolio.
Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as follow-on investments, in order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not to make follow-on investments or otherwise lack sufficient funds to make those investments. We will have the discretion to make any follow-on investments, subject to the availability of capital resources. The failure to make follow-on investments may, in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make a desired follow-on investment, we may elect not to make a follow-on investment because we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would prevent such follow-on investments or the desire to maintain our RIC tax treatment.
Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments.
Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that
35
a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock.
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the companys business and its financial condition. However, from time to time, we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment.
In addition, some of the loans in which we may invest may be covenant-lite loans. We use the term covenant-lite loans to refer generally to loans that do not have a complete set of financial maintenance covenants. Generally, covenant-lite loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrowers financial condition. Accordingly, to the extent we invest in covenant-lite loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans.
Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were
36
deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan on a pro-rata basis with other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio companys common equity only after all of its obligations relating to its debt and preferred securities had been satisfied.
An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns.
We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.
Our portfolio companies may incur debt that ranks equally with, or senior to, some of our investments in such companies.
We invest primarily in senior secured loans, including second lien, as well as unsecured debt instruments issued by our portfolio companies. If we invest in second lien, or unsecured debt instruments, our portfolio companies typically may be permitted to incur other debt that ranks equally with, or senior to, such debt instruments. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation.
Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments.
Our investment strategy contemplates potential investments in debt securities of foreign companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed.
37
Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective.
We may expose ourselves to risks if we engage in hedging transactions.
If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.
The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in non-U.S. currencies because the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.
Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions.
Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus.
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK
38
securities are debt obligations that pay interest in the form of other debt obligations, instead of in cash. Each of these instruments is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest.
To the extent the Company invests in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of such non-cash income in taxable and accounting income prior to receipt of cash, including the following:
| The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan; |
| The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments; |
| PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral; |
| An election to defer PIK income payments by adding them to principal increases the Companys gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be payable on a larger principal amount, the PIK election also increases the Investment Advisers future income incentive fees at a compounding rate; |
| Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash; |
| The deferral of interest on a PIK loan increases its loan-to-value ratio, which is a measure of the riskiness of a loan; and |
| Original issue discount creates the risk of non-refundable cash payments to the Investment Adviser based on non-cash accruals that may never be realized. |
Risks Relating to an Investment in Our Securities
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. At our 2021 Annual Stockholders Meeting, our stockholders approved our ability to sell or otherwise issue shares of our common stock, not exceeding 25% of our then outstanding common stock immediately prior to each such offering, at a price or prices below the then current net asset value per share, in each case subject to the approval of our board of directors and compliance with the conditions set forth in the proxy statement pertaining thereto, during a period beginning on October 27, 2021 and expiring on the earlier of the one-year anniversary of the date of the 2021 Annual Stockholders Meeting and the date of our 2022 Annual Stockholders Meeting. However, notwithstanding such stockholder approval, since our initial public offering on February 24, 2011, we have not sold any shares of our common stock in an offering that resulted in proceeds to us of less than our then current net asset value per share. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted.
39
Our common stock price may be volatile and may decrease substantially.
The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following:
| price and volume fluctuations in the overall stock market from time to time; |
| investor demand for our shares; |
| significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies; |
| exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock; |
| changes in regulatory policies or tax guidelines with respect to RICs or BDCs; |
| failure to qualify as a RIC, or the loss of RIC tax treatment; |
| any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts; |
| changes, or perceived changes, in the value of our portfolio investments; |
| departures of SLR Capital Partners key personnel; |
| operating performance of companies comparable to us; |
| changes in the prevailing interest rates; |
| loss of a major funding source; or |
| general economic conditions and trends and other external factors. |
Our businesses may be adversely affected by litigation and regulatory proceedings.
From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or shareholder activism in connection with such acquisitions or investments. Securities litigation and shareholder activism, including potential proxy contests, could result in substantial costs and divert managements and our board of directors attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible.
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
We intend to make distributions on a monthly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified
40
level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report or incorporated herein by reference, including the COVID-19 pandemic described above. For example, if the temporary closure of many corporate offices, retail stores, and manufacturing facilities and factories in the jurisdictions, including the United States, affected by the COVID-19 pandemic were to continue for an extended period of time, it could result in reduced cash flows to us from our existing portfolio companies, which could reduce cash available for distribution to our stockholders. If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholders investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholders basis in our common stock and may therefore increase such stockholders tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price.
As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences, including possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all.
In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements.
Due to the COVID-19 pandemic or other disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order preserve cash and maintain flexibility.
In order to maintain our tax treatment as a RIC, we must distribute to shareholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to shareholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of capital losses for the one-year period ending on October 31 of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains.
Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to shareholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as spillover dividends, that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer
41
distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2022 until as late as December 31, 2023. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.
Due to the COVID-19 pandemic or other disruptions in the economy, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under We may choose to pay distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may distribute taxable distributions that are payable in cash or shares of our common stock at the election of each stockholder. Under certain applicable provisions of the Code and the published guidance, distributions payable of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder, electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock. Furthermore, with respect to non-U.S. stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock.
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
The 500,000 shares that were originally issued to Solar Senior Capital Investors LLC in the Concurrent Private Placement pursuant to the exemption from registration provided by Section 4(2) under the Securities Act were subject to a 180 day lock-up period. Upon expiration of this lock-up period, such shares became generally freely tradable in the public market, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
42
We have also committed to file a registration statement to register the resale of the shares of common stock that were issued in the Concurrent Private Placement to Solar Senior Capital Investors LLC within 60 days of receiving a request from Solar Senior Capital Investors LLC to do so. We have committed to use our commercially reasonable efforts to obtain effectiveness of such registration statement as soon as reasonably practicable after the filing of such registration statement. Assuming effectiveness of such registration statement, Solar Senior Capital Investors LLC will generally be able to resell its shares of common stock without restriction.
We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree.
We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations.
We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering.
The net asset value per share of our common stock may be diluted if we sell shares of our common stock in one or more offerings at prices below the then current net asset value per share of our common stock.
At our 2021 Annual Stockholders Meeting, our stockholders approved our ability to sell or otherwise issue shares of our common stock, not exceeding 25% of our then outstanding common stock immediately prior to each such offering, at a price or prices below the then current net asset value per share, in each case subject to the approval of our board of directors and compliance with the conditions set forth in the proxy statement pertaining thereto, during a period beginning on October 27, 2021 and expiring on the earlier of the one-year anniversary of the date of the 2021 Annual Stockholders Meeting and the date of our 2022 Annual Stockholders Meeting. However, notwithstanding such stockholder approval, since our initial public offering on February 24, 2011, we have not sold any shares of our common stock in an offering that resulted in proceeds to us of less than our then current net asset value per share. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval.
We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. To the extent we receive the necessary approval, any decision to sell shares of our common stock below its then current net asset value per share would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders best interests.
If we were to sell shares of our common stock below its then current net asset value per share, such sales would result in an immediate dilution to the net asset value per share of our common stock. This dilution would occur as a result of the sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.
43
Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
If we issue preferred stock, the net asset value and market value of our common stock may become more volatile.
We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs.
Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners.
Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights, voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock.
Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event
44
distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion to open-end status, and accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements.
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, our cost of funds would increase, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt. We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act.
You should also be aware that a rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our pre-incentive fee net investment income.
Further, rising interest rates could also adversely affect our performance if we hold investments with floating interest rates, subject to specified minimum interest rates (such as a LIBOR floor), while at the same time engaging in borrowings subject to floating interest rates not subject to such minimums. In such a scenario, rising interest rates may increase our interest expense, even though our interest income from Investments is not increasing in a corresponding manner as a result of such minimum interest rates.
We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings.
Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference.
Risks Relating to Our Business and Structure
We are dependent upon SLR Capital Partners key personnel for our future success.
We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the
45
diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser.
The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Senior Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross serves as Co-Chief Executive Officer and President of SLR Senior Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC. In addition, Mr. Spohler serves as Co-Chief Executive Officer and Chief Operating Officer of SLR Senior Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC.
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio.
A disruption in the capital markets and the credit markets could negatively affect our business.
As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.
If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally.
46
If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities, and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
Our financial condition and results of operations will depend on SLR Capital Partners ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
Our ability to achieve our investment objective and to grow depends on SLR Capital Partners ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Investment Advisory and Management Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SLR Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations.
We may need to raise additional capital to grow because we must distribute most of our income.
We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock.
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the
47
1940 Act as a closed-end investment company. Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations.
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as senior securities, up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness.
As of December 31, 2021, we had $76.5 million outstanding under our senior secured revolving credit facility (the Credit Facility) and $85.0 million outstanding on our senior unsecured notes due 2025 (the 2025 Unsecured Notes). If we issue preferred stock, the preferred stock would rank senior to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest.
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Senior Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholders interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value.
48
At our 2021 Annual Stockholders Meeting, our stockholders approved our ability to sell or otherwise issue shares of our common stock, not exceeding 25% of our then outstanding common stock immediately prior to each such offering, at a price or prices below the then current net asset value per share, in each case subject to the approval of our board of directors and compliance with the conditions set forth in the proxy statement pertaining thereto, during a period beginning on October 27, 2021 and expiring on the earlier of the one-year anniversary of the date of the 2021 Annual Stockholders Meeting and the date of our 2022 Annual Stockholders Meeting. However, notwithstanding such stockholder approval, since our initial public offering on February 24, 2011, we have not sold any shares of our common stock in an offering that resulted in proceeds to us of less than our then current net asset value per share. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval.
Our credit ratings may not reflect all risks of an investment in our debt securities.
Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities.
Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance.
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2021, we had $76.5 outstanding under the Credit Facility and $85.0 million outstanding on our 2025 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the FLLP Facility, and the 2025 Unsecured Notes will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners.
49
As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. Some of our wholly and/or substantially owned portfolio companies, including SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate SLR Business Credit and SLR Healthcare ABL and their leverage is non-recourse to us. Additionally, our credit facilities require us to comply with certain financial and other restrictive covenants, including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Advisers and our board of directors assessment of market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.
In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code.
The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock.
Illustration. The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
Assumed total return (net of interest expense) |
||||||||||||||||||||
(10)% | (5)% | 0% | 5% | 10% | ||||||||||||||||
Corresponding return to stockholder(1) |
(25.3 | )% | (13.8 | )% | (2.2 | )% | 9.4 | % | 20.9 | % |
(1) | Assumes $572.9 million in total assets and $161.5 million in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2021, and a cost of funds of 3.36%. Excludes non-leverage related expenses. |
In order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2021, we must achieve annual returns on our December 31, 2021 total assets of at least 0.9%.
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings.
50
Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment.
The terms of future available financing may place limits on our financial and operation flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures.
Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline.
We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline.
Our investments may be in portfolio companies that may have limited operating histories and financial resources.
We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that began in mid-2007, the European financial crisis, and the COVID-19 related economic downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies. We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies.
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with U.S. generally accepted accounting principles (GAAP). Our board of directors utilizes the services of third-party
51
valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio companys ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.
Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment.
If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public companys stock, inside information on a companys performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment.
There are significant potential conflicts of interest, including SLR Capital Partners management of other investment funds such as SLR Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC, which could impact our investment returns, and an investment in SLR Senior Investment Corp. is not an investment in SLR Investment Corp., SCP Private Credit Income BDC LLC, or SLR HC BDC LLC.
Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners, presently serves as the Investment Adviser to (i) SLR Investment Corp., a publicly-traded BDC whose principal focus is to invest in senior secured loans, and to a lesser extent unsecured loans and equity securities, (ii) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including non-traditional asset-based loans and first lien loans, and (iii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry. In addition, Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer and board member, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SLR Investment Corp., SCP Private Credit Income BDC LLC, and SLR HC BDC LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future, and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment.
52
As a BDC, we were substantially limited in our ability to co-invest in privately negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the Exemptive Order), permits us to participate in negotiated co-investment transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entitys investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners allocation procedures. Related party transactions may occur among SLR Senior Investment Corp., SLR Business Credit and SLR Healthcare ABL. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Business Credit and SLR Healthcare ABL.
In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a gross basis and receive distributions on a net basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict.
We have entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted us a non-exclusive license to use the marks SOLAR and SLR. Under the license agreement, we have the right to use the SLR Senior Investment name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor.
Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.
Through comprehensive new global regulatory regimes impacting derivatives (e.g., the Dodd-Frank Act, European Market Infrastructure Regulation (EMIR), Markets in Financial Investments Regulation (MIFIR)/Markets in Financial Instruments Directive (MIFID II)), certain over-the-counter derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms, pre-and post-trade transparency reporting requirements and mandatory bi-lateral exchange of initial margin for non-cleared swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as swap dealers, security-based swap dealers, major swap participants, and major security-based
53
swap participants who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if the Company itself is not located in a particular jurisdiction or directly subject to the jurisdictions derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdictions derivatives regulations.
Based on information available as of the date of this annual report on Form 10-K, the effect of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs, increased overall transaction costs, and significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us.
In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject to a value-at-risk leverage limit, certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a limited derivatives user, as defined in the SECs adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess of our pre-incentive fee net investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance threshold. Our pre-incentive fee net investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter. Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.
54
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.
The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In addition, the catch-up portion of the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment companys expenses, including management and performance fees. We will also remain obligated to pay management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest.
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements.
| The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S. federal income tax. |
| The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities or similar sources. |
55
| The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be in private companies, and therefore will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses. |
If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock.
We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income.
In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loans term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of the following: end-of-term payments, exit fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash.
Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in original issue discount for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements.
Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income.
Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock.
The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Senior Investment Corp. or the removal of our directors.
56
We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the Control Share Act) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests.
We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and , to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholders shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders.
Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland Rule 16-308 or any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the Exchange Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
57
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the Exchange Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
The occurrence of a disaster, such as a cyber-attack against us or against a third-party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data.
We depend heavily upon computer systems to perform necessary business functions. Despite our implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical and electronic break-ins or unauthorized tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems we have implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Advisers operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.
A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all.
58
Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above.
In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage.
We and our service providers are currently impacted by quarantines and similar measures being enacted by governments in response to the global COVID-19 pandemic, which are obstructing the regular functioning of business workforces (including requiring employees to work from external locations and their homes). Policies of extended periods of remote working, whether by us or by our Service Providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts that seek to exploit the COVID-19 pandemic. Accordingly, the risks described above are heightened under current conditions.
We, our Investment Adviser and our portfolio companies are subject to risks associated with phishing and other cyber-attacks.
Our business and the business of our portfolio companies relies upon secure information technology systems for data processing, storage and reporting. Despite careful security and controls design, implementation and updating, ours and our portfolio companies information technology systems could become subject to cyber-attacks. Cyber-attacks include, but are not limited to, gaining unauthorized access to digital systems (e.g., through hacking, malicious software coding, social engineering or phishing attempts) for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusions, including by computer hackers, nation-state affiliated actors, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. Cyber-attacks may also be carried out in a manner that does not require gaining unauthorized access, such as causing denial-of service attacks on websites (i.e., efforts to make network services unavailable to intended users). Our Investment Advisers employees have been and expect to continue to be the target of fraudulent calls, emails and other forms of potentially malicious or otherwise negatively impacting activities. The result of these incidents may include disrupted operations, misstated or unreliable financial data, liability for stolen information, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. In addition, we may be required to expend significant additional resources to modify our protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks.
Our Investment Advisers and other service providers increased use of mobile and cloud technologies could heighten the risk of a cyber-attack as well as other operational risks, as certain aspects of the security of such technologies may be complex, unpredictable or beyond their control. Our Investment Advisers and other service providers reliance on mobile or cloud technology or any failure by mobile technology and cloud service providers to adequately safeguard their systems and prevent cyber-attacks could disrupt their operations and result in misappropriation, corruption or loss of personal, confidential or proprietary information. In addition, there is a risk that encryption and other protective measures against cyber-attacks may be circumvented,
59
particularly to the extent that new computing technologies increase the speed and computing power available. Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. Accordingly, we and our service providers may be unable to anticipate these techniques or to implement adequate security barriers or other preventative measures, and thus it is impossible for us and our service providers to entirely mitigate this risk. Cybersecurity risks require continuous and increasing attention and other resources from us to, among other actions, identify and quantify these risks, upgrade and expand our technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that our efforts will be effective.
Additionally, remote working environments may be less secure and more susceptible to cyber-attacks, including phishing and social engineering attempts that seek to exploit the COVID-19 pandemic. Accordingly, the risks associated with cyber-attacks are heightened under current conditions.
We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions.
Our business is highly dependent on our and third parties communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business. There could be:
| sudden electrical or telecommunications outages; |
| natural disasters such as earthquakes, tornadoes and hurricanes; |
| events arising from local or larger scale political or social matters, including terrorist acts; and |
| cyber-attacks. |
These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders.
Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval.
Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional
60
regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of managements time from other business activities.
Changes in laws or regulations governing our operations may adversely affect our business.
Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs, RICs or non-depository commercial lenders could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition.
Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.
Our Investment Adviser can resign on 60 days notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.
Our Investment Adviser has the right, under the Investment Advisory and Management Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar expertise and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the expertise possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.
General Risk Factors
Volatility or a prolonged disruption in the credit markets could materially damage our business.
We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse
61
effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. At our 2021 Annual Stockholders Meeting, our stockholders approved our ability to sell or otherwise issue shares of our common stock, not exceeding 25% of our then outstanding common stock immediately prior to each such offering, at a price or prices below the then current net asset value per share, in each case subject to the approval of our board of directors and compliance with the conditions set forth in the proxy statement pertaining thereto, during a period beginning on October 27, 2021 and expiring on the earlier of the one-year anniversary of the date of the 2021 Annual Stockholders Meeting and the date of our 2022 Annual Stockholders Meeting. However, notwithstanding such stockholder approval, since our initial public offering on February 24, 2011, we have not sold any shares of our common stock in an offering that resulted in proceeds to us of less than our then current net asset value per share. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations.
Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments.
The significant disruption in the capital markets experienced in the past, including the disruption caused by the COVID-19 pandemic, has had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations.
Adverse developments in the credit markets may impair our ability to secure debt financing.
In past economic downturns, such as the financial crisis in the United States that began in mid-2007 and during other times of extreme market volatility, many commercial banks and other financial institutions stopped lending or significantly curtailed their lending activity. In addition, in an effort to stem losses and reduce their exposure to segments of the economy deemed to be high risk, some financial institutions limited routine refinancing and loan modification transactions and even reviewed the terms of existing facilities to identify bases for accelerating the maturity of existing lending facilities. If these conditions recur, for example as a result of the COVID-19
62
pandemic, it may be difficult for us to obtain desired financing to finance the growth of our investments on acceptable economic terms, or at all.
So far, the COVID-19 pandemic has resulted in among other things, increased draws by borrowers on revolving lines of credit and increased requests by borrowers for amendments, modifications and waivers of their credit agreements to avoid default or change payment terms, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans. In addition, the duration and effectiveness of responsive measures implemented by governments and central banks cannot be predicted. The commencement, continuation, or cessation of government and central bank policies and economic stimulus programs, including changes in monetary policy involving interest rate adjustments or governmental policies, may contribute to the development of or result in an increase in market volatility, illiquidity and other adverse effects that could negatively impact the credit markets and the Company.
If we are unable to consummate credit facilities on commercially reasonable terms, our liquidity may be reduced significantly. If we are unable to repay amounts outstanding under any facility we may enter into and are declared in default or are unable to renew or refinance any such facility, it would limit our ability to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility of the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.
We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term.
The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties.
Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion of the non-bank financial sector will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased regulation of non-bank credit extension could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations.
Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them.
In 2010, a financial crisis emerged in Europe, triggered by high budget deficits and rising direct and contingent sovereign debt, which created concerns about the ability of certain nations to continue to service their sovereign
63
debt obligations. Risks resulting from such debt crisis, including any austerity measures taken in exchange for bailout of certain nations, and any future debt crisis in Europe or any similar crisis elsewhere could have a detrimental impact on the global economic recovery, sovereign and non-sovereign debt in certain countries and the financial condition of financial institutions generally. In addition on January 31, 2020, the United Kingdom (UK) ended its membership in the European Union (EU) referred to as Brexit (Brexit). Following the termination of a transition period, the UK and the EU entered into a trade and cooperation agreement to govern the future relationship between the parties, which was provisionally applied as of January 1, 2021 and entered into force on May 1, 2021 following ratification by the EU. With respect to financial services, the agreement leaves decisions on equivalence and adequacy to be determined by each of the U.K. and EU unilaterally in due course. As a result, certain UK licensed entities are unable to provide regulated services in a number of EU jurisdictions from the end of December 2020, absent regulatory relief or other measures implemented by individual countries. Such agreement is untested and may lead to ongoing political and economic uncertainty and periods of exacerbated volatility in both the United Kingdom and in wider European and global markets for some time. The longer term economic, legal, political and social implications of Brexit are unclear at this stage. Brexit has led to ongoing political and economic uncertainty and periods of increased volatility in both the UK and in wider European markets for some time. Brexit could lead to calls for similar referendums in other European jurisdictions, which could cause increased economic volatility in the European and global markets. This mid- to long-term uncertainty could have adverse effects on the economy generally and on our ability to earn attractive returns. In particular, currency volatility could mean that our returns are adversely affected by market movements and could make it more difficult, or more expensive, for us to execute prudent currency hedging policies. Potential decline in the value of the British Pound and/or the Euro against other currencies, along with the potential further downgrading of the UKs sovereign credit rating, could also have an impact on the performance of certain investments made in the UK or Europe. Events such as war, terrorism and related geopolitical risks have led, and may in the future lead, to increased short-term market volatility and may have adverse long-term effects on U.S. and world economies and markets generally. Those events could also have an acute effect on individual issuers or related groups of issuers. These risks could also adversely affect individual issuers and securities markets, interest rates, auctions, secondary trading, ratings, credit risk, inflation, deflation and other factors relating to the Companys investments.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, escalating military conflict between Russia and Ukraine, and the COVID-19 pandemic, could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies.
Additionally, the Federal Reserve may raise, or may announce its intention to raise, the Federal Funds Rate in 2022. These developments, along with the United States governments credit and deficit concerns, global economic uncertainties and market volatility and the impacts of COVID-19, could cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms.
Events outside of our control, including the COVID-19 public health crises, could negatively affect our portfolio companies and our results of our operations.
Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the COVID-19 pandemic has delivered a shock to the global economy throughout much of 2020 and 2021. This outbreak has led and for an unknown period of time will continue to lead to disruptions in local, regional, national and global markets and economies affected thereby, including a recession and a steep increase in unemployment in the United States.
64
With respect to the U.S. credit markets (in particular for middle market loans), this outbreak has resulted in, and until fully resolved may continue to result in, the following among other things: (i) government imposition of various forms of shelter-in-place orders and the closing of non-essential businesses, resulting in significant disruption to the businesses of many middle-market loan borrowers including supply chain interruptions, increased inflationary pressure, demand and practical aspects of their operations, as well as in lay-offs of employees, and, while these effects are hoped to be temporary, some effects could be persistent or even permanent; (ii) increased draws by borrowers on revolving lines of credit; (iii) increased requests by borrowers for amendments and waivers of their credit agreements to avoid default, increased defaults by such borrowers and/or increased difficulty in obtaining refinancing at the maturity dates of their loans; (iv) volatility and disruption of these markets including greater volatility in pricing and spreads and difficulty in valuing loans during periods of increased volatility, and liquidity issues; and (v) rapidly evolving proposals and/or actions by state and federal governments to address problems being experienced by the markets and by businesses and the economy in general which will not necessarily adequately address the problems facing the loan market and middle market businesses.
During 2021, the economic recovery gained significant traction in countries in which comprehensive vaccination programs have led to the lifting of health and safety restrictions. However, other countries encountered more challenging circumstances as a result of slower distribution of vaccines and the spread of new variants, most notably the Delta and Omicron variants. The extent to which the COVID-19 pandemic will continue to affect our business, financial condition, liquidity, our portfolio companies results of operations and by extension our operating results will depend on future developments, such as the speed and extent of further vaccine distribution and the impact of the Delta and Omicron variants or other variants that might arise, which are highly uncertain and cannot be predicted. Additionally, as of February 2022, travelers from the United States are not allowed to visit Australia or certain countries in Europe, Asia, Africa and South America. These continued travel restrictions may prolong the global economic downturn. Even after the COVID-19 pandemic subsides, the U.S. economy and most other major global economies may continue to experience a recession, and we anticipate our business and operations could be materially adversely affected by a prolonged recession in the United States and other major markets.
This outbreak is having, and any future outbreaks could have, an adverse impact on the markets and the economy in general, which could have a material adverse impact on, among other things, the ability of lenders to originate loans, the volume and type of loans originated, and the volume and type of amendments and waivers granted to borrowers and remedial actions taken in the event of a borrower default, each of which could negatively impact the amount and quality of loans available for investment by us and returns to us, among other things. As of the date of this annual report on Form 10-K, it is impossible to determine the scope of this outbreak, or any future outbreaks, how long any such outbreak, market disruption or uncertainties may last, the effect any governmental actions will have or the full potential impact on us and our portfolio companies. Any potential impact to our results of operations will depend to a large extent on future developments and new information that could emerge regarding the duration and severity of COVID-19 and the actions taken by authorities and other entities to contain COVID-19 or treat its impact, all of which are beyond our control. These potential impacts, while uncertain, could adversely affect our and our portfolio companies operating results.
If the economy is unable to substantially reopen, and high levels of unemployment continue for an extended period of time, loan delinquencies, loan non-accruals, problem assets, and bankruptcies may increase. In addition, collateral for our loans may decline in value, which could cause loan losses to increase and the net worth and liquidity of loan guarantors could decline, impairing their ability to honor commitments to us. An increase in loan delinquencies and non-accruals or a decrease in loan collateral and guarantor net worth could result in increased costs and reduced income which would have a material adverse effect on our business, financial condition or results of operations. Central banks and governments have responded with liquidity injections to ease the strain on financial systems and stimulus measures to buffer the shock to businesses and consumers. These measures have helped stabilize certain portions of the financial markets over the short term, but volatility will likely remain elevated until the health crisis itself is under control (via fewer new cases, lower
65
infection rates and/or verified treatments). There are still many unknowns and new information is incoming daily, compounding the difficulty of modeling outcomes for epidemiologists and economists alike.
We cannot be certain as to the duration or magnitude of the economic impact of the COVID-19 pandemic in the markets in which we and our portfolio companies operate, including with respect to travel restrictions, business closures, mitigation efforts (whether voluntary, suggested, or mandated by law) and corresponding declines in economic activity that may negatively impact the U.S. economy and the markets for the various types of goods and services provided by U.S. middle market companies. Depending on the duration, magnitude and severity of these conditions and their related economic and market impacts, certain portfolio companies may suffer declines in earnings and could experience financial distress, which could cause them to default on their financial obligations to us and their other lenders.
We will also be negatively affected if our operations and effectiveness or the operations and effectiveness of a portfolio company (or any of the key personnel or service providers of the foregoing) is compromised or if necessary or beneficial systems and processes are disrupted.
Any public health emergency, including the COVID-19 pandemic or any outbreak of other existing or new epidemic diseases, or the threat thereof, and the resulting financial and economic market uncertainty could have a significant adverse impact on us and the fair value of our investments. Our valuations, and particularly valuations of private investments and private companies, are inherently uncertain, may fluctuate over short periods of time and are often based on estimates, comparisons and qualitative evaluations of private information that may not show the complete impact of the COVID-19 pandemic and the resulting measures taken in response thereto. These potential impacts, while uncertain, could adversely affect our and our portfolio companies operating results.
We are currently operating in a period of capital markets disruption and economic uncertainty.
The U.S. capital markets have experienced extreme volatility and disruption following the global outbreak of COVID-19 that began in December 2019. The global impact of the outbreak is rapidly evolving, and many countries have reacted by instituting quarantines, prohibitions on travel and the closure of offices, businesses, schools, retail stores and other public venues. Businesses are also implementing similar precautionary measures. Such measures, as well as the general uncertainty surrounding the dangers and impact of COVID-19, have created significant disruption in supply chains and economic activity. The impact of COVID-19 has led to significant volatility and declines in the global public equity markets and it is uncertain how long this volatility will continue. As COVID-19 continues to spread, the potential impacts, including a global, regional or other economic recession, are increasingly uncertain and difficult to assess. Some economists and major investment banks have expressed concern that the continued spread of the virus globally could lead to a world-wide economic downturn.
General uncertainty surrounding the dangers and impact of COVID-19 (including the preventative measures taken in response thereto and additional uncertainty regarding new variants of COVID-19 that continue to emerge throughout the world) has to date created significant disruption in supply chains and economic activity. Disruptions in the capital markets caused by the COVID-19 pandemic have increased the spread between the yields realized on risk-free and higher risk securities, resulting in illiquidity in parts of the capital markets. These and future market disruptions and/or illiquidity would be expected to have an adverse effect on our business, financial condition, results of operations and cash flows. Unfavorable economic conditions also would be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. These events have limited and could continue to limit our investment originations, limit our ability to grow and have a material negative impact on our operating results and the fair values of our debt and equity investments.
In addition, due to the outbreak in the United States, certain personnel of our Investment Adviser are currently working remotely, which may introduce additional operational risk to us. Staff members of certain of our other
66
service providers may also work remotely during the COVID-19 outbreak. An extended period of remote working could lead to service limitations or failures that could impact us or our performance.
Further, current market conditions resulting from the COVID-19 pandemic may make it difficult for us to obtain debt capital on favorable terms and any failure to do so could have a material adverse effect on our business. The debt capital that will be available to us in the future, if at all, may be at a higher cost and on less favorable terms and conditions than what we would otherwise expect, including being at a higher cost in rising rate environments. If we are unable to raise debt, then our equity investors may not benefit from the potential for increased returns on equity resulting from leverage and we may be limited in our ability to make or fund commitments to portfolio companies. An inability to obtain indebtedness could have a material adverse effect on our business, financial condition or results of operations.
The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business.
Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by U.S. and non-U.S. government and regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of the global COVID-19 pandemic, negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, rising interest rates and/or a return to unfavorable economic conditions could adversely affect our business.
There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
As a result of the November 2020 elections in the United States, the Democratic Party gained control of both the Presidency and the Senate from the Republican Party. Therefore, changes in federal policy, including tax policies, and at regulatory agencies are expected to occur over time through policy and personnel changes, which may lead to changes involving the level of oversight and focus on the financial services industry or the tax rates paid by corporate entities. The nature, timing and economic and political effects of potential changes to the current legal and regulatory framework affecting financial institutions remain highly uncertain. Uncertainty surrounding future changes may adversely affect our operating environment and therefore our business, financial condition, results of operations and growth prospects.
We are exposed to risks associated with changes in interest rates, including the transition away from LIBOR and the adoption of alternative reference rates.
LIBOR, the London Interbank Offered Rate, is the basic rate of interest used in lending between banks on the London interbank market and is widely used as a reference for setting the interest rate on loans globally. We typically use LIBOR as a reference rate in term loans we extend to portfolio companies such that the interest due to us pursuant to a term loan extended to a portfolio company is calculated using LIBOR. The terms of our debt investments generally include minimum interest rate floors which are calculated based on LIBOR.
Per an announcement by the United Kingdoms Financial Conduct Authority (the FCA), which regulates LIBOR, on March 5, 2021: (i) 24 LIBOR settings ceased to exist after December 31, 2021 (all seven euro LIBOR settings; all seven Swiss franc LIBOR settings; the Spot Next, 1-week, 2-month, and 12-month Japanese yen LIBOR settings; the overnight, 1-week, 2-month, and 12-month sterling LIBOR settings; and the 1-week and 2-month US dollar LIBOR settings); (ii) the overnight and 12-month US LIBOR settings would cease to exist after June 30, 2023; and (iii) the FCA would consult on whether the remaining nine LIBOR settings should
67
continue to be published on a synthetic basis for a certain period using the FCAs proposed new powers that the UK government is legislating to grant to them. Central banks and regulators in a number of major jurisdictions (for example, United States, United Kingdom, European Union, Switzerland and Japan) have convened working groups to find, and implement the transition to, suitable replacements for interbank offered rates. To identify a successor rate for U.S. dollar LIBOR, the Alternative Reference Rates Committee (ARRC), a U.S.-based group convened by the Federal Reserve Board and the Federal Reserve Bank of New York, was formed. The ARRC has identified the Secured Overnight Financing Rate (SOFR) as its preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. On July 29, 2021, the ARCC formally recommended SOFR as its preferred alternative replacement rate for U.S. dollar LIBOR. At this time, it is not possible to predict the effect of any such changes, any establishment of alternative reference rates or other reforms to LIBOR that may be enacted in the United States, United Kingdom or elsewhere or, whether the COVID-19 pandemic will have further effect on LIBOR transition plans.
Given the inherent differences between LIBOR and SOFR, or any other alternative reference rates that may be established, the transition from LIBOR may disrupt the overall financial markets and adversely affect the market for LIBOR-based securities, including our portfolio of LIBOR-indexed, floating-rate debt securities, or the cost of our borrowings. In addition, changes or reforms to the determination or supervision of LIBOR may result in a sudden or prolonged increase or decrease in reported LIBOR, which could have an adverse impact on the market for LIBOR-based securities, including the value and/or transferability of the LIBOR-indexed, floating-rate debt securities in our portfolio, or the cost of our borrowings. Additionally, if as currently expected LIBOR ceases to exist, we may need to renegotiate the credit agreements extending beyond June 30, 2023, with our credit facility lenders and our portfolio companies that utilize LIBOR as a factor in determining the interest rate to replace LIBOR with SOFR or other alternative reference rates, The transition from LIBOR to SOFR or other alternative reference rates may also introduce operational risks in our accounting, financial reporting, loan servicing, liability management and other aspects of our business. We are assessing the impact of a transition from LIBOR; however, we cannot reasonably estimate the impact of the transition at this time.
Inflation may adversely affect the business, results of operations and financial condition of our portfolio companies.
Certain of our portfolio companies are in industries that may be impacted by inflation. If such portfolio companies are unable to pass any increases in their costs of operations along to their customers, it could adversely affect their operating results and impact their ability to pay interest and principal on our loans, particularly if interest rates rise in response to inflation. In addition, any projected future decreases in our portfolio companies operating results due to inflation could adversely impact the fair value of those investments. Any decreases in the fair value of our investments could result in future realized or unrealized losses and therefore reduce our net assets resulting from operations.
Technological innovations and industry disruptions may negatively impact us.
Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments.
We are subject to risks related to corporate social responsibility.
Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (ESG) activities. We risk damage to our brand and reputation if we fail
68
to act responsibly in a number of areas, such as diversity, equity and inclusion, environmental stewardship, support for local communities, corporate governance and transparency and considering ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.
Additionally, new regulatory initiatives related to ESG that are applicable to us and our portfolio companies could adversely affect our business. In May 2018, the European Commission adopted an action plan on financing sustainable growth. The action plan is, among other things, designed to define and reorient investment toward sustainability. The action plan contemplates: establishing EU labels for green financial products; increasing disclosure requirements in the financial services sector around ESG and strengthening the transparency of companies on their ESG policies and introducing a green supporting factor in the EU prudential rules for banks and insurance companies to incorporate climate risks into banks and insurance companies risk management policies. There is a risk that a significant reorientation in the market following the implementation of these and further measures could be adverse to our portfolio companies if they are perceived to be less valuable as a consequence of, e.g., their carbon footprint or greenwashing (i.e., the holding out of a product as having green or sustainable characteristics where this is not, in fact, the case). We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability.
The effect of global climate change may impact the operations of our portfolio companies.
There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change.
In December 2015 the United Nations, of which the U.S. is a member, adopted a climate accord (the Paris Agreement) with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues.
We cannot predict how new tax legislation will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.
Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. The Biden Administration has proposed significant changes to the existing U.S. tax rules, and there are a number of proposals in Congress that would similarly modify the existing U.S. tax rules. The likelihood of any such legislation being enacted is uncertain, but new legislation and any U.S. Treasury regulations, administrative interpretations or court decisions interpreting such legislation could significantly and negatively affect our ability to qualify for tax treatment as a RIC or the U.S.
69
federal income tax consequences to us and our investors of such qualification, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations.
The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and difficult-to-quantify macroeconomic and political risks with potentially far-reaching implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas.
A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders.
Item 1B. | Unresolved Staff Comments |
None.
Item 2. | Properties |
Our executive offices are located at 500 Park Avenue, New York, New York 10022, and are provided by SLR Capital Management in accordance with the terms of the Administration Agreement. We believe that our office facilities are suitable and adequate for our business as it is presently conducted.
Item 3. | Legal Proceedings |
On January 31, 2022, two putative class action stockholder complaints were filed in the Circuit Court for Baltimore City, Maryland against us and the members of the Board, captioned respectively Neal v. Gross, et al., No. 24-C-22-000557 (Md. Cir. Ct. Baltimore City) (the Neal Complaint), and Tobin v. Gross, et al., 24-C-22-000558 (Md. Cir. Ct. Baltimore City) (the Tobin Complaint). On February 8, 2022, a stockholder complaint was filed in the United States District Court for the Southern District of New York, against us and the members of the Board, entitled Kershner v. SLR Senior Investment Corp., et al., No. 1:22-cv-01096 (the Kershner Complaint). On February 21, 2022, a stockholder complaint was filed in the United States District Court for the Southern District of New York, against us and the members of the Board, entitled Sharp v. SLR
70
Senior Investment Corp., et al., No. 1:22-cv-01418 (the Sharp Complaint). On February 22, 2022, a stockholder complaint was filed in the United States District Court for the Southern District of New York, against us, the members of the Board, SLR Investment Corp.(SLRC), and SLR Capital Partners, LLC (SCP) entitled Ciccotelli v. SLR Senior Investment Corp., et al., No. 1:22-cv-01454 (the Ciccotelli Complaint). On February 22, 2022, a stockholder complaint was filed in the United States District Court for the Eastern District of Pennsylvania, against us and the members of the Board entitled Justice v. SLR Senior Investment Corp., et al., No. 2:22-cv-00673 (the Justice Complaint and together with the Neal Complaint, Tobin Complaint, Kershner Complaint, Sharp Complaint, and Ciccotelli Complaint, the Merger Complaints).
Each of the Neal Complaint and Tobin Complaint alleges, among other things, that the members of the Board breached their fiduciary duties when they approved the proposed merger between us and SLRC, and that the disclosures in the joint proxy statement/prospectus relating to the Mergers contains materially misleading and incomplete disclosures. Each of the Neal Complaint and Tobin Complaint raises these claims under Maryland law, and seeks: (i) certification that the case can be maintained as a class action, with the plaintiff named as a representative of the proposed class (consisting of the public shareholders of us); (ii) an order enjoining the shareholder vote to approve the proposed merger between us and SLRC; and (iii) rescission of the proposed merger between us and SLRC.
Each of the Kershner Complaint, Sharp Complaint, Ciccotelli Complaint, and Justice Complaint alleges, among other things, that the joint proxy statement/prospectus filed with the SEC on February 3, 2022 contains materially misleading and incomplete disclosures. Each of these Complaints seeks, among other things, that supplemental disclosures be made to the joint proxy statement/prospectus to address the alleged materially misleading and incomplete disclosures. As a result of the alleged omissions, each of these Complaints seeks to hold us and our directors liable for violating Section 14(a) of the Exchange Act and Rule 14a-9 promulgated thereunder, and additionally seeks to hold our directors, and in the case of the Ciccotelli Complaint SLRC and SCP, liable as control persons pursuant to Section 20(a) of the Exchange Act.
We and the members of the Board (the individual defendants) believe that we have disclosed in the joint proxy statement/prospectus all information required to be disclosed therein and that the additional disclosures requested by the plaintiffs are immaterial. Neither we nor the individual defendants have yet responded to the Merger Complaints. Each of the Merger Complaints seeks, among other relief, an injunction preventing the closing of the Mergers, rescission of the Merger Agreement or any of its terms to the extent already implemented or awarding of rescissory damages, and expenses incurred by prosecuting the Merger Complaints, including an award of attorneys and experts fees.
While we and the individual defendants believe these claims are without merit and intend to defend the lawsuits vigorously, there can be no assurance that we and the individual defendants will ultimately prevail in any of the Merger Complaints. Additionally, further lawsuits may be filed before our special meeting to vote on the approval of the Mergers and/or the consummation of the Mergers. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.
Item 4. | Mine Safety Disclosures |
Not applicable.
71
PART II
Item 5. | Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Common Stock
Our common stock is traded on the NASDAQ Global Select Market under the symbol SUNS. The following table sets forth, for each fiscal quarter during the last two fiscal years, the net asset value (NAV) per share of our common stock, the high and low closing sale prices for our common stock, such sale prices as a percentage of NAV per share and quarterly distributions per share.
Price Range | Premium or (Discount) of High Closing Sale Price to NAV (2) |
Premium or (Discount) of Low Closing Sale Price to NAV (2) |
Declared Distributions (3) |
|||||||||||||||||||||
NAV(1) | High | Low | ||||||||||||||||||||||
Fiscal 2021 |
||||||||||||||||||||||||
Fourth Quarter |
$ | 15.43 | $ | 16.11 | $ | 13.65 | 4.4 | % | (11.5 | )% | $ | 0.30 | ||||||||||||
Third Quarter |
15.73 | 16.16 | 15.26 | 2.7 | (3.0 | ) | 0.30 | |||||||||||||||||
Second Quarter |
15.87 | 16.30 | 14.74 | 2.7 | (7.1 | ) | 0.30 | |||||||||||||||||
First Quarter |
15.91 | 15.65 | 14.14 | (1.6 | ) | (11.1 | ) | 0.30 | ||||||||||||||||
Fiscal 2020 |
||||||||||||||||||||||||
Fourth Quarter |
$ | 15.91 | $ | 14.98 | $ | 12.30 | (5.8 | )% | (22.7 | )% | $ | 0.30 | ||||||||||||
Third Quarter |
15.79 | 13.78 | 12.03 | (12.7 | ) | (23.8 | ) | 0.30 | ||||||||||||||||
Second Quarter |
15.55 | 13.86 | 9.48 | (10.9 | ) | (39.0 | ) | 0.3175 | ||||||||||||||||
First Quarter |
14.59 | 18.29 | 6.95 | 25.4 | (52.4 | ) | 0.3525 |
(1) | Net asset value per share is determined as of the last day in the relevant quarter and therefore may not reflect the net asset value per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period. |
(2) | Calculated as the respective high or low closing sales price divided by NAV and subtracting 1. |
(3) | Represents the cash distribution declared for the specified quarter. |
On February 25, 2022 the last reported sales price of our common stock was $13.63 per share. As of February 25, 2022, we had 4 shareholders of record.
Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. The possibility that our shares of common stock will trade at a discount from net asset value or at premiums that are unsustainable over the long term are separate and distinct from the risk that our net asset value will decrease. Since our IPO on February 24, 2011, our shares of common stock have traded at both a discount and a premium to the net assets attributable to those shares. As of February 25, 2022, our shares of common stock traded at a discount equal to approximately 13.2% of the net assets attributable to those shares based upon our net asset value as of December 31, 2021. It is not possible to predict whether the shares offered hereby will trade at, above, or below net asset value.
DISTRIBUTIONS
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future monthly distributions, if any, will be determined by the Companys board of directors (the Board). We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or non-taxable return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we
72
currently intend to distribute realized net capital gains (i.e., net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an opt out dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically opt out of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual payment-in-kind income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
We cannot assure stockholders that they will receive any distributions at a particular level.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are generally automatically reinvested in shares of our common stock. As a result, stockholders that do not participate in the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
Recent Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
None.
73
STOCK PERFORMANCE GRAPH
This graph compares the cumulative total return on our common stock with that of the Standard & Poors BDC Index, Standard & Poors 500 Stock Index and the Russell 2000 Financial Services Index, for the period from December 31, 2016 through December 31, 2021. The graph assumes that a person invested $10,000 in each of the following: our common stock (SUNS), the S&P BDC Index, the S&P 500 Index, and the Russell 2000 Financial Services Index. The graph measures total stockholder return, which takes into account both changes in stock price and dividends. It assumes that dividends paid are invested in additional shares of the same class of equity securities at the frequency with which dividends are paid of such securities during the applicable fiscal year.
The graph and other information furnished under this Part II Item 5 of this Form 10-K shall not be deemed to be soliciting material or to be filed with the SEC or subject to Regulation 14A or 14C, or to the liabilities of Section 18 of the 1934 Act. The stock price performance included in the above graph is not necessarily indicative of future stock price performance.
FEES AND EXPENSES
The following table is intended to assist an investor in understanding the costs and expenses that you will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this report contains a reference to fees or expenses paid by us or SLR Senior, or that we will pay fees or expenses, you will indirectly bear such fees or expenses as an investor in SLR Senior.
Stockholder transaction expenses: |
||||
Sales load (as a percentage of offering price) |
| %(1) | ||
Offering expenses (as a percentage of offering price) |
| %(2) | ||
Dividend reinvestment plan expenses |
| %(3) | ||
Total stockholder transaction expenses (as a percentage of offering price) |
| %(2) |
74
Annual expenses (as a percentage of net assets attributable to common stock):(4) |
||||
Base management fee |
1.58 | %(5) | ||
Incentive fees payable under our Investment Advisory and Management Agreement (up to 20%) |
| %(6) | ||
Interest payments on borrowed funds |
2.80 | %(7) | ||
Acquired fund fees and expenses |
| % | ||
Other expenses (estimated) |
1.68 | %(8) | ||
Total annual expenses |
6.06 | % |
(1) | In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the Example will be updated accordingly. |
(2) | The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses. |
(3) | The expenses of the dividend reinvestment plan are included in other expenses. |
(4) | Annual Expenses are presented in this manner because common shareholders will bear all costs of running the Company. |
(5) | Our 1% base management fee under the Investment Advisory and Management Agreement is based on our gross assets, which is defined as all the assets of SLR Senior, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes the base management fee remains consistent with fees incurred for the fiscal year ended December 31, 2021. |
(6) | Assumes that annual gross incentive fees, if any, earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2021. The incentive fee consists of two parts: |
The first part, which is payable quarterly in arrears, equals 20% of the excess, if any, of our Pre-Incentive Fee Net Investment Income that exceeds a 1.75% quarterly (7.00% annualized) hurdle rate, which we refer to as the Hurdle, subject to a catch-up provision measured at the end of each calendar quarter. The first part of the incentive fee is computed and paid on income that may include interest that is accrued but not yet received in cash. The operation of the first part of the incentive fee for each quarter is as follows:
| no incentive fee is payable to our investment adviser in any calendar quarter in which our Pre-Incentive Fee Net Investment Income does not exceed the Hurdle of 1.75%; |
| 50% of our Pre-Incentive Fee Net Investment Income with respect to that portion of such Pre-Incentive Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.9167% in any calendar quarter (11.67% annualized) is payable to our investment adviser. We refer to this portion of our Pre-Incentive Fee Net Investment Income (which exceeds the Hurdle but is less than 2.9167%) as the catch-up. The catch-up is meant to provide our investment adviser with 20% of our Pre-Incentive Fee Net Investment Income, as if a Hurdle did not apply when our Pre-Incentive Fee Net Investment Income exceeds 2.9167% in any calendar quarter; and |
| 20% of the amount of our Pre-Incentive Fee Net Investment Income, if any, that exceeds 2.9167% in any calendar quarter (11.67% annualized) is payable to our investment adviser (once the Hurdle is reached and the catch-up is achieved, 20% of all Pre-Incentive Fee Investment Income thereafter is allocated to our investment adviser). |
The second part of the incentive fee equals 20% of our Incentive Fee Capital Gains, if any, which equals our realized capital gains on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The second part of the incentive fee is payable, in arrears, at the end of each calendar year (or upon termination of the Investment Advisory and Management Agreement, as of the termination date).
75
(7) | We currently borrow funds under our credit facilities and may borrow additional funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly born by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2021. We used the LIBOR or similar base rate on December 31, 2021 and the interest rate on our credit facilities on December 31, 2021. We have also included, as applicable, the estimated amortization of fees incurred in establishing the credit facilities as of December 31, 2021. Additionally, we included the estimated cost of commitment fees for unused balances on our credit facilities. As of December 31, 2021, we had $161.5 million outstanding and $148.5 million remaining available to us under our credit facilities. Although we do not have any current plans to issue subscription rights, preferred stock, or warrants, we may issue subscription rights, preferred stock, or warrants, subject to our compliance with applicable requirements under the 1940 Act. |
(8) | Other expenses are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2021 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement. |
Example
The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses would remain at the levels set forth in the table above and have excluded performance-based incentive fees. As such, the below example is based on an annual expense ratio of 6.06% See Note 7 above for additional information regarding certain assumptions regarding our level of leverage. In the event that shares are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load.
1 Year | 3 Years | 5 Years | 10 Years | |||||||||||||
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return |
$ | 61 | $ | 180 | $ | 296 | $ | 578 |
The example and the expenses in the tables above should not be considered a representation of our future expenses, and actual expenses may be greater or less than those shown. While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. The incentive fee under the Investment Advisory and Management Agreement, which, assuming a 5% annual return, would either not be payable or would have an insignificant impact on the expense amounts shown above, is not included in the example. This illustration assumes that we will not realize any capital gains (computed net of all realized capital losses and unrealized capital depreciation) in any of the indicated time periods. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses and returns to our investors would be higher. For example, if we assumed that we received our 5% annual return completely in the form of net realized capital gains on our investments, computed net of all cumulative unrealized depreciation on our investments, the projected dollar amount of total cumulative expenses set forth in the above illustration would be as follows:
1 Year | 3 Years | 5 Years | 10 Years | |||||||||||||
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return |
$ | 71 | $ | 207 | $ | 339 | $ | 644 |
In addition, the example assumes no sales load. Also, while the example assumes reinvestment of all distributions at net asset value, participants in our dividend reinvestment plan will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by
76
the market price per share of our common stock at the close of trading on the distribution payment date, which may be at, above or below net asset value unless the company makes open market purchases and the shares received will be determined based on the average price paid by our agents, plus commissions.
Item 6. | Reserved |
Item 7. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
The information contained in this section should be read in conjunction with the Selected Financial and Other Data and our Consolidated Financial Statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
| our future operating results, including our ability to achieve objectives as a result of the current COVID-19 pandemic; |
| our business prospects and the prospects of our portfolio companies; |
| the impact of investments that we expect to make; |
| our contractual arrangements and relationships with third parties; |
| the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the COVID-19 pandemic thereon; |
| the impact of any protracted decline in the liquidity of credit markets on our business and the impact of the COVID-19 pandemic thereon; |
| the ability of our portfolio companies to achieve their objectives, including as a result of the current COVID-19 pandemic; |
| the valuation of our investments in portfolio companies, particularly those having no liquid trading market, and the impact of the COVID-19 pandemic thereon; |
| market conditions and our ability to access alternative debt markets and additional debt and equity capital, and the impact of the COVID-19 pandemic thereon; |
| our expected financings and investments; |
| the adequacy of our cash resources and working capital; |
| the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the COVID-19 pandemic thereon; and |
| the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments and the impacts of the COVID-19 pandemic thereon. |
| changes in the political conditions and relations between the United States, Russia, Ukraine and other nations. |
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
| an economic downturn, including as a result of the current COVID-19 pandemic, could impair our portfolio companies ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies; |
77
| a contraction of available credit and/or an inability to access the equity markets, including as a result of the current COVID-19 pandemic, could impair our lending and investment activities; |
| interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy; |
| currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars; |
| the ability of the parties to consummate the Mergers on the expected timeline, or at all; |
| the ability to realize the anticipated benefits of the Mergers; |
| the effects of disruption on our business from the proposed Mergers; |
| the combined companys plans, expectations, objectives and intentions as a result of the Mergers; |
| any potential termination of the Merger Agreement; |
| the actions of our stockholders or the stockholders of SLRC with respect to the proposals submitted for their approval in connection with the Mergers; and |
| the risks, uncertainties and other factors we identify in Item 1A. Risk Factors contained in this Annual Report on Form 10-K for the year ended December 31, 2021 and in our other filings with the SEC. |
We generally use words such as anticipates, believes, expects, intends and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in Risk Factors and elsewhere in this report.
We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.
Overview
SLR Senior Investment Corp. (SLR Senior, the Company, we or our), a Maryland corporation formed in December 2010, is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940, as amended (the 1940 Act). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 946. In addition, for tax purposes, the Company has elected to be treated, and intend to qualify annually, as a regulated investment company (RIC) under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code).
On February 24, 2011, we priced our initial public offering, selling 9.0 million shares, including the underwriters over-allotment, raising approximately $168 million in net proceeds. Concurrent with this offering, Solar Senior Capital Investors LLC, an entity controlled by Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, and Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, purchased an additional 500,000 shares through a concurrent private placement, raising another $10 million.
78
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. We define middle market to refer to companies with annual revenues between $50 million and $1 billion. Our investment objective is to seek to maximize current income consistent with the preservation of capital. We seek to achieve our investment objective by directly and indirectly investing in senior loans, including first lien and second lien debt instruments, made to private middle-market companies whose debt is rated below investment grade, which we refer to collectively as senior loans. We may also invest in debt of public companies that are thinly traded or in equity securities. Under normal market conditions, at least 80% of the value of our net assets (including the amount of any borrowings for investment purposes) will be invested directly and indirectly in senior loans. Senior loans typically pay interest at rates which are determined periodically on the basis of a floating base lending rate, primarily LIBOR, plus a premium. Senior loans in which we invest are typically made to U.S. and, to a limited extent, non-U.S. corporations, partnerships and other business entities which operate in various industries and geographical regions. Senior loans typically are rated below investment grade. Securities rated below investment grade are often referred to as leveraged loans, high yield or junk securities, and may be considered high risk compared to debt instruments that are rated investment grade. In addition, some of our debt investments are not scheduled to fully amortize over their stated terms, which could cause us to suffer losses if the respective issuer of such debt investment is unable to refinance or repay their remaining indebtedness at maturity. While the Company does not typically seek to invest in traditional equity securities as part of its investment objective, the Company may occasionally acquire some equity securities in connection with senior loan investments and in certain other unique circumstances, such as the Companys equity investments in SLR Healthcare ABL (SLR Healthcare) and SLR Business Credit.
We invest in senior loans made primarily to private, leveraged middle-market companies with approximately $20 million to $100 million of earnings before income taxes, depreciation and amortization (EBITDA). Our business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our direct investments in individual securities will generally range between $5 million and $30 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or strategic initiatives. In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These opportunistic investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. We may invest up to 30% of our total assets in such opportunistic investments, including loans issued by non-U.S. issuers, subject to compliance with our regulatory obligations as a BDC under the 1940 Act. Our investment activities are managed by SLR Capital Partners, LLC (SLR Capital Partners or Investment Adviser) and supervised by the Board, a majority of whom are non-interested, as such term is defined in the 1940 Act. SLR Capital Management, LLC (SLR Capital Management or Administrator) provides the administrative services necessary for us to operate.
As of December 31, 2021, the Investment Adviser has directly invested approximately $12.5 billion in more than 450 different portfolio companies since 2006. Over the same period, the Investment Adviser completed transactions with over 200 different financial sponsors.
Merger Agreement
On December 1, 2021, we entered into the Merger Agreement, which provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into us, with us continuing as the surviving company and as SLRCs wholly-owned subsidiary and, immediately thereafter, we will merge with and into SLRC, with SLRC continuing as the surviving company. Both the Board and SLRCs board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us or SLRC, as applicable, have approved the Merger Agreement and the transactions contemplated thereby.
At the effective time of the Merger (Effective Time), each share of our common stock issued and outstanding immediately prior to the Effective Time (other than shares owned by SLRC or any of its controlled
79
subsidiaries (the Cancelled Shares)) will be converted into the right to receive a number of shares of SLRCs common stock equal to the Exchange Ratio (as defined below) (cash may be paid in lieu of fractional shares).
As of a mutually agreed date no earlier than 48 hours (excluding Sundays and holidays) prior to the Effective Time (such date, the Determination Date), each of us and SLRC will deliver to the other a calculation of its NAV as of such date, in each case using a pre-agreed set of assumptions, methodologies and adjustments. We refer to such calculation with respect to us as the Closing SUNS Net Asset Value and with respect to SLRC as the Closing SLRC Net Asset Value. Based on such calculations, the parties will calculate the SUNS Per Share NAV, which will be equal to (i) the Closing SUNS Net Asset Value divided by (ii) the number of shares of our common stock issued and outstanding as of the Determination Date (excluding any Cancelled Shares), and the SLRC Per Share NAV, which will be equal to (A) the Closing SLRC Net Asset Value divided by (B) the number of shares of SLRC Common Stock issued and outstanding as of the Determination Date. The Exchange Ratio will be equal to the quotient (rounded to four decimal places) of (i) the SUNS Per Share NAV divided by (ii) the SLRC Per Share NAV.
We and SLRC will update and redeliver the Closing SUNS Net Asset Value or the Closing SLRC Net Asset Value, respectively, in the event of a material change to such calculation between the Determination Date and the closing of the Mergers and if needed to ensure that the calculation is determined within 48 hours (excluding Sundays and holidays) prior to the Effective Time.
The Merger Agreement contains customary representations and warranties by each of us, SLRC and SLR Capital Partners. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SLRCs businesses during the period prior to the closing of the Mergers.
Consummation of the Mergers, which is currently anticipated to occur during the first half of calendar year 2022, is subject to certain closing conditions, including requisite approvals of our and SLRCs stockholders and certain other closing conditions.
The Merger Agreement also contains certain termination rights in favor of us and SLRC, including if the Mergers are not completed on or before December 1, 2022 or if the requisite approvals of our or SLRCs stockholders are not obtained. The Merger Agreement provides that, upon the termination of the Merger Agreement under certain circumstances, a third party acquiring us may be required to pay SLRC a termination fee of approximately $7.6 million. The Merger Agreement provides that, upon the termination of the Merger Agreement under certain circumstances, a third party acquiring SLRC may be required to pay to us a termination fee of approximately $25.6 million.
The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is incorporated by reference as Exhibit 2.1 to this Annual Report on Form 10-K and incorporated by reference herein. The representations, warranties, covenants and agreements contained in the Merger Agreement were made only for purposes of the Merger Agreement and as of specific dates; were solely for the benefit of the parties to the Merger Agreement (except as may be expressly set forth in the Merger Agreement); may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors and security holders should not rely on such representations, warranties, covenants or agreements, or any descriptions thereof, as characterizations of the actual state of facts or condition of any of the parties to the Merger Agreement or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties, covenants and agreements may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in public disclosures by the parties to the Merger Agreement.
80
Recent Developments
On January 5, 2022, the Board declared a monthly dividend of $0.10 per share payable on February 2, 2022 to holders of record as of January 20, 2022.
On February 3, 2022, the Board declared a monthly dividend of $0.10 per share payable on March 1, 2022 to holders of record as of February 17, 2022.
On March 1, 2022, the Board declared a monthly dividend of $0.10 per share payable on April 1, 2022 to holders of record as of March 18, 2022.
The global outbreak of the COVID-19 pandemic, and the related effect on the U.S. and global economies, has continued to have adverse consequences for the business operations of some of the Companys portfolio companies and, as a result, has had adverse effects on the Companys operations. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual issuers, including the Company, remain uncertain. The operational and financial performance of the issuers of securities in which the Company invests depends on future developments, including the duration and spread of the outbreak, and such uncertainty may in turn adversely affect the value and liquidity of the Companys investments and negatively impact the Companys performance.
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than qualifying assets specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in eligible portfolio companies. The definition of eligible portfolio company includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (LIBOR), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be bi-monthly or semi-annually. In addition, our investments may provide payment-in-kind (PIK) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
Expenses
All investment professionals of the Investment Adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by SLR Capital Partners. We bear all other costs and expenses of our operations and transactions, including (without limitation):
| the cost of our organization and public offerings; |
| the cost of calculating our net asset value, including the cost of any third-party valuation services; |
| the cost of effecting sales and repurchases of our shares and other securities; |
81
| interest payable on debt, if any, to finance our investments; |
| fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees; |
| transfer agent and custodial fees; |
| fees and expenses associated with marketing efforts; |
| federal and state registration fees, any stock exchange listing fees; |
| federal, state and local taxes; |
| independent directors fees and expenses; |
| brokerage commissions; |
| fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums; |
| direct costs and expenses of administration, including printing, mailing, long distance telephone and staff; |
| fees and expenses associated with independent audits and outside legal costs; |
| costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and |
| all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs. |
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
Portfolio and Investment Activity
During our fiscal year ended December 31, 2021, we invested approximately $192 million across 38 portfolio companies through a combination of primary and secondary market purchases. This compares to investing approximately $71 million in 23 portfolio companies for the fiscal year ended December 31, 2020. Investments sold or prepaid during the fiscal year ended December 31, 2021 totaled approximately $129 million versus approximately $186 million for the fiscal year ended December 31, 2020.
At December 31, 2021, our portfolio consisted of 50 portfolio companies and was invested 71.2% directly in senior secured loans and 28.8% in common equity/equity interests/warrants (of which 8.9% is SLR Healthcare ABL and 19.8% is SLR Business Credit, through which the Company indirectly invests in senior secured loans), in each case, measured at fair value versus 44 portfolio companies invested 72.4% directly in senior secured loans and 27.6% in common equity/equity interests/warrants (of which 10.4% is SLR Healthcare ABL and 17.2% is SLR Business Credit) at December 31, 2020.
82
At December 31, 2021, 96.5% or $388.7 million of our income producing investment portfolio* was floating rate and 3.5% or $14.2 million was fixed rate, measured at fair value. At December 31, 2020, 96.0% or $327.2 million of our income producing investment portfolio* was floating rate and 4.0% or $13.5 million was fixed rate, measured at fair value.
Since the initial public offering of SLR Senior on February 24, 2011 and through December 31, 2021, invested capital totaled over $1.9 billion in over 175 portfolio companies. Over the same period, SLR Senior completed transactions with more than 75 different financial sponsors.
* | We have included SLR Healthcare ABL and SLR Business Credit within our income producing investment portfolio. |
SLR Healthcare ABL
We acquired an equity interest in Gemino Healthcare Finance LLC (Gemino) on September 30, 2013. Effective February 25, 2021, Gemino and its related companies is doing business as SLR Healthcare ABL. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. Our initial investment in SLR Healthcare was $32.8 million. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of December 31, 2021, SLR Healthcares management team and SLR Senior own approximately 7% and 93% of the equity in SLR Healthcare, respectively.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year, non-recourse, $100.0 million credit facility with non-affiliates, which was expandable to $150.0 million under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105.0 million and again on June 27, 2014 to $110.0 million. On May 27, 2016, SLR Healthcare entered into a new $125.0 million credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200.0 million and had a maturity date of May 27, 2020. On June 28, 2019, this $125.0 million facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2021, the portfolio totaled approximately $183.5 million of commitments with a total net investment in loans of $81.6 million on total assets of $91.3 million. As of December 31, 2020, the portfolio totaled approximately $218.0 million of commitments with a total net investment in loans of $39.3 million on total assets of $58.9 million. At December 31, 2021, the portfolio consisted of 36 issuers with an average balance of approximately $2.3 million versus 37 issuers with an average balance of approximately $1.1 million at December 31, 2020. All of the commitments in SLR Healthcares portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcares credit facility, which is non-recourse to us, had approximately $60.0 million and $25.0 million of borrowings outstanding at December 31, 2021 and December 31, 2020, respectively. For the years ended December 31, 2021 and 2020, SLR Healthcare had net income of $0.7 million and $4.3 million, respectively, on gross income of $10.1 million and $10.4 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Healthcares funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Healthcare will be able to maintain consistent dividend payments to us. SLR Healthcares consolidated financial statements for the fiscal years ended December 31, 2021 and December 31, 2020 are attached as an exhibit to this annual report on Form 10-K.
SLR Business Credit
We acquired 100% of the equity interests of North Mill Capital LLC (NMC) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries.
83
We invested approximately $51 million to effect the transaction. Subsequently, the Company contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, the Company and ESP SSC Corporation contributed their equity interests to North Mill. On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. The Company and ESP SSC Corporation own 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco, LLC (NM Holdco), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and medium-sized businesses. As part of this transaction, the Companys 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMCs credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from us of $19.0 million and borrowings on NMCs credit facility of $47.7 million.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2021, the portfolio totaled approximately $513.9 million of commitments, of which $248.7 million were funded, on total assets of $290.8 million. As of December 31, 2020, the portfolio totaled approximately $387.2 million of commitments, of which $148.7 million were funded, on total assets of $177.7 million. At December 31, 2021, the portfolio consisted of 125 issuers with an average balance of approximately $2.0 million versus 126 issuers with an average balance of approximately $1.2 million at December 31, 2020. NMC has a senior credit facility with a bank lending group for $225.0 million which expires on November 13, 2024. Borrowings are secured by substantially all of NMCs assets. NMCs credit facility, which is non-recourse to us, had approximately $183.3 million and $111.1 million of borrowings outstanding at December 31, 2021 and December 31, 2020, respectively. For the years ended December 31, 2021 and December 31, 2020, SLR Business Credit had net income of $7.3 million and $4.5 million, respectively on gross income of $24.0 million and $19.7 million, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credits funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credits consolidated financial statements for the fiscal years ended December 31, 2021 and 2020 are attached as an exhibit to this annual report on Form 10-K.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. Our valuation procedures are set forth in more detail in Note 2(b) to the Companys Consolidated Financial Statements.
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
84
Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on non-accrual status when principal or interest/dividend cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in managements judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon managements judgment. Some of our investments may have contractual PIK income. PIK income is computed at the contractual rate, as applicable, and is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on non-accrual status. When a PIK investment is placed on non-accrual status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on non-accrual status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the loan-to-value ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on non-cash accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the fiscal years ended December 31, 2021, 2020 and 2019, capitalized PIK income totaled $0.2 million, $0.4 million and $0.7 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLR Senior, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by
85
the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is evaluating the potential impact that the adoption of this guidance will have on the Companys financial statements.
RESULTS OF OPERATIONS
Results comparisons are for the fiscal years ended December 31, 2021 and December 31, 2020. Results for the fiscal year ended December 31, 2019 can be found in Item 7 of the Companys report on Form 10-K filed on February 24, 2021, which is incorporated by reference herein.
Investment Income
For the fiscal years ended December 31, 2021 and 2020, gross investment income totaled $29.3 million and $31.8 million, respectively. The decrease in gross investment income year over year was primarily due to a slightly lower average portfolio yield on a smaller, on average, income producing investment portfolio.
Expenses
Net expenses totaled $15.0 million and $11.4 million, respectively, for the fiscal years ended December 31, 2021 and 2020, of which $3.9 million and $4.2 million, respectively, were gross base management fees and gross performance-based incentive fees, and $6.9 million and $7.9 million, respectively, were interest and other credit facility expenses. Over the same periods, $0 and $3.7 million of base management fees were waived and $0 and $0.1 million of performance-based incentive fees were waived. Administrative services and other general and administrative expenses totaled $4.2 million and $3.1 million, respectively, for the fiscal years ended December 31, 2021 and 2020. Expenses generally consist of management fees, performance-based incentive fees, administrative services expenses, insurance, legal expenses, directors expenses, audit and tax expenses, transfer agent fees and expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in net expenses year over year is primarily due to higher management fees from a decrease in the waivers of fees as well as higher general and administrative expenses resulting from $0.7 million of expenses related to the potential merger with SLR Investment Corp.
Net Investment Income
The Companys net investment income totaled $14.3 million or $0.89 per average share and $20.4 million or $1.27 per average share, for the fiscal years ended December 31, 2021 and 2020, respectively.
Net Realized Gain (Loss)
The Company had investment sales and prepayments totaling approximately $129 million and $186 million, respectively, for the fiscal years ended December 31, 2021 and 2020. Net realized gain (loss) for the fiscal years ended December 31, 2021 and 2020 totaled ($0.1) million and $0.2 million, respectively. Net realized losses for
86
the fiscal year ended December 31, 2021 were primarily related to the sale of select assets. Net realized gains for the fiscal year ended December 31, 2020 were primarily related to the sale of select assets.
Net Change in Unrealized Loss
For the fiscal years ended December 31, 2021 and 2020, the net change in unrealized loss on the Companys investments totaled $2.7 million and $6.7 million, respectively. Net unrealized loss for the fiscal year ended December 31, 2021 is primarily due to depreciation on our investments in American Teleconferencing Services, Ltd., PPT Management Holdings, LLC, and Logix Holding Company, LLC, among others, partially offset by appreciation on our investments in SLR Business Credit, Composite Technology Acquisition Corp. and SLR Healthcare ABL, among others. Net unrealized loss for the fiscal year ended December 31, 2020 is primarily due to depreciation on our investments in North Mill Holdco LLC, Gemino Healthcare Finance, LLC, Composite Technology Acquisition Corp., SHO Holdings I Corporation and DISA Holdings Acquisition Subsidiary Corp., among others, partially offset by appreciation on our investments in Aegis Toxicology Sciences Corporation, Confie Seguros Holding II Co. and Galway Partners Holdings, LLC, among others.
Net Increase in Net Assets From Operations
For the fiscal years ended December 31, 2021 and 2020, the Company had a net increase in net assets resulting from operations of $11.5 million and $13.9 million, respectively. For the fiscal years ended December 31, 2021 and 2020, earnings per average share were $0.72 and $0.87, respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Companys liquidity and capital resources are generally available through its revolving credit facilities, unsecured notes and through periodic follow-on equity offerings, as well as from cash flows from operations, investment sales and pre-payments of investments. At December 31, 2021, the Company had $161.5 million in borrowings outstanding on its credit facilities and $148.5 million of unused capacity, subject to borrowing base limits.
On March 31, 2020, the Company closed a private offering of $85,000 of senior unsecured notes due 2025 (the 2025 Unsecured Notes) with a fixed interest rate of 3.90% and a maturity date of March 31, 2025. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. The 2025 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On June 1, 2018, the $200 million senior secured revolving credit facility with our wholly-owned subsidiary SUNS SPV LLC as borrower and Citibank, N.A. acting as administrative agent (the Credit Facility) was refinanced by way of amendment, allowing for greater investment flexibility and the extension of the maturity date, among other changes. On July 13, 2018, commitments to the Credit Facility, as amended, were increased from $200 million to $225 million by utilizing the accordion feature.
In September 2016, the Company closed a follow-on public equity offering of 4.5 million shares of common stock at $16.76 per share raising approximately $75.0 million in net proceeds. In the future, if the merger with SLR Investment Corp. does not close, the Company may raise additional equity or debt capital, among other considerations. The primary uses of funds will be investments in portfolio companies, reductions in debt outstanding and other general corporate purposes. The issuance of debt or equity securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or
87
near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time-to-time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on our credit facilities, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held approximately $160 million of cash equivalents as of December 31, 2021.
Debt
Unsecured Notes
On March 31, 2020, the Company closed a private offering of $85 million of the 2025 Unsecured Notes with a fixed interest rate of 3.90% and a maturity date of March 31, 2025. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. The 2025 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
Revolving Loan Facilities
On August 26, 2011, the Company established our wholly-owned subsidiary, SUNS SPV LLC (the SUNS SPV) which entered into the Credit Facility with Citigroup Global Markets Inc. acting as administrative agent. On January 10, 2017, commitments to the Credit Facility, as amended, were increased from $175 million to $200 million by utilizing the accordion feature. The commitment can also be expanded up to $600 million. The stated interest rate on the Credit Facility is LIBOR plus 2.00% with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the Credit Facility, SLR Senior and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The Credit Facility also includes usual and customary events of default for credit facilities of this nature. The Credit Facility was amended on November 7, 2012, June 30, 2014 and May 29, 2015 to extend maturities and add greater investment flexibility, among other changes. On June 1, 2018, the Credit Facility was refinanced by way of amendment, allowing for greater investment flexibility and the extension of the maturity date, among other changes. On July 13, 2018, commitments to the Credit Facility, as amended, were increased from $200 million to $225 million by utilizing the accordion feature. On June 7, 2021, the Credit Facility maturity date was extended to June 1, 2026 and was amended to add greater investment flexibility, among other changes. As of December 31, 2021, there were $76.5 million of borrowings outstanding under the Credit Facility.
On May 31, 2019, the Company as transferor and FLLP 2015-1, LLC, a wholly-owned subsidiary of the Company, as borrower entered into amendment number five to the $75 million FLLP Facility with Wells Fargo Bank, NA acting as administrative agent. The Company acts as servicer under the FLLP Facility. The FLLP Facility is scheduled to mature on May 31, 2024. The FLLP Facility generally bears interest at a rate of LIBOR plus a range of 2.15-2.25%. The Company and FLLP 2015-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The FLLP Facility also includes usual and customary events of default for credit facilities of this nature. On May 11, 2021, the maximum facility amount was reduced from $75.0 million to $11.3 million and the reinvestment period was terminated. On September 30, 2021, the FLLP Facility was repaid and terminated.
At December 31, 2021, the Company was in compliance with all financial and operational covenants required by its credit facilities.
88
Contractual Obligations
Payments due by Period as of December 31, 2021 (dollars in millions) |
||||||||||||||||||||
Total | Less than 1 year |
1-3 years | 3-5 years | More than 5 years |
||||||||||||||||
Revolving credit facilities (1) |
$ | 76.5 | $ | | $ | | $ | 76.5 | $ | | ||||||||||
Unsecured senior notes |
85.0 | | | 85.0 | |
(1) | At December 31, 2021, we had a total of $148.5 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits. |
Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which SLR Capital Partners has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which SLR Capital Management has agreed to furnish us with the facilities and administrative services necessary to conduct our day-to-day operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a two-part incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrators overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and Administration Agreement without penalty upon 60 days written notice to the other. See note 3 to our Consolidated Financial Statements.
Senior Securities
Information about our senior securities is shown in the following table as of the year ended December 31, 2021 and each year ended December 31 since the Company commenced operations, unless otherwise noted. The indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
Class and Year |
Total Amount Outstanding(1) |
Asset Coverage Per Unit(2) |
Involuntary Liquidating Preference Per Unit(3) |
Average Market Value Per Unit(4) |
||||||||||||
Credit Facility |
||||||||||||||||
Fiscal 2021 |
$ | 76,500 | $ | 1,200 | $ | | N/A | |||||||||
Fiscal 2020 |
| | | N/A | ||||||||||||
Fiscal 2019 |
157,600 | 1,671 | | N/A | ||||||||||||
Fiscal 2018 |
119,200 | 1,770 | | N/A | ||||||||||||
Fiscal 2017 |
124,200 | 3,175 | | N/A | ||||||||||||
Fiscal 2016 |
98,300 | 3,738 | | N/A | ||||||||||||
Fiscal 2015 |
116,200 | 2,621 | | N/A | ||||||||||||
Fiscal 2014 |
143,200 | 2,421 | | N/A | ||||||||||||
Fiscal 2013 |
61,400 | 4,388 | | N/A | ||||||||||||
Fiscal 2012 |
39,100 | 5,453 | | N/A | ||||||||||||
Fiscal 2011 |
8,600 | 21,051 | | N/A |
89
Class and Year |
Total Amount Outstanding(1) |
Asset Coverage Per Unit(2) |
Involuntary Liquidating Preference Per Unit(3) |
Average Market Value Per Unit(4) |
||||||||||||
FLLP Facility |
||||||||||||||||
Fiscal 2021 |
| | | N/A | ||||||||||||
Fiscal 2020 |
5,403 | 229 | | N/A | ||||||||||||
Fiscal 2019 |
53,602 | 569 | | N/A | ||||||||||||
Fiscal 2018 |
51,371 | 762 | | N/A | ||||||||||||
2025 Unsecured Notes |
||||||||||||||||
Fiscal 2021 |
85,000 | 1,334 | | N/A | ||||||||||||
Fiscal 2020 |
85,000 | 3,596 | | N/A | ||||||||||||
Total Senior Securities |
| |||||||||||||||
Fiscal 2021 |
$ | 161,500 | $ | 2,534 | $ | | N/A | |||||||||
Fiscal 2020 |
90,403 | 3,825 | | N/A | ||||||||||||
Fiscal 2019 |
211,202 | 2,240 | | N/A | ||||||||||||
Fiscal 2018 |
170,571 | 2,532 | | N/A | ||||||||||||
Fiscal 2017 |
124,200 | 3,175 | | N/A | ||||||||||||
Fiscal 2016 |
98,300 | 3,738 | | N/A | ||||||||||||
Fiscal 2015 |
116,200 | 2,621 | | N/A | ||||||||||||
Fiscal 2014 |
143,200 | 2,421 | | N/A | ||||||||||||
Fiscal 2013 |
61,400 | 4,388 | | N/A | ||||||||||||
Fiscal 2012 |
39,100 | 5,453 | | N/A | ||||||||||||
Fiscal 2011 |
8,600 | 21,051 | | N/A |
(1) | Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. |
(2) | The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit was divided based on the amount outstanding at the end of the period for each. As of December 31, 2021, asset coverage was 253.4%. |
(3) | The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. |
(4) | Not applicable, we do not have senior securities that are registered for public trading. |
90
The following is a schedule of financial highlights for the respective years:
Year ended December 31, 2016 |
Year ended December 31, 2015 |
Year ended December 31, 2014 |
Year ended December 31, 2013 |
Year ended December 31, 2012 |
||||||||||||||||
Per Share Data: (a) |
||||||||||||||||||||
Net asset value, beginning of year |
$ | 16.33 | $ | 17.65 | $ | 18.04 | $ | 18.33 | $ | 18.15 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
1.42 | 1.33 | 1.20 | 1.17 | 1.31 | |||||||||||||||
Net realized and unrealized gain (loss) |
0.50 | (1.24 | ) | (0.18 | ) | (0.07 | ) | 0.15 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase in net assets resulting from operations |
1.92 | 0.09 | 1.02 | 1.10 | 1.46 | |||||||||||||||
Distributions to stockholders (see note 9a): |
||||||||||||||||||||
From net investment income |
(1.42 | ) | (1.41 | ) | (1.29 | ) | (1.20 | ) | (1.24 | ) | ||||||||||
From net realized gains |
| | | | (0.05 | ) | ||||||||||||||
From return of capital |
| | (0.12 | ) | (0.22 | ) | | |||||||||||||
Anti-dilution |
| | | 0.05 | | |||||||||||||||
Offering costs and other |
(0.03 | ) | | | (0.02 | ) | 0.01 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 16.80 | $ | 16.33 | $ | 17.65 | $ | 18.04 | $ | 18.33 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Per share market value, end of year |
$ | 16.44 | $ | 14.90 | $ | 14.97 | $ | 18.22 | $ | 18.66 | ||||||||||
Total Return(b) |
20.70 | % | 8.90 | % | (10.47 | %) | 5.39 | % | 27.65 | % | ||||||||||
Net assets, end of year |
$ | 269,145 | $ | 188,304 | $ | 203,519 | $ | 208,017 | $ | 174,103 | ||||||||||
Shares outstanding, end of year |
16,025,011 | 11,533,315 | 11,533,315 | 11,529,303 | 9,500,100 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to average net assets: |
||||||||||||||||||||
Net investment income |
8.68 | % | 7.63 | % | 6.69 | % | 6.46 | % | 7.14 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses |
2.65 | %* | 2.92 | %* | 2.50 | %* | 2.46 | % | 3.20 | % | ||||||||||
Interest and other credit facility expenses** |
1.56 | % | 2.08 | % | 1.52 | % | 0.62 | % | 1.40 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses |
4.21 | %* | 5.00 | %* | 4.02 | %* | 3.08 | % | 4.60 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Average debt outstanding |
$ | 109,938 | $ | 136,900 | $ | 72,132 | $ | 41,261 | $ | 41,439 | ||||||||||
Portfolio turnover ratio |
38.4 | % | 34.0 | % | 47.5 | % | 56.8 | % | 74.5 | % |
(a) | Calculated using the average shares outstanding method. |
(b) | Total return is based on the change in market price per share during the year and takes into account any distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. |
* | The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a voluntary incentive fee waiver (see note 3). |
For the year ended December 31, 2016, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.60% and 5.15%, respectively, without the voluntary management and incentive fee waivers. For the year ended December 31, 2015, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.29% and 5.37%, respectively, without the voluntary management and incentive fee waivers. For the year ended December 31, 2014, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.61% and 4.13%, respectively, without the voluntary management and incentive fee waivers.
** | Ratios shown without the non-recurring costs associated with the amendments of the Credit Facility would be 1.56%, 1.67%, 1.05%, 0.62% and 0.85%, respectively, for the years ended December 31, 2016, 2015, 2014, 2013 and 2012. |
91
Off-Balance Sheet Arrangements
From time-to-time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Companys liquidity and cash available for investment, prudent portfolio management of issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at December 31, 2021 and December 31, 2020, respectively:
December 31, 2021 | December 31, 2020 | |||||||
(in millions) | ||||||||
Arcutis Biotherpeutics, Inc |
$ | 6.7 | $ | | ||||
CC SAG Holdings Corp. (Spectrum Automotive) |
6.2 | | ||||||
NAC Holdings Corp |
5.1 | | ||||||
Glooko, Inc |
4.7 | | ||||||
Vessco Midco Holdings, LLC |
4.6 | | ||||||
BridgeBio Pharma, Inc |
4.0 | | ||||||
Plastics Management, LLC |
3.5 | | ||||||
Tilley Chemical Buyer, Inc |
2.3 | | ||||||
Maurices, Inc |
2.2 | | ||||||
Ivy Fertility Services, LLC |
1.5 | | ||||||
Drilling Info Holdings, Inc. |
1.4 | 1.0 | ||||||
SLR Healthcare ABL* |
1.4 | 1.4 | ||||||
RQM+ Corp |
1.3 | | ||||||
Composite Technology Acquisition Corp. |
1.3 | 1.3 | ||||||
RxSense Holdings LLC. |
1.3 | 1.2 | ||||||
Erie Construction Mid-west, LLC |
1.2 | | ||||||
TAUC Management, LLC |
1.2 | | ||||||
GSM Acquisition Corp |
0.9 | | ||||||
High Street Buyer, Inc |
0.8 | | ||||||
SOC Telemed, Inc |
0.7 | | ||||||
Foundation Consumer Brands, LLC |
0.7 | | ||||||
BayMark Health Services, Inc |
0.7 | | ||||||
Pinnacle Treatment Centers, Inc. |
0.4 | 0.4 | ||||||
Ultimate Baked Goods Midco, LLC |
0.3 | | ||||||
Neuronetics, Inc. |
0.3 | 1.0 | ||||||
SunMed Group Holdings, LLC |
0.3 | | ||||||
World Insurance Associates, LLC. |
0.3 | 1.1 | ||||||
American Teleconferencing Services, Ltd |
0.3 | | ||||||
All State Ag Parts, LLC |
0.3 | | ||||||
ENS Holdings III Corp. & ES Opco USA LLC |
0.2 | 0.6 | ||||||
Smile Doctors LLC |
| 8.7 | ||||||
RSC Acquisition, Inc |
| 3.0 | ||||||
Higginbotham Insurance Agency, Inc. |
| 1.4 | ||||||
Worldwide Facilities, LLC. |
| 1.3 | ||||||
Kindred Biosciences, Inc |
| 1.1 | ||||||
Trinity Partners, LLC. |
| 0.7 | ||||||
Sentry Data Systems, Inc. |
| 0.5 | ||||||
AQA Acquisition Holding, Inc. |
| 0.1 | ||||||
|
|
|
|
|||||
Total Commitments |
$ | 56.1 | $ | 24.8 |
* | The Company controls the funding of the SLR Healthcare ABL commitment and may cancel it at its discretion. |
92
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio companys achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2021 and December 31, 2020, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
Date Declared |
Record Date | Payment Date | Amount | |||||||||
Fiscal 2022 |
||||||||||||
March 1, 2022 |
March 18, 2022 | April 1, 2022 | $ | 0.10 | ||||||||
February 3, 2022 |
February 17, 2022 | March 1, 2022 | 0.10 | |||||||||
January 5, 2022 |
January 20, 2022 | February 2, 2022 | 0.10 | |||||||||
|
|
|||||||||||
YTD Total (2022) |
$ | 0.30 | ||||||||||
|
|
|||||||||||
Fiscal 2021 |
||||||||||||
December 1, 2021 |
December 16, 2021 | January 5, 2022 | $ | 0.10 | ||||||||
November 3, 2021 |
November 18, 2021 | December 2, 2021 | 0.10 | |||||||||
October 6, 2021 |
October 21, 2021 | November 3, 2021 | 0.10 | |||||||||
September 9, 2021 |
September 23, 2021 | October 1, 2021 | 0.10 | |||||||||
August 3, 2021 |
August 19, 2021 | September 3, 2021 | 0.10 | |||||||||
July 7, 2021 |
July 22, 2021 | August 3, 2021 | 0.10 | |||||||||
June 4, 2021 |
June 23, 2021 | July 2, 2021 | 0.10 | |||||||||
May 5, 2021 |
May 20, 2021 | June 2, 2021 | 0.10 | |||||||||
April 6, 2021 |
April 21, 2021 | April 30, 2021 | 0.10 | |||||||||
February 24, 2021 |
March 18, 2021 | April 2, 2021 | 0.10 | |||||||||
February 3,2021 |
February 18, 2021 | March 2, 2021 | 0.10 | |||||||||
January 8, 2021 |
January 25, 2021 | February 2, 2021 | 0.10 | |||||||||
|
|
|||||||||||
Total (2021) |
$ | 1.20 | ||||||||||
|
|
|||||||||||
Fiscal 2022 |
||||||||||||
March 1, 2022 |
March 18, 2022 | April 1, 2022 | $ | 0.10 | ||||||||
February 3, 2022 |
February 17, 2022 | March 1, 2022 | 0.10 | |||||||||
January 5, 2022 |
January 20, 2022 | February 2, 2022 | 0.10 | |||||||||
|
|
|||||||||||
YTD Total (2022) |
$ | 0.30 | ||||||||||
|
|
93
Date Declared |
Record Date | Payment Date | Amount | |||||
Fiscal 2020 |
||||||||
December 8, 2020 |
December 22, 2020 | January 5, 2021 | $ | 0.10 | ||||
November 5, 2020 |
November 19, 2020 | December 2, 2020 | 0.10 | |||||
October 6, 2020 |
October 22, 2020 | October 30, 2020 | 0.10 | |||||
September 9, 2020 |
September 24, 2020 | October 2, 2020 | 0.10 | |||||
August 4, 2020 |
August 20, 2020 | September 2, 2020 | 0.10 | |||||
July 7, 2020 |
July 22, 2020 | July 31, 2020 | 0.10 | |||||
June 4, 2020 |
June 18, 2020 | July 1, 2020 | 0.10 | |||||
May 7, 2020 |
May 22, 2020 | June 2, 2020 | 0.10 | |||||
April 2, 2020 |
April 23, 2020 | May 1, 2020 | 0.1175 | |||||
February 20, 2020 |
March 19, 2020 | April 3, 2020 | 0.1175 | |||||
February 4,2020 |
February 20, 2020 | February 28, 2020 | 0.1175 | |||||
January 8, 2020 |
January 23, 2020 | January 31, 2020 | 0.1175 | |||||
|
|
|||||||
Total (2020) |
$ | 1.27 | ||||||
|
|
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future distributions, if any, will be determined by our Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or non-taxable return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC status, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (i.e., net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an opt out dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically opt out of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual payment-in-kind income, which represents contractual interest added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders. For the fiscal years ended December 31, 2021 and December 31, 2020, 0.0% and 18.4% of distributions were funded from the waiver of management and/or incentive fees.
94
Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
| We have entered into the Advisory Agreement with SLR Capital Partners. Mr. Gross, our Chairman, Co-Chief Executive Officer and President and Mr. Spohler, our Co-Chief Executive Office, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for SLR Capital Partners. |
| The Administrator provides us with the office facilities and administrative services necessary to conduct day-to-day operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs. |
| We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a non-exclusive, royalty-free license to use the licensed marks Solar and SLR. |
The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SLR Investment Corp., a publicly traded BDC, which focuses on investing in senior secured loans, and to a lesser extent unsecured loans and equity securities, as well as SCP Private Income BDC LLC, an unlisted BDC that focuses primarily in senior secured loans, including asset-based loans and first lien loans and SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry. In addition, Michael S. Gross, our Chairman, Co-Chief Executive Officer and President, Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SLR Investment Corp., SCP Private Credit Income BDC LLC and SLR HC BDC LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Advisers allocation procedures. On June 13, 2017, the Adviser received an exemptive order that permits the Company to participate in negotiated co-investment transactions with certain affiliates, in a manner consistent with the Companys investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the Order). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entitys investment strategy, on an alternating basis. Although the Advisers investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Adviser.
Related party transactions may occur among SLR Senior Investment Corp., SLR Healthcare ABL and SLR Business Credit. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Healthcare ABL or SLR Business Credit.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
95
Item 7A. | Quantitative and Qualitative Disclosures About Market Risk |
We are subject to financial market risks, including changes in interest rates. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global COVID-19 pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in value of the securities that we hold. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In connection with the COVID-19 pandemic, the U.S. Federal Reserve and other central banks have reduced certain interest rates and LIBOR has decreased. In a prolonged low interest rate environment, including a reduction of LIBOR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net investment income. During the fiscal year ended December 31, 2021, certain of the investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have LIBOR floors. The Company also has revolving credit facilities that are generally based on floating LIBOR. Assuming no changes to our balance sheet as of December 31, 2021 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR on our comprehensive floating rate assets and liabilities would decrease our net investment income by one cent per average share over the next twelve months. Assuming no changes to our balance sheet as of December 31, 2021 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR on our comprehensive floating rate assets and liabilities would decrease our net investment income by approximately two cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time-to-time by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At December 31, 2021, we have no interest rate hedging instruments outstanding on our balance sheet.
Increase (Decrease) in LIBOR |
(1.00 | %) | 1.00 | % | ||||
|
|
|
|
|||||
Increase (Decrease) in Net Investment Income Per Share Per Year |
$ | (0.01 | ) | $ | (0.02 | ) | ||
|
|
|
|
Item 8. | Financial Statements and Supplementary Data |
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
96
Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Senior Investment Corp. (formerly, Solar Senior Capital Ltd.):
Opinion on the Consolidated Financial Statements
We have audited the accompanying consolidated statements of assets and liabilities, including the consolidated schedules of investments, of SLR Senior Investment Corp. (and subsidiaries) (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, changes in net assets, and cash flows for each of the years in the three-year period ended December 31, 2021, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.
Basis for Opinion
These consolidated financial statements are the responsibility of the Companys management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our procedures included confirmation of securities owned as of December 31, 2021 and 2020, by correspondence with the custodian, portfolio companies or agents. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Fair value of investments
As described in Notes 2 and 6 to the consolidated financial statements, the Company measures its investments at fair value. Investments are valued using a market approach, an income approach, or both approaches, as applicable. In determining the fair value of investments whose market quotations are not
97
readily available, the Company makes subjective judgments and estimates using unobservable inputs. As of December 31, 2021, the fair value of such investments was $403 million.
We identified the assessment of the fair value of investments with no readily determinable market value as a critical audit matter. A high degree of auditor judgment was required to assess the Companys fair value assumptions. Specifically, subjective auditor judgment was required to assess the (1) credit risk associated with the borrower and its ability to make interest and principal payments for debt investments and (2) selection of comparable companies and the financial performance multiples of such comparable companies used in the market approach for equity investments. Additionally, the involvement of valuation professionals with specialized skills and knowledge was required to assist in evaluating the Companys fair value estimates.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design of certain internal controls over the Companys process to measure the fair value of investments, including controls related to the development of the above assumptions. For recently purchased investments we evaluated changes in the borrowers assessed credit risk and market yields from the purchase date to year end. We evaluated the Companys ability to estimate fair value by comparing dispositions to the Companys most recent fair value estimate prior to the disposition. We also involved valuation professionals with specialized skills and knowledge, who for a selection of investments developed estimates of fair value by assessing available market information using market yields of comparable companies of similar credit risk, for debt investments fair valued using an income approach, and financial performance multiples of comparable companies, for equity investments fair valued using a market approach, and compared the results to the Companys fair value estimates.
/s/ KPMG LLP
We have served as the Companys auditor since 2010.
New York, New York
March 1, 2022
98
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
December 31, 2021 | December 31, 2020 | |||||||
Assets |
||||||||
Investments at fair value: |
||||||||
Companies less than 5% owned (cost: $297,174 and $251,163, respectively) |
$ | 287,255 | $ | 246,963 | ||||
Companies more than 25% owned (cost: $117,439 and $98,439, respectively) |
115,867 | 93,867 | ||||||
Cash |
5,839 | 3,851 | ||||||
Cash equivalents (cost: $160,000 and $299,998, respectively) |
160,000 | 299,998 | ||||||
Interest receivable |
1,323 | 1,373 | ||||||
Dividends receivable |
2,143 | 1,753 | ||||||
Receivable for investments sold |
263 | | ||||||
Prepaid expenses and other assets |
197 | 192 | ||||||
|
|
|
|
|||||
Total assets |
$ | 572,887 | $ | 647,997 | ||||
|
|
|
|
|||||
Liabilities |
||||||||
Debt ($161,500 and $90,403 face amounts, respectively, reported net of unamortized debt issuance costs of $1,581 and $1,910, respectively. See note 7) |
$ | 159,919 | $ | 88,493 | ||||
Payable for cash equivalents purchased |
160,000 | 299,998 | ||||||
Distributions payable |
1,605 | 1,605 | ||||||
Management fee payable (see note 3) |
1,038 | | ||||||
Interest payable (see note 7) |
1,081 | 1,312 | ||||||
Administrative services payable (see note 3) |
846 | 646 | ||||||
Other liabilities and accrued expenses |
715 | 539 | ||||||
|
|
|
|
|||||
Total liabilities |
$ | 325,204 | $ | 392,593 | ||||
|
|
|
|
|||||
Commitments and contingencies (see note 11) |
||||||||
Net Assets |
||||||||
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 16,049,034 and 16,049,034 issued and outstanding, respectively |
$ | 160 | $ | 160 | ||||
Paid-in capital in excess of par (see note 2f) |
270,781 | 274,205 | ||||||
Accumulated distributable net loss (see note 2f) |
(23,258 | ) | (18,961 | ) | ||||
|
|
|
|
|||||
Total net assets |
$ | 247,683 | $ | 255,404 | ||||
|
|
|
|
|||||
Net Asset Value Per Share |
$ | 15.43 | $ | 15.91 | ||||
|
|
|
|
See notes to consolidated financial statements.
99
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share amounts)
Year ended December 31, | ||||||||||||
2021 | 2020 | 2019 | ||||||||||
INVESTMENT INCOME: |
||||||||||||
Interest: |
||||||||||||
Companies less than 5% owned |
$ | 20,095 | $ | 22,830 | $ | 30,496 | ||||||
Companies 5% to 25% owned |
| | 386 | |||||||||
Dividends: |
||||||||||||
Companies more than 25% owned |
9,130 | 8,500 | 9,060 | |||||||||
Other income: |
||||||||||||
Companies less than 5% owned |
94 | 474 | 122 | |||||||||
Companies 5% to 25% owned |
| | 27 | |||||||||
|
|
|
|
|
|
|||||||
Total investment income |
29,319 | 31,804 | 40,091 | |||||||||
|
|
|
|
|
|
|||||||
EXPENSES: |
||||||||||||
Management fees (see note 3) |
$ | 3,907 | $ | 4,119 | $ | 4,799 | ||||||
Performance-based incentive fees (see note 3) |
| 95 | 1,484 | |||||||||
Interest and other credit facility expenses (see note 7) |
6,923 | 7,898 | 10,738 | |||||||||
Administrative services expense (see note 3) |
1,710 | 1,575 | 1,575 | |||||||||
Other general and administrative expenses |
2,459 | 1,485 | 1,667 | |||||||||
|
|
|
|
|
|
|||||||
Total expenses |
14,999 | 15,172 | 20,263 | |||||||||
|
|
|
|
|
|
|||||||
Management fees waived (see note 3) |
| (3,655 | ) | (1,317 | ) | |||||||
Performance-based incentive fees waived (see note 3) |
| (95 | ) | (1,476 | ) | |||||||
|
|
|
|
|
|
|||||||
Net expenses |
14,999 | 11,422 | 17,470 | |||||||||
|
|
|
|
|
|
|||||||
Net investment income |
$ | 14,320 | $ | 20,382 | $ | 22,621 | ||||||
|
|
|
|
|
|
|||||||
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS: |
||||||||||||
Net realized gain (loss) on investments and cash equivalents: |
||||||||||||
Companies less than 5% owned |
$ | (63 | ) | $ | 193 | $ | (6,741 | ) | ||||
Companies 5% to 25% owned |
| | 1,979 | |||||||||
|
|
|
|
|
|
|||||||
Net realized gain (loss) on investments and cash equivalents |
(63 | ) | 193 | (4,762 | ) | |||||||
|
|
|
|
|
|
|||||||
Net change in unrealized gain (loss) on investments and cash equivalents: |
||||||||||||
Companies less than 5% owned |
(5,719 | ) | (1,918 | ) | 4,861 | |||||||
Companies 5% to 25% owned |
| | 1,174 | |||||||||
Companies more than 25% owned |
3,000 | (4,733 | ) | (950 | ) | |||||||
|
|
|
|
|
|
|||||||
Net change in unrealized gain (loss) on investments and cash equivalents |
(2,719 | ) | (6,651 | ) | 5,085 | |||||||
|
|
|
|
|
|
|||||||
Net realized and unrealized gain (loss) on investments and cash equivalents |
(2,782 | ) | (6,458 | ) | 323 | |||||||
|
|
|
|
|
|
|||||||
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS |
$ | 11,538 | $ | 13,924 | $ | 22,944 | ||||||
|
|
|
|
|
|
|||||||
EARNINGS PER SHARE (see note 5) |
$ | 0.72 | $ | 0.87 | $ | 1.43 | ||||||
|
|
|
|
|
|
See notes to consolidated financial statements.
100
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS
(in thousands, except share amounts)
Year ended December 31, | ||||||||||||
2021 | 2020 | 2019 | ||||||||||
Increase (decrease) in net assets resulting from operations: |
||||||||||||
Net investment income |
$ | 14,320 | $ | 20,382 | $ | 22,621 | ||||||
Net realized gain (loss) |
(63 | ) | 193 | (4,762 | ) | |||||||
Net change in unrealized gain (loss) |
(2,719 | ) | (6,651 | ) | 5,085 | |||||||
|
|
|
|
|
|
|||||||
Net increase in net assets resulting from operations |
11,538 | 13,924 | 22,944 | |||||||||
|
|
|
|
|
|
|||||||
Distributions to stockholders (see note 9a): |
||||||||||||
From net investment income |
(15,974 | ) | (12,544 | ) | (15,924 | ) | ||||||
From return of capital |
(3,285 | ) | (7,838 | ) | (6,697 | ) | ||||||
|
|
|
|
|
|
|||||||
Net distributions to stockholders |
(19,259 | ) | (20,382 | ) | (22,621 | ) | ||||||
|
|
|
|
|
|
|||||||
Capital transactions (see note 13): |
||||||||||||
Reinvestment of distributions |
| 48 | 99 | |||||||||
|
|
|
|
|
|
|||||||
Net increase in net assets resulting from capital transactions |
| 48 | 99 | |||||||||
|
|
|
|
|
|
|||||||
Total increase (decrease) in net assets |
(7,721 | ) | (6,410 | ) | 422 | |||||||
Net assets at beginning of year |
255,404 | 261,814 | 261,392 | |||||||||
|
|
|
|
|
|
|||||||
Net assets at end of year |
$ | 247,683 | $ | 255,404 | $ | 261,814 | ||||||
|
|
|
|
|
|
|||||||
Capital share activity (see note 13): |
||||||||||||
Common stock issued from reinvestment of distributions |
| 2,820 | 5,729 | |||||||||
|
|
|
|
|
|
|||||||
Net increase from capital share activity |
| 2,820 | 5,729 | |||||||||
|
|
|
|
|
|
See notes to consolidated financial statements.
101
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Year ended December 31, | ||||||||||||
2021 | 2020 | 2019 | ||||||||||
Cash Flows from Operating Activities: |
||||||||||||
Net increase in net assets resulting from operations |
$ | 11,538 | $ | 13,924 | $ | 22,944 | ||||||
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities: |
||||||||||||
Net realized (gain) loss on investments and cash equivalents |
63 | (193 | ) | 4,762 | ||||||||
Net change in unrealized (gain) loss on investments and cash equivalents |
2,719 | 6,651 | (5,085 | ) | ||||||||
(Increase) decrease in operating assets: |
||||||||||||
Purchase of investments |
(191,893 | ) | (70,737 | ) | (108,104 | ) | ||||||
Proceeds from disposition of investments |
128,116 | 185,203 | 99,300 | |||||||||
Net accretion of discount on investments |
(1,054 | ) | (1,094 | ) | (1,262 | ) | ||||||
Capitalization of payment-in-kind income |
(243 | ) | (395 | ) | (513 | ) | ||||||
Collection of payment-in-kind income |
| | 748 | |||||||||
Receivable for investments sold |
(263 | ) | 6,667 | (6,580 | ) | |||||||
Interest receivable |
50 | 560 | 208 | |||||||||
Dividends receivable |
(390 | ) | 140 | | ||||||||
Prepaid expenses and other assets |
(5 | ) | 56 | (60 | ) | |||||||
Increase (decrease) in operating liabilities: |
||||||||||||
Payable for investments and cash equivalents purchased |
(139,998 | ) | 198,187 | 79,006 | ||||||||
Management fee payable |
1,038 | (426 | ) | (763 | ) | |||||||
Performance-based incentive fees payable |
| | (106 | ) | ||||||||
Administrative services expense payable |
200 | (180 | ) | (97 | ) | |||||||
Interest payable |
(231 | ) | 140 | (88 | ) | |||||||
Other liabilities and accrued expenses |
176 | (184 | ) | (103 | ) | |||||||
Deferred financing costs |
805 | 722 | 527 | |||||||||
|
|
|
|
|
|
|||||||
Net Cash Provided by (Used in) Operating Activities |
(189,372 | ) | 339,041 | 84,734 | ||||||||
|
|
|
|
|
|
|||||||
Cash Flows from Financing Activities: |
||||||||||||
Cash distributions paid |
(19,259 | ) | (20,614 | ) | (22,522 | ) | ||||||
Proceeds from issuance of unsecured debt |
| 84,270 | | |||||||||
Proceeds from secured borrowings |
199,124 | 92,500 | 141,765 | |||||||||
Repayments of secured borrowings |
(128,503 | ) | (298,300 | ) | (101,900 | ) | ||||||
|
|
|
|
|
|
|||||||
Net Cash Provided by (Used in) Financing Activities |
51,362 | (142,144 | ) | 17,343 | ||||||||
|
|
|
|
|
|
|||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
(138,010 | ) | 196,897 | 102,077 | ||||||||
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR |
303,849 | 106,952 | 4,875 | |||||||||
|
|
|
|
|
|
|||||||
CASH AND CASH EQUIVALENTS AT END OF YEAR |
$ | 165,839 | $ | 303,849 | $ | 106,952 | ||||||
|
|
|
|
|
|
|||||||
Supplemental disclosure of cash flow information: |
||||||||||||
Cash paid for interest |
$ | 7,154 | $ | 7,758 | $ | 10,826 | ||||||
|
|
|
|
|
|
Non-cash financing activities consist of the reinvestment of dividends of $0, $48 and $99 for the fiscal years ended December 31, 2021, 2020 and 2019, respectively.
See notes to consolidated financial statements.
102
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2021
(in thousands, except share/unit amounts)
Description |
Industry |
Spread above Index (3) |
Libor Floor |
Interest Rate(1) | Acquisition Date |
Maturity Date |
Par Amount |
Cost | Fair Value |
|||||||||||||||||||||
Bank Debt/Senior Secured Loans 115.9% |
| |||||||||||||||||||||||||||||
Aegis Toxicology Sciences Corporation(2) |
Health Care Providers & Services | L+550 | 1.00 | % | 6.50 | % | 5/7/2018 | 5/9/2025 | $ | 7,905 | $ | 7,825 | $ | 7,905 | ||||||||||||||||
Alimera Sciences, Inc.(2). |
Pharmaceuticals | L+765 | 1.78 | % | 9.43 | % | 12/31/2019 | 7/1/2024 | 3,085 | 3,152 | 3,147 | |||||||||||||||||||
All State Ag Parts, LLC(2). |
Trading Companies & Distributors | L+500 | 1.00 | % | 6.00 | % | 9/1/2021 | 9/1/2026 | 2,152 | 2,122 | 2,152 | |||||||||||||||||||
Alteon Health, LLC (f/k/a Island Medical)(2) |
Health Care Providers & Services | L+650 | 1.00 | % | 7.50 | % | 3/31/2017 | 9/1/2023 | 6,904 | 6,886 | 6,904 | |||||||||||||||||||
American Teleconferencing Services, Ltd.* |
Communications Equipment | L+650 | 1.00 | % | 7.50 | % | 5/5/2016 | 9/9/2021 | 11,313 | 11,133 | 1,525 | |||||||||||||||||||
American Teleconferencing Services, Ltd.* |
Communications Equipment | L+650 | 1.00 | % | 7.50 | % | 9/17/2021 | 3/31/2022 | 2,085 | 2,052 | 2,085 | |||||||||||||||||||
Arcutis Biotherapeutics, Inc. (4) |
Pharmaceuticals | L+745 | 0.10 | % | 7.55 | % | 12/22/2021 | 1/1/2027 | 3,333 | 3,319 | 3,318 | |||||||||||||||||||
BayMark Health Services, Inc. (2) |
Health Care Providers & Services | L+500 | 1.00 | % | 6.00 | % | 6/29/2021 | 6/11/2027 | 12,250 | 12,132 | 12,250 | |||||||||||||||||||
BridgeBio Pharma, Inc. (4) |
Biotechnology | | | 9.00 | % | 11/17/2021 | 11/17/2026 | 6,000 | 5,915 | 5,910 | ||||||||||||||||||||
CC SAG Holdings Corp. (Spectrum Automotive) (2) |
Diversified Consumer Services | L+575 | 0.75 | % | 6.50 | % | 6/29/2021 | 6/29/2028 | 4,032 | 3,975 | 4,032 | |||||||||||||||||||
Cerapedics, Inc. (2) |
Health Care Equipment & Supplies | L+695 | 2.50 | % | 9.45 | % | 3/22/2019 | 3/1/2025 | 4,121 | 4,222 | 4,214 | |||||||||||||||||||
Community Brands ParentCo, LLC (f/k/a Ministry Brands) (2) |
Software | L+400 | 1.00 | % | 5.00 | % | 6/11/2021 | 12/2/2022 | 13,883 | 13,859 | 13,883 | |||||||||||||||||||
Composite Technology Acquisition Corp. (ClockSpring) (2) |
Building Products | L+500 | 1.00 | % | 6.00 | % | 2/1/2019 | 2/1/2025 | 10,712 | 10,623 | 10,605 | |||||||||||||||||||
DISA Holdings Acquisition Subsidiary Corp.(2) |
Professional Services | L+400 | 1.00 | % | 5.00 | % | 6/14/2018 | 6/30/2022 | 9,061 | 9,053 | 9,061 | |||||||||||||||||||
Drilling Info Holdings, Inc.(2) |
IT Services | L+450 | | 4.60 | % | 1/31/2020 | 7/30/2025 | 11,306 | 11,091 | 11,306 | ||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin)(2) |
Trading Companies & Distributors | L+475 | 1.00 | % | 5.75 | % | 12/31/2019 | 12/31/2025 | 6,041 | 5,956 | 6,041 | |||||||||||||||||||
Erie Construction Mid-west, LLC(2) |
Building Products | L+475 | 1.00 | % | 5.75 | % | 8/5/2021 | 7/30/2027 | 9,189 | 9,037 | 9,189 | |||||||||||||||||||
Foundation Consumer Brands, LLC(2) |
Personal Products | L+638 | 1.00 | % | 7.38 | % | 2/12/2021 | 2/12/2027 | 10,886 | 10,647 | 10,886 | |||||||||||||||||||
Glooko, Inc.(2) |
Health Care Technology | L+790 | 0.10 | % | 8.00 | % | 9/30/2021 | 10/1/2026 | 1,563 | 1,558 | 1,555 | |||||||||||||||||||
GSM Acquisition Corp.(2) |
Leisure Equipment & Products | L+500 | 1.00 | % | 6.00 | % | 4/20/2021 | 11/16/2026 | 11,102 | 10,999 | 11,102 | |||||||||||||||||||
Higginbotham Insurance Agency, Inc.(2) |
Insurance | L+550 | 0.75 | % | 6.25 | % | 11/25/2020 | 11/25/2026 | 6,286 | 6,204 | 6,286 | |||||||||||||||||||
High Street Buyer, Inc.(2) |
Insurance | L+600 | 0.75 | % | 6.75 | % | 4/16/2021 | 4/16/2028 | 7,240 | 7,101 | 7,240 | |||||||||||||||||||
Ivy Fertility Services, LLC |
Health Care Providers & Services | L+625 | 1.00 | % | 7.25 | % | 12/22/2021 | 2/25/2026 | 7,183 | 7,058 | 7,057 | |||||||||||||||||||
KORE Wireless Group, Inc.(2)(4) |
Wireless Telecommunication Services | L+550 | | 5.72 | % | 12/21/2018 | 12/21/2024 | 11,803 | 11,671 | 11,803 | ||||||||||||||||||||
Logix Holding Company, LLC(2) |
Communications Equipment | L+575 | 1.00 | % | 6.75 | % | 8/11/2017 | 12/22/2024 | 11,018 | 10,956 | 10,687 | |||||||||||||||||||
Maurices, Incorporated(2) |
Specialty Retail | L+675 | 1.00 | % | 7.75 | % | 8/27/2021 | 6/1/2024 | 1,996 | 1,960 | 1,996 | |||||||||||||||||||
NAC Holdings Corporation (Jaguar)(2) |
Insurance | L+525 | 1.00 | % | 6.25 | % | 7/30/2021 | 9/28/2024 | 5,277 | 5,212 | 5,250 | |||||||||||||||||||
National Spine and Pain Centers, LLC |
Health Care Providers & Services | L+500 | 1.00 | % | 6.00 | % | 9/18/2018 | 6/2/2024 | 2,506 | 2,501 | 2,481 | |||||||||||||||||||
Neuronetics, Inc.(2). |
Health Care Equipment & Supplies | L+765 | 1.66 | % | 9.31 | % | 3/2/2020 | 2/28/2025 | 2,400 | 2,440 | 2,440 | |||||||||||||||||||
Pinnacle Treatment Centers, Inc.(2) |
Health Care Providers & Services | L+575 | 1.00 | % | 6.75 | % | 1/22/2020 | 12/31/2022 | 3,768 | 3,754 | 3,768 | |||||||||||||||||||
Plastics Management, LLC(2) |
Health Care Providers & Services | L+500 | 1.00 | % | 6.00 | % | 8/26/2021 | 8/18/2027 | 5,701 | 5,619 | 5,644 | |||||||||||||||||||
PPT Management Holdings, LLC(2) |
Health Care Providers & Services | L+800(8) | 1.00 | % | 9.00 | % | 12/15/2016 | 12/16/2022 | 9,077 | 9,062 | 7,897 | |||||||||||||||||||
RQM+ Corp.(2) |
Life Sciences Tools & Services | L+575 | 1.00 | % | 6.75 | % | 8/20/2021 | 8/12/2026 | 5,469 | 5,417 | 5,455 | |||||||||||||||||||
RSC Acquisition, Inc.(2) |
Insurance | L+550 | 0.75 | % | 6.25 | % | 10/5/2020 | 11/1/2026 | 3,921 | 3,814 | 3,921 | |||||||||||||||||||
Rubius Therapeutics, Inc. (2)(4) |
Pharmaceuticals | L+550 | 2.10 | % | 7.60 | % | 12/21/2018 | 6/1/2026 | 6,182 | 6,306 | 6,305 | |||||||||||||||||||
RxSense Holdings LLC(2) |
Diversified Consumer Services | L+500 | 1.00 | % | 6.00 | % | 3/17/2020 | 3/13/2026 | 8,461 | 8,339 | 8,461 | |||||||||||||||||||
scPharmaceuticals, Inc. (2) |
Pharmaceuticals | L+795 | 2.23 | % | 10.18 | % | 9/17/2019 | 9/17/2023 | 629 | 639 | 638 | |||||||||||||||||||
SHO Holding I Corporation (Shoes for Crews)(2) |
Footwear | L+523 | 1.00 | % | 6.23 | % | 11/20/2015 | 4/27/2024 | 5,764 | 5,749 | 5,476 | |||||||||||||||||||
SOC Telemed, Inc. (2) |
Health Care Providers & Services | L+747 | 0.13 | % | 7.60 | % | 3/26/2021 | 4/1/2026 | 5,197 | 5,210 | 5,210 | |||||||||||||||||||
SunMed Group Holdings, LLC(2) |
Health Care Equipment & Supplies | L+575 | 0.75 | % | 6.50 | % | 6/16/2021 | 6/16/2028 | 6,142 | 6,041 | 6,081 | |||||||||||||||||||
TAUC Management, LLC(2) |
Health Care Providers & Services | L+525 | 1.00 | % | 6.25 | % | 2/12/2021 | 2/12/2027 | 6,052 | 5,972 | 5,992 | |||||||||||||||||||
Tilley Chemical Buyer,Inc |
Trading Companies & Distributors | L+600 | 1.00 | % | 7.00 | % | 12/8/2021 | 12/31/2026 | 7,675 | 7,580 | 7,579 | |||||||||||||||||||
Ultimate Baked Goods Midco LLC (Rise Baking)(2) |
Packaged Foods & Meats | L+625 | 1.00 | % | 7.25 | % | 8/12/2021 | 8/13/2027 | 6,422 | 6,270 | 6,262 | |||||||||||||||||||
Vessco Midco Holdings, LLC(2). |
Water Utilities | L+450 | 1.00 | % | 5.50 | % | 9/3/2021 | 11/2/2026 | 1,037 | 1,027 | 1,027 | |||||||||||||||||||
World Insurance Associates, LLC(2). |
Insurance | L+575 | 1.00 | % | 6.75 | % | 10/12/2020 | 4/1/2026 | 14,993 | 14,648 | 14,993 | |||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
Total Bank Debt/Senior Secured Loans |
|
$ | 296,106 | $ | 287,019 | |||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
Common Equity/Equity Interests/Warrants 46.9% | Shares/Units | |||||||||||||||||||||||||||||
Essence Group Holdings Corporation (Lumeris) Warrants. .. |
Health Care Technology | 3/22/2017 | 52,000 | $ | 16 | $ | 64 | |||||||||||||||||||||||
Senseonics Holdings, Inc.(4) |
Health Care Equipment & Supplies | 7/25/2019 | 62,430 | 18 | 167 | |||||||||||||||||||||||||
SLR Business Credit (f/k/a/ North Mill)(4)(5)(7) |
Diversified Financial Services | 10/20/2017 | 100 | 86,000 | 80,000 | |||||||||||||||||||||||||
SLR Healthcare ABL (f/k/a/ Gemino)(4)(5) |
Diversified Financial Services | 9/30/2013 | 32,839 | 31,439 | 35,867 | |||||||||||||||||||||||||
TwentyEighty Investors, LLC. |
Professional Services | 1/31/2017 | 17,214 | 1,000 | 5 | |||||||||||||||||||||||||
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) |
Health Care Equipment & Supplies | 5/10/2018 | 6,078 | 34 | | |||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
Total Common Equity/Equity Interests/Warrants |
|
$ | 118,507 | $ | 116,103 | |||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
Total Investments(6) 162.8% |
|
$ | 414,613 | $ | 403,122 | |||||||||||||||||||||||||
Par Amount | ||||||||||||||||||||||||||||||
Cash Equivalents 64.6% |
| |||||||||||||||||||||||||||||
U.S. Treasury Bill |
Government | 12/31/2021 | 1/25/2022 | $ | 160,000 | $ | 160,000 | $ | 160,000 | |||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||
Total Investments & Cash Equivalents 227.4% |
|
$ | 574,613 | $ | 563,122 | |||||||||||||||||||||||||
Liabilities in Excess of Other Assets (127.4%) |
|
(315,439 | ) | |||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||
Net Assets 100.0% |
|
$ | 247,683 | |||||||||||||||||||||||||||
|
|
See notes to consolidated financial statements.
103
SLR SENIOR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands)
(1) | Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (LIBOR or L) index rate or the prime index rate (PRIME or P), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2021. |
(2) | Indicates an investment that is wholly or partially held by SLR Senior Investment Corp. (the Company, we, us or our) through its wholly-owned financing subsidiary SUNS SPV LLC (the SUNS SPV). Such investments are pledged as collateral under the Senior Secured Revolving Credit Facility (the Credit Facility) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. |
(3) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor. |
(4) | Indicates assets that the Company believes may not represent qualifying assets under Section 55(a) of the Investment Company Act of 1940 (1940 Act), as amended. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 25.0% of the total assets of the Company. |
(5) | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows: |
Name of Issuer |
Fair Value at December 31, 2020 |
Gross Additions |
Gross Reductions |
Realized Gain (Loss) |
Change in Unrealized Gain (Loss) |
Dividend /Other Income |
Fair Value at December 31, 2021 |
|||||||||||||||||||||
SLR Healthcare ABL |
$ | 35,367 | $ | | $ | | $ | | $ | 500 | $ | 3,460 | $ | 35,867 | ||||||||||||||
SLR Business Credit |
58,500 | 19,000 | | | 2,500 | 5,670 | 80,000 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | 93,867 | $ | 19,000 | $ | | $ | | $ | 3,000 | $ | 9,130 | $ | 115,867 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) | Aggregate net unrealized depreciation for U.S. federal income tax purposes is $631; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $70,926 and $71,557, respectively, based on a tax cost of $403,753. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the Securities Act). These investments are generally subject to certain limitations on resale, and may be deemed to be restricted securities under the Securities Act. All investments are Level 3 unless otherwise indicated. |
(7) | Our equity investment in SLR Business Credit is partially held through ESP SSC Corporation, a taxable consolidated subsidiary. |
(8) | Spread is 6.00% Cash / 2.00% PIK. |
| Non-income producing security. |
| Investment contains a payment-in-kind (PIK) feature. |
* | Investment is on non-accrual status. |
See notes to consolidated financial statements.
104
SLR SENIOR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
Industry Classification |
Percentage of Total Investments (at fair value) as of December 31, 2021 |
|||
Diversified Financial Services (includes SLR Healthcare ABL and SLR Business Credit) |
28.7 | % | ||
Health Care Providers & Services |
16.2 | % | ||
Insurance |
9.3 | % | ||
Building Products |
4.9 | % | ||
Trading Companies & Distributors |
3.9 | % | ||
Communications Equipment |
3.5 | % | ||
Software |
3.4 | % | ||
Pharmaceuticals |
3.3 | % | ||
Health Care Equipment & Supplies |
3.2 | % | ||
Diversified Consumer Services |
3.1 | % | ||
Wireless Telecommunication Services |
2.9 | % | ||
IT Services |
2.8 | % | ||
Leisure Equipment & Products |
2.8 | % | ||
Personal Products |
2.7 | % | ||
Professional Services |
2.2 | % | ||
Packaged Foods & Meats |
1.6 | % | ||
Biotechnology |
1.5 | % | ||
Footwear |
1.4 | % | ||
Life Sciences Tools & Services |
1.4 | % | ||
Specialty Retail |
0.5 | % | ||
Health Care Technology |
0.4 | % | ||
Water Utilities |
0.3 | % | ||
|
|
|||
Total Investments |
100.0 | % | ||
|
|
See notes to consolidated financial statements.
105
SLR SENIOR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2020
(in thousands, except share/unit amounts)
Description |
Industry |
Spread above Index (3) |
Libor Floor |
Interest Rate(1) | Acquisition Date |
Maturity Date |
Par Amount |
Cost | Fair Value |
|||||||||||||||||||||||||
Bank Debt/Senior Secured Loans 96.6% |
| |||||||||||||||||||||||||||||||||
Aegis Toxicology Sciences Corporation(2)(9) |
Health Care Providers & Services | L+550 | 1.00 | % | 6.50 | % | 5/7/2018 | 5/9/2025 | $ | 10,752 | $ | 10,618 | $ | 10,537 | ||||||||||||||||||||
Alimera Sciences, Inc.(2). |
Pharmaceuticals | L+765 | 1.78 | % | 9.43 | % | 12/31/2019 | 7/1/2024 | 3,085 | 3,118 | 3,116 | |||||||||||||||||||||||
Alteon Health, LLC (f/k/a Island Medical)(2)(9) |
Health Care Providers & Services | L+650 | 1.00 | % | 7.50 | % | 3/31/2017 | 9/1/2023 | 6,991 | 6,962 | 6,851 | |||||||||||||||||||||||
American Teleconferencing Services, Ltd. (PGI) (2) |
Communications Equipment | L+650 | 1.00 | % | 7.50 | % | 5/5/2016 | 6/8/2023 | 13,666 | 13,439 | 12,641 | |||||||||||||||||||||||
AQA Acquisition Holding, Inc. (2) |
Software | L+425 | 1.00 | % | 5.25 | % | 9/7/2018 | 5/24/2023 | 5,560 | 5,529 | 5,560 | |||||||||||||||||||||||
Cerapedics, Inc. (2) |
Health Care Equipment & Supplies | L+695 | 2.50 | % | 9.45 | % | 3/22/2019 | 3/1/2024 | 3,709 | 3,759 | 3,765 | |||||||||||||||||||||||
Composite Technology Acquisition Corp. (ClockSpring) (2)(9). |
Building Products | L+475 | 1.00 | % | 5.75 | % | 2/1/2019 | 2/1/2025 | 10,823 | 10,708 | 10,174 | |||||||||||||||||||||||
Confie Seguros Holding II Co.(2)(9) |
Insurance | L+475 | 1.00 | % | 5.75 | % | 10/13/2016 | 4/19/2022 | 14,173 | 14,135 | 13,998 | |||||||||||||||||||||||
DISA Holdings Acquisition Subsidiary Corp.(2) |
Professional Services | L+425 | 1.00 | % | 5.25 | % | 6/14/2018 | 6/30/2022 | 9,664 | 9,643 | 9,277 | |||||||||||||||||||||||
Drilling Info Holdings, Inc.(2) |
IT Services | L+450 | | 4.65 | % | 1/31/2020 | 7/30/2025 | 11,452 | 11,180 | 11,252 | ||||||||||||||||||||||||
Empower Payments Acquisition, Inc. (RevSpring).(2) |
Professional Services | L+425 | | 4.47 | % | 11/28/2016 | 10/11/2025 | 4,900 | 4,891 | 4,802 | ||||||||||||||||||||||||
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin)(2) |
Trading Companies & Distributors | L+475 | 1.00 | % | 5.75 | % | 12/31/2019 | 12/31/2025 | 6,138 | 6,032 | 6,107 | |||||||||||||||||||||||
Galway Partners Holdings, LLC (f/k/a Edgewood)(2)(9) |
Insurance | L+425 | 1.00 | % | 5.25 | % | 3/28/2018 | 9/8/2024 | 16,541 | 16,505 | 16,541 | |||||||||||||||||||||||
GenMark Diagnostics, Inc(2)(4) |
Health Care Providers & Services | L+590 | 2.51 | % | 8.41 | % | 2/1/2019 | 2/1/2023 | 7,598 | 7,808 | 7,807 | |||||||||||||||||||||||
Higginbotham Insurance Agency, Inc.(2) |
Insurance | L+575 | 0.75 | % | 6.50 | % | 11/25/2020 | 11/25/2026 | 4,927 | 4,854 | 4,853 | |||||||||||||||||||||||
Kindred Biosciences, Inc(2)(10) |
Pharmaceuticals | L+675 | 2.17 | % | 8.92 | % | 9/30/2019 | 9/30/2024 | 1,408 | 1,415 | 1,415 | |||||||||||||||||||||||
KORE Wireless Group, Inc.(2) |
Wireless Telecommunication Services | L+550 | | 5.75 | % | 12/21/2018 | 12/21/2024 | 11,805 | 11,634 | 11,805 | ||||||||||||||||||||||||
Logix Holding Company, LLC(2)(9) |
Communications Equipment | L+575 | 1.00 | % | 6.75 | % | 8/11/2017 | 12/22/2024 | 10,463 | 10,396 | 10,253 | |||||||||||||||||||||||
MHE Intermediate Holdings, LLC (TFS-Miner)(2)(9) |
Air Freight & Logistics | L+500 | 1.00 | % | 6.00 | % | 3/8/2017 | 3/10/2024 | 5,859 | 5,827 | 5,800 | |||||||||||||||||||||||
Ministry Brands, LLC(2)(9) |
Software | L+400 | 1.00 | % | 5.00 | % | 11/21/2016 | 12/2/2022 | 14,029 | 13,979 | 13,818 | |||||||||||||||||||||||
National Spine and Pain Centers, LLC (9) |
Health Care Providers & Services | L+525 | 1.00 | % | 6.25 | % | 9/18/2018 | 6/2/2024 | 2,532 | 2,525 | 2,469 | |||||||||||||||||||||||
Neuronetics, Inc.(2). |
Health Care Equipment & Supplies | L+765 | 1.66 | % | 9.31 | % | 3/2/2020 | 2/28/2025 | 2,400 | 2,411 | 2,411 | |||||||||||||||||||||||
Pet Holdings ULC & Pet Supermarket, Inc. (4)(9) |
Specialty Retail | L+550 | 1.00 | % | 6.50 | % | 9/18/2018 | 7/5/2022 | 4,500 | 4,479 | 4,455 | |||||||||||||||||||||||
Pinnacle Treatment Centers, Inc.(9) |
Health Care Providers & Services | L+625 | 1.00 | % | 7.25 | % | 1/22/2020 | 12/31/2022 | 3,698 | 3,671 | 3,698 | |||||||||||||||||||||||
PPT Management Holdings, LLC(2) |
Health Care Providers & Services | L+850 | (8) | 1.00 | % | 9.50 | % | 12/15/2016 | 12/16/2022 | 8,947 | 8,916 | 8,142 | ||||||||||||||||||||||
RSC Acquisition, Inc.(2) |
Insurance | L+550 | 1.00 | % | 6.50 | % | 10/5/2020 | 11/1/2026 | 958 | 930 | 929 | |||||||||||||||||||||||
Rubius Therapeutics, Inc. (2)(4) |
Pharmaceuticals | L+550 | | 5.65 | % | 12/21/2018 | 12/21/2023 | 6,182 | 6,243 | 6,251 | ||||||||||||||||||||||||
RxSense Holdings LLC(2) |
Diversified Consumer Services | L+500 | 1.00 | % | 6.00 | % | 3/17/2020 | 3/13/2026 | 8,296 | 8,149 | 8,296 | |||||||||||||||||||||||
scPharmaceuticals, Inc. (2) |
Pharmaceuticals | L+795 | 2.23 | % | 10.18 | % | 9/17/2019 | 9/17/2023 | 719 | 724 | 725 | |||||||||||||||||||||||
Sentry Data Systems, Inc.(2). |
Software | L+675 | 1.00 | % | 7.75 | % | 9/27/2020 | 10/6/2025 | 5,144 | 5,045 | 5,041 | |||||||||||||||||||||||
SHO Holding I Corporation (Shoes for Crews)(2) |
Footwear | L+523 | (11) | 1.00 | % | 6.23 | % | 11/20/2015 | 4/27/2024 | 5,792 | 5,769 | 5,213 | ||||||||||||||||||||||
SI-BONE, Inc. (2)(4) |
Health Care Equipment & Supplies | L+940 | 0.33 | % | 9.73 | % | 5/29/2020 | 6/1/2025 | 2,742 | 2,744 | 2,742 | |||||||||||||||||||||||
Smile Doctors LLC. |
Personal Products | L+600 | 1.00 | % | 7.00 | % | 12/17/2020 | 10/6/2022 | 1,077 | 1,056 | 1,056 | |||||||||||||||||||||||
Trinity Partners, LLC(2). |
Professional Services | L+525 | 1.00 | % | 6.25 | % | 12/11/2020 | 2/21/2025 | 2,049 | 2,029 | 2,029 | |||||||||||||||||||||||
U.S. Acute Care Solutions, LLC(2)(9) |
Health Care Providers & Services | L+600 | (12) | 1.00 | % | 7.00 | % | 12/22/2016 | 5/15/2021 | 6,271 | 6,265 | 6,271 | ||||||||||||||||||||||
World Insurance Associates, LLC(2). |
Insurance | L+550 | 1.00 | % | 6.50 | % | 10/12/2020 | 4/1/2026 | 10,025 | 9,731 | 9,724 | |||||||||||||||||||||||
Worldwide Facilities, LLC(2) |
Insurance | L+450 | | 4.65 | % | 9/13/2019 | 9/5/2026 | 7,088 | 6,965 | 7,052 | ||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total Bank Debt/Senior Secured Loans |
|
$ | 250,084 | $ | 246,876 | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Common Equity/Equity Interests/Warrants 36.8% | Shares/Units | |||||||||||||||||||||||||||||||||
Essence Group Holdings Corporation (Lumeris) Warrants. .. |
Health Care Technology | 3/22/2017 | 52,000 | $ | 16 | $ | 65 | |||||||||||||||||||||||||||
Gemino Healthcare Finance, LLC(4)(5) |
Diversified Financial Services | 9/30/2013 | 32,839 | 31,439 | 35,367 | |||||||||||||||||||||||||||||
North Mill Holdco LLC(4)(5)(7) |
Diversified Financial Services | 10/20/2017 | 100 | 67,000 | 58,500 | |||||||||||||||||||||||||||||
Senseonics Holdings, Inc. Warrants |
Health Care Equipment & Supplies | 7/25/2019 | 80,838 | 18 | 12 | |||||||||||||||||||||||||||||
TwentyEighty Investors, LLC. |
Professional Services | 1/31/2017 | 17,214 | 1,011 | 10 | |||||||||||||||||||||||||||||
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) |
Health Care Equipment & Supplies | 5/10/2018 | 6,078 | 34 | | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total Common Equity/Equity Interests/Warrants |
|
$ | 99,518 | $ | 93,954 | |||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total Investments(6) 133.4% |
|
$ | 349,602 | $ | 340,830 | |||||||||||||||||||||||||||||
Par Amount | ||||||||||||||||||||||||||||||||||
Cash Equivalents 117.5% |
||||||||||||||||||||||||||||||||||
U.S. Treasury Bill |
Government | 12/31/2020 | 2/23/2021 | $ | 300,000 | $ | 299,998 | $ | 299,998 | |||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||
Total Investments & Cash Equivalents 250.9% |
|
$ | 649,600 | $ | 640,828 | |||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||
Liabilities in Excess of Other Assets (150.9%) |
|
(385,424 | ) | |||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||
Net Assets 100.0% |
$ | 255,404 | ||||||||||||||||||||||||||||||||
|
|
See notes to consolidated financial statements.
106
SLR SENIOR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2020
(in thousands)
(1) | Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (LIBOR or L) index rate or the prime index rate (PRIME or P), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2020. |
(2) | Indicates an investment that is wholly or partially held by SLR Senior Investment Corp. through its wholly-owned financing subsidiary SUNS SPV LLC (the SUNS SPV). Such investments are pledged as collateral under the Senior Secured Revolving Credit Facility (the Credit Facility) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. |
(3) | Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor. |
(4) | Indicates assets that the Company believes may not represent qualifying assets under Section 55(a) of the Investment Company Act of 1940 (1940 Act), as amended. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2020, on a fair value basis, non-qualifying assets in the portfolio represented 17.8% of the total assets of the Company. |
(5) | Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2020 in these controlled investments are as follows: |
Name of Issuer |
Fair Value at December 31, 2019 |
Gross Additions |
Gross Reductions |
Realized Gain (Loss) |
Change in Unrealized Gain (Loss) |
Dividend /Other Income |
Fair Value at December 31, 2020 |
|||||||||||||||||||||
Gemino Healthcare Finance, LLC |
$ | 36,100 | $ | | $ | | $ | | $ | (733 | ) | $ | 3,460 | $ | 35,367 | |||||||||||||
North Mill Holdco LLC |
62,500 | | | | (4,000 | ) | 5,040 | 58,500 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
$ | 98,600 | $ | | $ | | $ | | $ | (4,733 | ) | $ | 8,500 | $ | 93,867 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6) | Aggregate net unrealized appreciation for U.S. federal income tax purposes is $3,226; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $59,516 and $56,290, respectively, based on a tax cost of $337,604. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the Securities Act). These investments are generally subject to certain limitations on resale, and may be deemed to be restricted securities under the Securities Act. All investments are Level 3 unless otherwise indicated. |
(7) | Our equity investment in North Mill Capital LLC is partially held through ESP SSC Corporation, a taxable consolidated subsidiary. |
(8) | Spread is 6.00% Cash / 2.50% PIK. |
(9) | Indicates an investment that is wholly or partially held by SLR Senior Investment Corp. through its wholly-owned financing subsidiary FLLP 2015-1 LLC (the FLLP SPV). Such investments are pledged as collateral under the FLLP 2015-1, LLC Credit Facility (the FLLP Facility) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. |
(10) | Kindred Biosciences, Inc., KindredBio Equine, Inc. and Centaur Biopharmaceutical Services, Inc. are co-borrowers. |
(11) | Spread is 3.00% Cash / 2.23% PIK. |
(12) | Spread is 5.00% Cash / 1.00% PIK. |
| Non-income producing security. |
| Investment contains a payment-in-kind (PIK) feature. |
See notes to consolidated financial statements.
107
SLR SENIOR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2020
Industry Classification |
Percentage of Total Investments (at fair value) as of December 31, 2020 |
|||
Diversified Financial Services (includes Gemino Healthcare Finance, LLC and North Mill Holdco LLC) |
27.6 | % | ||
Insurance |
15.6 | % | ||
Health Care Providers & Services |
12.7 | % | ||
Software |
7.2 | % | ||
Communications Equipment |
6.7 | % | ||
Professional Services |
4.7 | % | ||
Wireless Telecommunication Services |
3.5 | % | ||
Pharmaceuticals |
3.4 | % | ||
IT Services |
3.3 | % | ||
Building Products |
3.0 | % | ||
Health Care Equipment & Supplies |
2.6 | % | ||
Diversified Consumer Services |
2.4 | % | ||
Trading Companies & Distributors |
1.8 | % | ||
Air Freight & Logistics |
1.7 | % | ||
Footwear |
1.5 | % | ||
Specialty Retail |
1.3 | % | ||
Commercial Services & Supplies |
0.7 | % | ||
Personal Products |
0.3 | % | ||
Health Care Technology |
0.0 | % | ||
|
|
|||
Total Investments |
100.0 | % | ||
|
|
See notes to consolidated financial statements.
108
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2021
(in thousands, except share amounts)
Note 1. Organization
SLR Senior Investment Corp. (SLR Senior, the Company, SUNS, we, us, or our), a Maryland corporation formed on December 16, 2010, is a closed-end, externally managed, non-diversified management investment company that has elected to be regulated as a business development company (BDC) under the Investment Company Act of 1940, as amended (the 1940 Act). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 946. In addition, for U.S. federal income tax purposes, we have elected to be treated, and intend to qualify annually, as a regulated investment company (RIC), under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code).
On January 28, 2011, SLR Senior was capitalized with initial equity of $2 and commenced operations. On February 24, 2011, SLR Senior priced its initial public offering, selling 9.0 million shares, including the underwriters over-allotment, raising approximately $168,000 of net proceeds. Concurrent with this offering, our senior management team purchased an additional 500,000 shares through a private placement, raising another $10,000.
The Companys investment objective is to seek to maximize current income consistent with the preservation of capital. We seek to achieve our investment objective by investing directly or indirectly in senior secured loans, including first lien and second lien debt instruments, made primarily to leveraged private middle-market companies whose debt is rated below investment grade, which the Company refers to collectively as senior loans. From time to time, we may also invest in public companies that are thinly traded. Under normal market conditions, at least 80% of the value of the Companys net assets (including the amount of any borrowings for investment purposes) will be directly or indirectly invested in senior loans.
On December 1, 2021, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with SLR Investment Corp., a Maryland corporation (SLRC), Solstice Merger Sub, Inc., a Maryland corporation and a wholly-owned subsidiary of SLRC (Merger Sub), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (f/k/a Solar Capital Partners, LLC) (the Investment Adviser). The Merger Agreement provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into us, with us continuing as the surviving company and as SLRCs wholly-owned subsidiary (the Merger,) and, immediately thereafter, we will merge with and into SLRC, with SLRC continuing as the surviving company (together with the Merger, the Mergers). See Note 14 for additional information.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (GAAP), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to current period presentation.
The preparation of consolidated financial statements in conformity with GAAP and pursuant to the requirements for reporting on Form 10-K and Regulation S-X, as appropriate, also requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the
109
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.
In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
(a) | Investment transactions are accounted for on the trade date; |
(b) | The Company conducts the valuation of its assets in accordance with GAAP and the 1940 Act. The Company generally values its assets on a quarterly basis, or more frequently if required. Investments for which market quotations are readily available on an exchange are valued at the closing price on the date of valuation. The Company may also obtain quotes with respect to certain of its investments from pricing services or brokers or dealers in order to value assets. When doing so, management determines whether the quote obtained is sufficient according to GAAP to determine the fair value of the investment. If determined adequate, the Company uses the quote obtained. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Companys board of directors (the Board). |
Investments for which reliable market quotations are not readily available or for which the pricing sources do not provide a valuation or methodology or provide a valuation or methodology that, in the judgment of the Investment Adviser or the Board does not represent fair value, shall be valued as follows: (i) each portfolio company or investment is initially valued by the investment professionals responsible for the portfolio investment; (ii) preliminary valuations are discussed with senior management of the Investment Adviser; (iii) independent valuation firms engaged by, or on behalf of, the Board will conduct independent appraisals and review the Investment Advisers preliminary valuations and make their own independent assessment for (a) each portfolio investment that, when taken together with all other investments in the same portfolio company, exceeds 10% of estimated total assets, plus available borrowings, as of the end of the most recently completed fiscal quarter, and (b) each portfolio investment that is presently in payment default and the Investment Adviser does not expect to reach an agreement with the portfolio company in the subsequent quarter; (iv) the Board will discuss the valuations and determine the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser and, where appropriate, the respective independent valuation firm.
The recommendation of fair value generally considers the following factors among others, as relevant: applicable market yields; the nature and realizable value of any collateral; the portfolio companys ability to make payments; the portfolio companys earnings and discounted cash flow; the markets in which the issuer does business; and comparisons to publicly traded securities, among others.
When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the
110
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
values that would have been used had a readily available market value existed for such investments, and the differences could be material.
Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio companys ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2021, there has been no change to the Companys valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level 2: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level 3: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
(c) | Gains or losses on investments are calculated by using the specific identification method. |
(d) | The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned. |
(e) | The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all |
111
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. |
(f) | Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Companys capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly at December 31, 2021, $139 was reclassified on our balance sheet between accumulated distributable net loss and paid-in capital in excess of par. Total earnings and net asset value are not affected. |
(g) | Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. |
(h) | In accordance with Regulation S-X and ASC Topic 810Consolidation, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. |
(i) | The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Companys investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. |
(j) | In accordance with ASC 835-30, the Company reports origination and other expenses related to certain debt issuances, if any, as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. |
(k) | The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC 946-20-25. |
(l) | Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual status when principal or interest cash payments are past due 30 days or more and/or when it is no longer probable that principal or interest cash payments will be collected. Such non-accrual investments are restored to accrual status if past due principal and interest are paid in cash, and in managements judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on managements judgment. |
112
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
(m) | The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. |
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is evaluating the potential impact that the adoption of this guidance will have on the Companys financial statements.
Note 3. Agreements
SLR Senior has an Advisory Agreement with the Investment Adviser, under which the Investment Adviser manages the day-to-day operations of, and provides investment advisory services to, SLR Senior. For providing these services, the Investment Adviser receives a fee from SLR Senior, consisting of two componentsa base management fee and a performance-based incentive fee. The base management fee is calculated at an annual rate of 1.00% of gross assets. For services rendered under the Advisory Agreement, the base management fee is payable quarterly in arrears. The base management fee is calculated based on the average value of our gross assets at the end of the two most recently completed calendar quarters. Base management fees for any partial month or quarter will be appropriately pro-rated. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one is calculated and payable quarterly in arrears based on our pre-incentive fee net investment income for the immediately preceding calendar quarter. For this purpose, pre-incentive fee net investment income means interest income, dividend income and any other income (other than fees for providing managerial assistance) accrued during the calendar quarter, minus our operating expenses for the quarter (excluding the performance-based incentive fee). Pre-incentive fee net investment income includes, in the case of investments, if any, with a deferred interest feature (such as original issue discount, debt instruments with pay-in-kind interest and zero-coupon securities), accrued income that we have not yet received in cash. Pre-incentive fee net investment income does not include any realized capital gains or losses or unrealized capital appreciation or depreciation. Pre-incentive fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle of 1.75% per quarter (7.00% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to pre-incentive fee net investment income for each calendar quarter as follows:
| no performance-based incentive fee in any calendar quarter in which our pre-incentive fee net investment income does not exceed the hurdle of 1.75%; |
113
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
| 50% of pre-incentive fee net investment income with respect to that portion of such pre-incentive fee net investment income, if any, that exceeds the hurdle but is less than 2.9167% in any calendar quarter (11.67% annualized); |
and
| 20% of the amount of pre-incentive fee net investment income, if any, that exceeds 2.9167% in any calendar quarter (11.67% annualized) will be payable to the Investment Adviser. |
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Investment Advisory Agreement, as of the termination date) and will equal 20% of the Companys cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross investment-by-investment basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the fiscal years ended December 31, 2021, 2020 and 2019.
For the fiscal years ended December 31, 2021, 2020 and 2019, the Company recognized $3,907, $4,119 and $4,799, respectively, in gross base management fees and $0, $95 and $1,484, respectively, in gross performance-based incentive fees. For the fiscal years ended December 31, 2021, 2020 and 2019, $0, $3,655 and $1,317, respectively, of such base management fees were waived. For the fiscal years ended December 31, 2021, 2020 and 2019, $0, $95 and $1,476, respectively, of such performance-based incentive fees were waived. For the fiscal years ended December 31, 2021, 2020 and 2019, there were no performance-based incentive fees recaptured by the Investment Adviser. The below voluntary fee waivers were made at the Investment Advisers discretion and are subject to recapture by the Investment Adviser and reimbursement by the Company under the conditions noted below. No fees will be recouped by the Investment Adviser if (i) for the period in which recoupment occurs, the ratio of operating expenses to average net assets, when considering the reimbursement, exceeds the same ratio for the period in which the waiver occurred; (ii) for the period in which recoupment occurs, the annualized distribution rate cannot fall below the annualized distribution rate for the period in which the waiver occurred; and (iii) recoupment can only occur within three years from the date of the waiver. In the event the merger with SLR Investment Corp. is consummated, the Investment Adviser will not recoup any of the below fees. The table below presents a summary of fees waived that may be subject to recoupment:
Three Months Ended |
Management and Performance- Based Incentive Fees Waived |
Management and Performance-Based Incentive Fees Recouped |
Unreimbursed Management and Performance-Based Incentive Fees |
Ratio of Operating Expense to Average Net Assets for the Period(1) |
Annualized Distribution Rate for the Period(2) |
Eligible for Recoupment Through |
||||||||||||||||||
June 30, 2020 |
$ | 959 | $ | | $ | 959 | 0.23 | % | 8.71 | % | March 31, 2022 | |||||||||||||
September 30, 2020 |
722 | | 722 | 0.33 | % | 7.72 | % | June 30, 2022 | ||||||||||||||||
December 31, 2020 |
1,049 | | 1,049 | 0.31 | % | 7.60 | % | September 30, 2022 | ||||||||||||||||
|
|
|
|
|
|
|||||||||||||||||||
Total |
$ | 2,730 | $ | | $ | 2,730 | ||||||||||||||||||
|
|
|
|
|
|
(1) | Operating expense includes all expenses borne by the Company, except for organizational and offering costs, base management fees, performance-based incentive fees and interest expense. The ratios presented are not annualized. |
114
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
(2) | Annualized distribution rate equals the annualized rate of distributions paid to stockholders based on the amount of the distributions declared prior to the date that the waivers of expenses related to management and performance-based incentive fees were incurred. |
SLR Senior has also entered into an Administration Agreement with SLR Capital Management, LLC (the Administrator) under which the Administrator provides administrative services for SLR Senior. For providing these services, facilities and personnel, SLR Senior reimburses the Administrator for SLR Seniors allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on SLR Seniors behalf, managerial assistance to those portfolio companies to which SLR Senior is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the fiscal years ended December 31, 2021, 2020 and 2019, the Company recognized expenses under the Administration Agreement of $1,710, $1,575 and $1,575, respectively. No managerial assistance fees were accrued or collected for the fiscal years ended December 31, 2021, 2020 and 2019.
Note 4. Net Asset Value Per Share
At December 31, 2021, the Companys total net assets and net asset value per share were $247,683 and $15.43, respectively. This compares to total net assets and net asset value per share at December 31, 2020 of $255,404 and $15.91, respectively.
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC 260-10, for the years ended December 31, 2021, 2020 and 2019:
Year ended December 31, 2021 |
Year ended December 31, 2020 |
Year ended December 31, 2019 |
||||||||||
Earnings per share (basic & diluted) |
||||||||||||
Numeratornet increase in net assets resulting from operations: |
$ | 11,538 | $ | 13,924 | $ | 22,944 | ||||||
Denominatorweighted average shares: |
16,049,034 | 16,048,777 | 16,043,542 | |||||||||
Earnings per share: |
$ | 0.72 | $ | 0.87 | $ | 1.43 |
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level 1. Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
115
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Level 2. Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
a) | Quoted prices for similar assets or liabilities in active markets; |
b) | Quoted prices for identical or similar assets or liabilities in non-active markets; |
c) | Pricing models whose inputs are observable for substantially the full term of the asset or liability; and |
d) | Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. |
Level 3. Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect managements and, if applicable, an independent third-party valuation firms own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2021 and December 31, 2020:
Fair Value Measurements
As of December 31, 2021
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
||||||||||||||||
Bank Debt/Senior Secured Loans |
$ | | $ | | $ | 287,019 | $ | 287,019 | ||||||||
Common Equity/Equity Interests/Warrants |
167 | | 115,936 | 116,103 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Investments$ |
$ | 167 | $ | | $ | 402,955 | $ | 403,122 | ||||||||
|
|
|
|
|
|
|
|
116
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Fair Value Measurements
As of December 31, 2020
Level 1 | Level 2 | Level 3 | Total | |||||||||||||
Assets: |
||||||||||||||||
Bank Debt/Senior Secured Loans |
$ | | $ | | $ | 246,876 | $ | 246,876 | ||||||||
Common Equity/Equity Interests/Warrants |
| | 93,954 | 93,954 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Investments |
$ | | $ | | $ | 340,830 | $ | 340,830 | ||||||||
|
|
|
|
|
|
|
|
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Bank Debt/Senior Secured Loans |
Common Equity/Equity Interests/Warrants |
Total | ||||||||||
Fair value, December 31, 2020 |
$ | 246,876 | $ | 93,954 | $ | 340,830 | ||||||
Total gains or losses included in earnings: |
||||||||||||
Net realized gain |
3 | | 3 | |||||||||
Net change in unrealized gain (loss) |
(5,879 | ) | 3,006 | (2,873 | ) | |||||||
Purchase of investment securities |
174,190 | 19,000 | 193,190 | |||||||||
Proceeds from dispositions of investment securities |
(128,171 | ) | (11 | ) | (128,182 | ) | ||||||
Transfers in/out of Level 3(1) |
| (13 | ) | (13 | ) | |||||||
|
|
|
|
|
|
|||||||
Fair value, December 31, 2021 |
$ | 287,019 | $ | 115,936 | $ | 402,955 | ||||||
|
|
|
|
|
|
|||||||
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: |
||||||||||||
Net change in unrealized gain (loss): |
$ | (5,879 | ) | $ | 3,006 | $ | (2,873 | ) | ||||
|
|
|
|
|
|
(1) | On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset. |
117
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2020, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2020:
Bank Debt/Senior Secured Loans |
Common Equity/Equity Interests/Warrants |
Total | ||||||||||
Fair value, December 31, 2019 |
$ | 361,456 | $ | 98,809 | $ | 460,265 | ||||||
Total gains or losses included in earnings: |
||||||||||||
Net realized gain |
169 | | 169 | |||||||||
Net change in unrealized loss |
(1,982 | ) | (4,671 | ) | (6,653 | ) | ||||||
Purchase of investment securities |
72,227 | | 72,227 | |||||||||
Proceeds from dispositions of investment securities |
(184,994 | ) | (184 | ) | (185,178 | ) | ||||||
Transfers in/out of Level 3 |
| | | |||||||||
|
|
|
|
|
|
|||||||
Fair value, December 31, 2020 |
$ | 246,876 | $ | 93,954 | $ | 340,830 | ||||||
|
|
|
|
|
|
|||||||
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period: |
||||||||||||
Net change in unrealized loss: |
$ | (1,982 | ) | $ | (4,671 | ) | $ | (6,653 | ) | |||
|
|
|
|
|
|
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Companys Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (EBITDA) multiples of similar companies, and comparable market transactions for equity securities.
118
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Quantitative information about the Companys Level 3 asset fair value measurements as of December 31, 2021 is summarized in the table below:
Asset or Liability |
Fair Value at December 31, 2021 |
Principal Valuation Technique/Methodology |
Unobservable Input | Range (Weighted Average) | ||||||||
Bank Debt / Senior Secured Loans |
Asset | $ | 283,409 | Income Approach | Market Yield | 4.7% 25.1% (7.6%) | ||||||
Asset | $ | 3,610 | Market Multiple(1) | Comparable Multiple | 2.0x-3.0x(2.5x)/2.0x- 3.0x(2.5x) | |||||||
|
|
|||||||||||
Common Equity/Equity Interests/Warrants |
Asset | $ | 115,936 | Market Approach(2) | Return on Equity | 6.1% 37.9% (19.3%) | ||||||
|
|
(1) | Investments are valued using a sum-of-the parts analysis, using expected EBITDA multiples (2x-3x) for certain segments of the business and expected revenue multiples (2x-3x) for certain segments of the business. |
(2) | Includes $64 of investments valued using a Black-Scholes model, $5 of investments valued using a weighted valuation approach and $115,867 of investments valued using a return on equity. |
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets.
Quantitative information about the Companys Level 3 asset fair value measurements as of December 31, 2020 is summarized in the table below:
Asset or Liability |
Fair Value at December 31, 2020 |
Principal Valuation Technique/Methodology |
Unobservable Input | Range (Weighted Average) | ||||||||
Bank Debt / Senior Secured Loans |
Asset | $ | 246,876 | Income Approach | Market Yield | 4.9% 13.1% (7.5%) | ||||||
|
|
|||||||||||
Common Equity/Equity Interests/Warrants |
Asset | $ | 93,954 | Market Approach(1) | Return on Equity | (10.3%) - 20.7% (16.2%) | ||||||
|
|
(1) | Includes $77 of investments valued using a Black-Scholes model, $10 of investments valued using a weighted valuation approach and $93,867 of investments valued using a return on equity. |
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask spreads, if applicable, would result in a significantly lower or higher fair value measurement for such assets.
119
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Note 7. Debt
Our debt obligations consisted of the following as of December 31, 2021 and December 31, 2020:
December 31, 2021 | December 31, 2020 | |||||||||||||||
Facility |
Face Amount | Carrying Value | Face Amount | Carrying Value | ||||||||||||
Credit Facility |
$ | 76,500 | $ | 75,410 | (1) | $ | | $ | (913 | )(1) | ||||||
FLLP Facility |
| | (2) | 5,403 | 5,036 | (2) | ||||||||||
2025 Unsecured Notes |
85,000 | 84,509 | (3) | 85,000 | 84,370 | (3) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 161,500 | $ | 159,919 | $ | 90,403 | $ | 88,493 | |||||||||
|
|
|
|
|
|
|
|
(1) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $1,090 and $913, respectively, as of December 31, 2021 and December 31, 2020. |
(2) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $0 and $367, respectively, as of December 31, 2021 and December 31, 2020. |
(3) | Carrying Value equals the Face Amount net of unamortized debt issuance costs of $491 and $630, respectively, as of December 31, 2021 and December 31, 2020. |
Unsecured Notes
On March 31, 2020, the Company closed a private offering of $85,000 of senior unsecured notes due 2025 (the 2025 Unsecured Notes) with a fixed interest rate of 3.90% and a maturity date of March 31, 2025. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. The 2025 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
Revolving Loan Facilities
On August 26, 2011, the Company established our wholly-owned subsidiary, SUNS SPV LLC (the SUNS SPV) which entered into the Credit Facility with Citigroup Global Markets Inc. acting as administrative agent. On January 10, 2017, commitments to the Credit Facility, as amended, were increased from $175,000 to $200,000 by utilizing the accordion feature. The commitment can also be expanded up to $600,000. The stated interest rate on the Credit Facility is LIBOR plus 2.00% with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the Credit Facility, SLR Senior and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The Credit Facility also includes usual and customary events of default for credit facilities of this nature. The Credit Facility was amended on November 7, 2012, June 30, 2014 and May 29, 2015 to extend maturities and add greater investment flexibility, among other changes. On June 1, 2018, the Credit Facility was refinanced by way of amendment, allowing for greater investment flexibility and the extension of the maturity date, among other changes. On July 13, 2018, commitments to the Credit Facility, as amended, were increased from $200,000 to $225,000 by utilizing the accordion feature. On June 7, 2021, the Credit Facility maturity date was extended to June 1, 2026 and was amended to add greater investment flexibility, among other changes. There were $76,500 of borrowings outstanding as of December 31, 2021 under the Credit Facility.
On May 31, 2019, the Company as transferor and FLLP 2015-1, LLC, a wholly-owned subsidiary of the Company, as borrower entered into amendment number five to the $75,000 FLLP Facility with Wells Fargo
120
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Bank, NA acting as administrative agent. The Company acts as servicer under the FLLP Facility. The FLLP Facility is scheduled to mature on May 31, 2024. The FLLP Facility generally bears interest at a rate of LIBOR plus a range of 2.15-2.25%. The Company and FLLP 2015-1, LLC, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The FLLP Facility also includes usual and customary events of default for credit facilities of this nature. On May 14, 2021, the maximum facility amount was reduced from $75,000 to $11,303 and the reinvestment period was terminated. On September 30, 2021, the FLLP Facility was repaid and terminated.
The average annualized interest cost for all borrowings for the year ended December 31, 2021 and the year ended December 31, 2020 was 3.36% and 3.49%, respectively. These costs are exclusive of other credit facility expenses such as unused fees and fees paid to the back-up servicer, if any. The maximum amount borrowed on the revolving credit facilities during the year ended December 31, 2021 and the year ended December 31, 2020, was $173,600 and $215,003, respectively.
Note 8. Financial Highlights
The following is a schedule of financial highlights for the respective years:
Year ended December 31, 2021 |
Year ended December 31, 2020 |
Year ended December 31, 2019 |
Year ended December 31, 2018 |
Year ended December 31, 2017 |
||||||||||||||||
Per Share Data: (a) |
||||||||||||||||||||
Net asset value, beginning of year |
$ | 15.91 | $ | 16.32 | $ | 16.30 | $ | 16.84 | $ | 16.80 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net investment income |
0.89 | 1.27 | 1.41 | 1.41 | 1.41 | |||||||||||||||
Net realized and unrealized gain (loss) |
(0.17 | ) | (0.41 | ) | 0.02 | (0.54 | ) | 0.04 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net increase in net assets resulting from operations |
0.72 | 0.86 | 1.43 | 0.87 | 1.45 | |||||||||||||||
Distributions to stockholders (see note 9a): |
||||||||||||||||||||
From net investment income |
(1.00 | ) | (0.78 | ) | (0.99 | ) | (1.41 | ) | (1.41 | ) | ||||||||||
From return of capital |
(0.20 | ) | (0.49 | ) | (0.42 | ) | | | ||||||||||||
Offering costs and other |
| | | | | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Net asset value, end of year |
$ | 15.43 | $ | 15.91 | $ | 16.32 | $ | 16.30 | $ | 16.84 | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Per share market value, end of year |
$ | 13.98 | $ | 14.46 | $ | 17.60 | $ | 15.12 | $ | 17.76 | ||||||||||
Total Return(b) |
5.28 | % | (9.77 | %) | 26.42 | % | (7.28 | %) | 17.11 | % | ||||||||||
Net assets, end of year |
$ | 247,683 | $ | 255,404 | $ | 261,814 | $ | 261,392 | $ | 270,131 | ||||||||||
Shares outstanding, end of year |
16,049,034 | 16,049,034 | 16,046,214 | 16,040,485 | 16,036,730 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Ratios to average net assets: |
||||||||||||||||||||
Net investment income |
5.63 | % | 8.16 | % | 8.63 | % | 8.38 | % | 8.39 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Operating expenses |
3.17 | % | 1.41 | %* | 2.57 | %* | 3.48 | %* | 2.12 | %* | ||||||||||
Interest and other credit facility expenses |
2.72 | % | 3.16 | % | 4.10 | % | 2.89 | % | 1.43 | % | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Total expenses |
5.89 | % | 4.57 | %* | 6.67 | %* | 6.37 | %* | 3.55 | %* | ||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Average debt outstanding |
$ | 126,518 | $ | 155,131 | $ | 212,465 | $ | 168,359 | $ | 100,700 | ||||||||||
Portfolio turnover ratio |
34.5 | % | 17.8 | % | 21.4 | % | 42.5 | % | 41.4 | % |
(a) | Calculated using the average shares outstanding method. |
(b) | Total return is based on the change in market price per share during the year and takes into account any distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load. |
121
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
* | The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a voluntary incentive fee waiver (see note 3). For the year ended December 31, 2020, the ratios of operating expenses to average net assets and total expenses to average net assets would be 2.91% and 6.08%, respectively, without the voluntary management and incentive fee waivers. For the year ended December 31, 2019, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.63% and 7.73%, respectively, without the voluntary management and incentive fee waivers. For the year ended December 31, 2018, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.89% and 6.78%, respectively, without the voluntary management and incentive fee waivers. For the year ended December 31, 2017, the ratios of operating expenses to average net assets and total expenses to average net assets would be 3.11% and 4.54%, respectively, without the voluntary management and incentive fee waivers. |
Note 9(a). Income Tax Information and Distributions to Stockholders
The tax character of distributions for the fiscal years ended December 31, 2021, 2020 and 2019 were as follows (1):
2021 | 2020 | 2019 | ||||||||||||||||||||||
Ordinary income |
$ | 15,974 | 82.9 | % | $ | 12,544 | 61.5 | % | $ | 15,924 | 70.4 | % | ||||||||||||
Capital gains |
| 0.0 | % | | 0.0 | % | | 0.0 | % | |||||||||||||||
Return of capital |
3,285 | 17.1 | % | 7,838 | 38.5 | % | 6,697 | 29.6 | % | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total distributions |
$ | 19,259 | 100.0 | % | $ | 20,382 | 100.0 | % | $ | 22,621 | 100.0 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2021, 2020 and 2019 the total accumulated earnings (loss) on a tax basis were as follows (1):
2021 | 2020 | 2019 | ||||||||||
Undistributed ordinary income |
$ | | $ | | $ | | ||||||
Undistributed long-term net capital gains |
| | | |||||||||
|
|
|
|
|
|
|||||||
Total undistributed net earnings |
| | | |||||||||
Other book/tax temporary differences |
1,057 | 1,049 | 1,044 | |||||||||
Post-October capital losses |
| | | |||||||||
Capital loss carryforward |
(23,684 | ) | (23,237 | ) | (23,426 | ) | ||||||
Net unrealized appreciation (depreciation) investments |
(631 | ) | 3,227 | 1,855 | ||||||||
|
|
|
|
|
|
|||||||
Total tax accumulated loss |
$ | (23,258 | ) | $ | (18,961 | ) | $ | (20,527 | ) | |||
|
|
|
|
|
|
(1) | Tax information for the fiscal years ended December 31, 2021, 2020 and 2019 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year. |
The Company recognizes in its consolidated financial statements the tax effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. To the best of our knowledge, we did not have any uncertain tax positions that met the recognition or measurement criteria of ASC 740-10-25 nor did we have any unrecognized tax benefits as of the periods presented herein. Although we file federal and state tax returns, our major tax jurisdiction is federal. Our tax returns for each of our
122
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
federal tax years since 2018 remain subject to examination by the Internal Revenue Service and the state department of revenue. The capital loss carryforwards shown above do not expire.
Note 9(b). Other Tax Information (unaudited)
No distributions paid during the fiscal years ended December 31, 2021, 2020 or 2019 were eligible for qualified dividend income treatment or were eligible for the dividends received deduction for corporate stockholders. For the fiscal years ended December 31, 2021, 2020, and 2019, 99.70%, 100% and 99.25%, respectively, of each of the distributions paid during the year represent interest-related dividends. For the fiscal years ended December 31, 2021, 2020 and 2019, none of the distributions represent short-term capital gains dividends.
Note 10. SLR Healthcare ABL
We acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (SLR Healthcare) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and mid-sized companies operating in the healthcare industry. Our initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare co-invested in the transaction and continues to lead SLR Healthcare. As of December 31, 2021, SLR Healthcares management team and SLR Senior own approximately 7% and 93% of the equity in SLR Healthcare, respectively.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year, non-recourse, $100,000 credit facility with non-affiliates, which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. As of December 31, 2020, the portfolio totaled approximately $218,028 of commitments with a total net investment in loans of $39,340 on total assets of $58,881. At December 31, 2021, the portfolio consisted of 36 issuers with an average balance of approximately $2,267 versus 37 issuers with an average balance of approximately $1,063 at December 31, 2020. All of the commitments in SLR Healthcares portfolio are floating-rate, senior-secured, cash-pay loans. SLR Healthcares credit facility, which is non-recourse to us, had approximately $60,000 and $25,000 of borrowings outstanding at December 31, 2021 and December 31, 2020, respectively. For the years ended December 31, 2021, 2020 and 2019, SLR Healthcare had net income of $662, $4,289 and $3,559, respectively, on gross income of $10,052, $10,367 and $12,717, respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcares consolidated financial statements for the fiscal years ended December 31, 2021 and December 31, 2020 are attached as an exhibit to this annual report on Form 10-K.
123
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
Note 11. Commitments and Contingencies
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Healthcare. The total amount of these unfunded commitments as of December 31, 2021 and December 31, 2020 is $56,135 and $24,760, respectively, comprised of the following:
December 31, 2021 | December 31, 2020 | |||||||
Arcutis Biotherpeutics, Inc |
$ | 6,667 | $ | | ||||
CC SAG Holdings Corp. (Spectrum Automotive) |
6,239 | | ||||||
NAC Holdings Corp |
5,119 | | ||||||
Glooko, Inc |
4,689 | | ||||||
Vessco Midco Holdings, LLC |
4,592 | | ||||||
BridgeBio Pharma, Inc |
4,000 | | ||||||
Plastics Management, LLC |
3,547 | | ||||||
Tilley Chemical Buyer, Inc |
2,286 | | ||||||
Maurices, Inc |
2,195 | | ||||||
Ivy Fertility Services, LLC |
1,502 | | ||||||
Drilling Info Holdings, Inc. |
1,411 | 1,005 | ||||||
SLR Healthcare ABL* |
1,400 | 1,400 | ||||||
RQM+ Corp |
1,265 | | ||||||
Composite Technology Acquisition Corp. |
1,259 | 1,245 | ||||||
RxSense Holdings LLC. |
1,250 | 1,216 | ||||||
Erie Construction Mid-west, LLC |
1,247 | | ||||||
TAUC Management, LLC |
1,147 | | ||||||
GSM Acquisition Corp |
892 | | ||||||
High Street Buyer, Inc |
846 | | ||||||
SOC Telemed, Inc |
742 | | ||||||
Foundation Consumer Brands, LLC |
740 | | ||||||
BayMark Health Services, Inc |
689 | | ||||||
Pinnacle Treatment Centers, Inc. |
444 | 435 | ||||||
Neuronetics, Inc. |
343 | 1,028 | ||||||
SunMed Group Holdings, LLC |
339 | | ||||||
World Insurance Associates, LLC. |
272 | 1,081 | ||||||
Ultimate Baked Goods Midco, LLC |
265 | | ||||||
American Teleconferencing Services, Ltd |
261 | | ||||||
All State Ag Parts, LLC |
257 | | ||||||
ENS Holdings III Corp. & ES Opco USA LLC |
230 | 559 | ||||||
Smile Doctors LLC |
| 8,724 | ||||||
RSC Acquisition, Inc |
| 2,987 | ||||||
Higginbotham Insurance Agency, Inc. |
| 1,387 | ||||||
Worldwide Facilities, LLC. |
| 1,287 | ||||||
Kindred Biosciences, Inc |
| 1,056 | ||||||
Trinity Partners, LLC. |
| 694 | ||||||
Sentry Data Systems, Inc. |
| 514 | ||||||
AQA Acquisition Holding, Inc. |
| 142 | ||||||
|
|
|
|
|||||
Total Commitments |
$ | 56,135 | $ | 24,760 | ||||
|
|
|
|
* | The Company controls the funding of the SLR Healthcare commitment and may cancel it at its discretion. |
124
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio companys achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2021 and December 31, 2020, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of off-balance sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
Note 12. SLR Business Credit
We acquired 100% of the equity interests of North Mill Capital LLC (NMC) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based small-to-medium-sized businesses primarily in the manufacturing, services and distribution industries. We invested approximately $51,000 to effect the transaction. Subsequently, the Company contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, the Company and ESP SSC Corporation contributed their equity interests to NorthMill LLC (North Mill). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. The Company and ESP SSC Corporation own 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (NM Holdco), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and medium-sized businesses. As part of this transaction, the Companys 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMCs credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from the Company of $19,000 and borrowings on NMCs credit facility of $47,671.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. As of December 31, 2020, the portfolio totaled approximately $387,193 of commitments, of which $148,691 were funded, on total assets of $177,701. At December 31, 2021, the portfolio consisted of 125 issuers with an average balance of approximately $1,989 versus 126 issuers with an average balance of approximately $1,180 at December 31, 2020. NMC has a senior credit facility with a bank lending group for $225,000 which expires on November 13, 2024. Borrowings are secured by substantially all of NMCs assets. NMCs credit facility, which is non-recourse to us, had approximately $183,252 and $111,091 of borrowings outstanding at December 31, 2021 and December 31, 2020, respectively. For the years ended December 31, 2021, 2020 and 2019, SLR Business Credit had net income of $7,295, $4,512 and $2,184, respectively, on gross income of $24,021, $19,715 and $20,212,
125
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
respectively. Due to timing and non-cash items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credits funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credits consolidated financial statements for the fiscal years ended December 31, 2021 and December 31, 2020 are attached as an exhibit to this annual report on Form 10-K.
Note 13. Capital Share Transactions
As of December 31, 2021 and December 31, 2020, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
Shares | Amount | |||||||||||||||
Year ended December 31, 2021 |
Year ended December 31, 2020 |
Year ended December 31, 2021 |
Year ended December 31, 2020 |
|||||||||||||
Shares issued in reinvestment of distributions |
| 2,820 | $ | | $ | 48 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net increase |
| 2,820 | $ | | $ | 48 | ||||||||||
|
|
|
|
|
|
|
|
Note 14. Pending Merger with SLRC
On December 1, 2021, we entered into the Merger Agreement, which provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into us, with us continuing as the surviving company and as SLRCs wholly-owned subsidiary and, immediately thereafter, we will merge with and into SLRC, with SLRC continuing as the surviving company. Both the Board and SLRCs board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us or SLRC, as applicable, have approved the Merger Agreement and the transactions contemplated thereby.
At the effective time of the Merger (Effective Time), each share of our common stock issued and outstanding immediately prior to the Effective Time (other than shares owned by SLRC or any of its controlled subsidiaries (the Cancelled Shares)) will be converted into the right to receive a number of shares of SLRCs common stock equal to the Exchange Ratio (as defined below) (cash may be paid in lieu of fractional shares).
As of a mutually agreed date no earlier than 48 hours (excluding Sundays and holidays) prior to the Effective Time (such date, the Determination Date), each of us and SLRC will deliver to the other a calculation of its NAV as of such date, in each case using a pre-agreed set of assumptions, methodologies and adjustments. We refer to such calculation with respect to us as the Closing SUNS Net Asset Value and with respect to SLRC as the Closing SLRC Net Asset Value. Based on such calculations, the parties will calculate the SUNS Per Share NAV, which will be equal to (i) the Closing SUNS Net Asset Value divided by (ii) the number of shares of our common stock issued and outstanding as of the Determination Date (excluding any Cancelled Shares), and the SLRC Per Share NAV, which will be equal to (A) the Closing SLRC Net Asset Value divided by (B) the number of shares of SLRC Common Stock issued and outstanding as of the Determination Date. The Exchange Ratio will be equal to the quotient (rounded to four decimal places) of (i) the SUNS Per Share NAV divided by (ii) the SLRC Per Share NAV.
126
SLR SENIOR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2021
(in thousands, except share amounts)
We and SLRC will update and redeliver the Closing SUNS Net Asset Value or the Closing SLRC Net Asset Value, respectively, in the event of a material change to such calculation between the Determination Date and the closing of the Mergers and if needed to ensure that the calculation is determined within 48 hours (excluding Sundays and holidays) prior to the Effective Time.
The Merger Agreement contains customary representations and warranties by each of us, SLRC and SLR Capital Partners. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SLRCs businesses during the period prior to the closing of the Mergers.
Consummation of the Mergers, which is currently anticipated to occur during the first half of calendar year 2022, is subject to certain closing conditions, including requisite approvals of our and SLRCs stockholders and certain other closing conditions.
The Merger Agreement also contains certain termination rights in favor of us and SLRC, including if the Mergers are not completed on or before December 1, 2022 or if the requisite approvals of our or SLRCs stockholders are not obtained. The Merger Agreement provides that, upon the termination of the Merger Agreement under certain circumstances, a third party acquiring us may be required to pay SLRC a termination fee of approximately $7,600. The Merger Agreement provides that, upon the termination of the Merger Agreement under certain circumstances, a third party acquiring SLRC may be required to pay to us a termination fee of approximately $25,600.
The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Merger Agreement, which is incorporated by reference as Exhibit 2.1 to this Annual Report and incorporated by reference herein. The representations, warranties, covenants and agreements contained in the Merger Agreement were made only for purposes of the Merger Agreement and as of specific dates; were solely for the benefit of the parties to the Merger Agreement (except as may be expressly set forth in the Merger Agreement); may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing these matters as facts; and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Investors and security holders should not rely on such representations, warranties, covenants or agreements, or any descriptions thereof, as characterizations of the actual state of facts or condition of any of the parties to the Merger Agreement or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties, covenants and agreements may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in public disclosures by the parties to the Merger Agreement.
Note 15. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On January 5, 2022, the Board declared a monthly dividend of $0.10 per share payable on February 2, 2022 to holders of record as of January 20, 2022.
On February 3, 2022, the Board declared a monthly dividend of $0.10 per share payable on March 1, 2022 to holders of record as of February 17, 2022.
On March 1, 2022, the Board declared a monthly dividend of $0.10 per share payable on April 1, 2022 to holders of record as of March 18, 2022.
127
Item 9. | Changes in and Disagreements With Accountants on Accounting and Financial Disclosure |
None.
Item 9A. | Controls and Procedures |
(a) Evaluation of Disclosure Controls and Procedures
As of December 31, 2021 (the end of the period covered by this report), we, including our Co-Chief Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the 1934 Act). Based on that evaluation, our management, including the Co-Chief Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SECs rules and forms, and that such information is accumulated and communicated to our management, including our Co-Chief Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
(b) Managements Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting, and for performing an assessment of the effectiveness of internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Companys internal control over financial reporting includes those policies and procedures that (i) pertain to assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Companys assets that could have a material effect on the financial statements.
Management performed an assessment of the effectiveness of the Companys internal control over financial reporting as of December 31, 2021 based upon the criteria in the 2013 Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on managements assessment, management determined that the Companys internal control over financial reporting was effective as of December 31, 2021.
Due to the Company having annual investment income of less than $100 million during the fiscal year, the Company was not required to obtain an attestation report from the Companys independent registered public accounting firm on the Companys internal control over financial reporting as of December 31, 2021.
(c) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Companys internal control over financial reporting that occurred during the fourth fiscal quarter of 2021 that has materially affected, or is reasonably likely to materially affect, the Companys internal control over financial reporting.
Item 9B. | Other Information |
None.
Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections |
Not Applicable.
128
PART III
Item 10. | Directors, Executive Officers and Corporate Governance |
Information about Directors
Certain information with respect to each of the current directors is set forth below, including their names, ages, a brief description of their recent business experience, including present occupations and employment, certain directorships that each person holds, the year in which each person became a director of the Company, and a discussion of their particular experience, qualifications, attributes or skills that lead us to conclude that such individual should serve as a director of the Company, in light of the Companys business and structure. There were no legal proceedings of the type described in Item 401(f) of Regulation S-K in the past 10 years against any of the directors or officers of the Company and none are currently pending. There is no arrangement or understanding between any of the Companys directors or officers pursuant to which they were selected as directors or officers and the Company or any other person or entity.
Mr. Gross is an interested person of SLR Senior as defined in the Investment Company Act of 1940 (the 1940 Act) due to his position as Co-Chief Executive Officer and President of the Company and a managing member of SLR Capital Partners, LLC (SLR Capital Partners), the Companys investment adviser. Mr. Spohler is an interested person of the Company as defined in the 1940 Act due to his position as Co-Chief Executive Officer and Chief Operating Officer of the Company and a managing member of SLR Capital Partners, the Companys investment adviser. Each of Mr. Wachter, Mr. Hochberg and Mr. Potter is not an interested person of the Company as defined in the 1940 Act.
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years(2) | ||||
Interested Director | ||||||||
Michael S. Gross, 60 | Chairman of the Board of Directors, Co-Chief Executive Officer and President. | Class III Director since 2007; Term expires 2024. | Co-Chief Executive Officer of SLR Investment Corp., SLR Senior Investment Corp. and SCP Private Credit Income BDC LLC since June 2019 and of SLR HC BDC LLC since September 2020 and President of SLR Investment Corp. since 2007, SLR Senior Investment Corp. since 2010, SCP Private Credit Income BDC LLC since 2018 and SLR HC BDC LLC since 2020; Sole Chief Executive Officer of SLR Investment Corp. (February 2007-June | Chairman of the Board of Directors of SLR Investment Corp. since 2010, of SCP Private Credit Income BDC LLC since 2018 and of SLR HC BDC LLC since 2020; Chairman of the Board of Directors of Global Ship Lease Inc.; Director of Jarden Corporation (2007-2016); Chairman of the Board of Mt. Sinai Childrens Center Foundation; Director of New York Road Runners; Member of the Kellogg Global Advisory Board; and Member of the Ross |
129
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years(2) | ||||
2019), of SLR Senior Investment Corp. (December 2010-June 2019) and of SCP Private Credit Income BDC LLC (June 2018-June 2019). | School Advisory Board at the University of Michigan. |
Mr. Gross intimate knowledge of the business and operations of SLR Capital Partners, extensive familiarity with the financial industry and the investment management process in particular, and experience as a director of other public and private companies not only gives the board of directors valuable insight but also positions him well to continue to serve as the Chairman of our board of directors.
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years (2) | ||||
Interested Director | ||||||||
Bruce Spohler, 61 | Co-Chief Executive Officer, Chief Operating Officer and Director | Class II Director since 2009; Term expires 2023. |
Co-Chief Executive Officer of SLR Investment Corp., SLR Senior Investment Corp. and SCP Private Credit Income BDC LLC since June 2019 and of SLR HC BDC LLC since September 2020; Chief Operating Officer of SLR Investment Corp. since February 2007, of SLR Senior Investment Corp. since December 2010 and of SCP Private Credit Income BDC LLC since June 2018, and of SLR HC BDC LLC since September 2020; previously, Managing Director and a former Co-Head of U.S. Leveraged Finance for CIBC World Markets Inc., the investment banking subsidiary of the Canadian Imperial Bank of Commerce. | Director of SLR Investment Corp. since 2010, of SCP Private Credit Income BDC LLC since 2018 and of SLR HC BDC LLC since 2020. |
Mr. Spohlers depth of experience in managerial positions in investment management, leveraged finance and financial services, as well as his intimate knowledge of SLR Capitals business and operations, gives the board of directors valuable industry-specific knowledge and expertise on these and other matters.
130
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years (2) | ||||
Independent Director | ||||||||
Steven Hochberg, 60 | Director | Class II Director since 2007; Term expires 2023. | Partner at Deerfield Management, a healthcare investment firm, since 2013. Co-founder and manager of Ascent Biomedical Ventures, a venture capital firm focused on early stage investment and development of biomedical companies, since 2004. | Director of SLR Investment Corp. since 2011, of SCP Private Credit Income BDC LLC since 2018 of SLR HC BDC LLC since 2020, and of several private companies. Since 2011, Mr. Hochberg had been the Chairman of the Board of Continuum Health Partners until its merger with Mount Sinai in 2013, where he is the Senior Vice Chairman of the Mount Sinai Health System, a non-profit healthcare integrated delivery system in New York City. Director of a number of private healthcare companies and the Cardiovascular Research Foundation, an organization focused on advancing new technologies and education in the field of cardiovascular medicine. |
Mr. Hochbergs varied experience in investing in medical technology companies provides the board of directors with particular knowledge of this field, and his role as chairman of other companies board of directors brings the perspective of a knowledgeable corporate leader.
131
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years (2) | ||||
Independent Director | ||||||||
Leonard A. Potter, 60 | Director | Class III Director since 2009; Term expires 2024. | President and Chief Investment Officer of Wildcat Capital Management, LLC since 2011; Co-founder and Senior Managing Director at Vida Ventures I and II, each a biotech venture fund, since 2017; Managing Director of Soros Private Equity at Soros Fund Management LLC from 2002 to 2009. | Director of SLR Investment Corp. since 2011, of SCP Private Credit Income BDC LLC since 2018, of SLR HC BDC LLC since 2020, of Hilton Grand Vacations Inc. since 2017, of SuRo Capital Corp. since 2011, and of several private companies. |
Mr. Potters experience practicing as a corporate lawyer provides valuable insight to the board of directors on regulatory and risk management issues. In addition, his tenure in private equity and other investments and service as a director of both public and private companies provide industry-specific knowledge and expertise to the board of directors.
Name, Address and Age(1) |
Position(s) Held with Company |
Terms of Office and Length of Time Served |
Principal Occupation(s) During Past 5 Years |
Other Directorships Held by Director or Nominee for Director During Past 5 Years (2) | ||||
Independent Director | ||||||||
David S. Wachter, 58 | Director | Class I Director since 2007; Term expires 2022. | Founding Partner and Managing Partner of W Capital Partners, a private equity fund manager, since 2001. | Director of SLR Investment Corp. since 2011, of SCP Private Credit Income BDC LLC since 2018, of SLR HC BDC LLC since 2020 and of several private companies. |
Mr. Wachters extensive knowledge of private equity and investment banking provides the board of directors with the valuable insight of an experienced financial manager.
(1) | The business address of the director nominee and other directors is c/o SLR Senior Investment Corp., 500 Park Avenue, New York, New York 10022. |
(2) | All of the Companys directors also serve as directors of SLR Investment Corp., SCP Private Credit Income BDC LLC and SLR HC BDC LLC, which are investment companies that have each elected to be regulated as a business development company (BDC) and for which SLR Capital Partners serves as investment adviser. Mr. Potter also serves as a director of SuRo Capital Corp., which is a closed-end management investment company that has elected to be regulated as a BDC. |
132
Information about Executive Officers Who Are Not Directors
The following information, as of December 31, 2021, pertains to our executive officers who are not directors of the Company.
Name, Address, and Age(1) |
Position(s) Held with Company |
Principal Occupation(s) During Past 5 Years | ||
Richard L. Peteka, 60 | Chief Financial Officer, Treasurer and Secretary | Chief Financial Officer, Treasurer and Secretary of the Company and of SLR Investment Corp. since May 2012, of SCP Private Credit Income BDC LLC since June 2018 and of SLR HC BDC LLC since September 2020. Mr. Peteka joined the Company from Apollo Investment Corporation, a publicly-traded business development company, where he served from 2004 to 2012 as the Chief Financial Officer and Treasurer. | ||
Guy Talarico, 66 | Chief Compliance Officer | Chief Compliance Officer of SLR Investment Corp. since 2008, of SLR Senior Investment Corp. since 2010, of SCP Private Credit Income BDC LLC since 2018, of SLR HC BDC LLC since 2020 and of SLR Capital Partners, LLC since February 2016all affiliated entities; and Chief Executive Officer of Alaric Compliance Services, LLC (successor to EOS Compliance Services LLC) from December 2005 to December 2021. In December 2021, Alaric was acquired by Foreside Consulting Services, LLC. Mr. Talarico serves as Senior Managing Director of Foreside Consulting Services, LLC. In conjunction with this primary occupation, Mr. Talarico has served and continues to serve as Chief Compliance Officer for other business development companies, funds, and/or investment advisers who are not affiliated with the SLR Capital Partners entities. |
(1) | The business address of the executive officers is c/o SLR Senior Investment Corp., 500 Park Avenue, New York, New York 10022. |
Our common stock is listed on the NASDAQ Global Select Market under the symbol SUNS.
Audit Committee
The Audit Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at http://www.slrseniorinvestmentcorp.com. The charter sets forth the responsibilities of the Audit Committee. The Audit Committees responsibilities include selecting the independent registered public accounting firm for the Company, reviewing with such independent registered public accounting firm the planning, scope and results of their audit of the Companys financial statements, pre-approving the fees for services performed, reviewing with the independent registered public accounting firm the adequacy of internal control systems, reviewing the Companys annual financial statements and periodic filings and receiving the Companys audit reports and financial statements. The Audit Committee also establishes guidelines and makes recommendations to our board of directors regarding the valuation of our investments. The Audit Committee is responsible for aiding our board of directors in determining the fair value of debt and equity securities that are not publicly traded or for which current market values are not readily available. The board of directors and Audit Committee utilize the services of nationally recognized third-party valuation firms to help determine the fair value of these securities. The Audit Committee is currently composed of Messrs. Hochberg, Wachter and Potter,
133
all of whom are considered independent under the rules of the NASDAQ Stock Market and are not interested persons of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Hochberg serves as Chairman of the Audit Committee. Our board of directors has determined that Mr. Hochberg is an audit committee financial expert as that term is defined under Item 407 of Regulation S-K, as promulgated under the Securities Exchange Act of 1934, as amended (the Exchange Act). Mr. Hochberg meets the current independence and experience requirements of Rule 10A-3 of the Exchange Act.
Communication with the Board of Directors
Stockholders with questions about the Company are encouraged to contact the Companys investor relations department. However, if stockholders believe that their questions have not been addressed, they may communicate with the Companys board of directors by sending their communications to SLR Senior Investment Corp., c/o Richard L. Peteka, Secretary, 500 Park Avenue, New York, New York 10022. All stockholder communications received in this manner will be delivered to one or more members of the board of directors.
Code of Ethics
The Company has adopted a code of ethics that applies to, among others, its senior officers, including its Co-Chief Executive Officers and its Chief Financial Officer, as well as every officer, director and employee of the Company. The Companys code of ethics can be accessed via its website at http://www.slrseniorinvestmentcorp.com. The Company intends to disclose amendments to or waivers from a required provision of the code of ethics on Form 8-K.
Nomination of Directors
There have been no material changes to the procedures by which stockholders may recommend nominees to our Board of Directors implemented since the filing of our Proxy Statement for our 2021 Annual Meeting of Stockholders.
Item 11. | Executive Compensation |
Compensation of Executive Officers
None of our officers receives direct compensation from the Company. As a result, we do not engage any compensation consultants. Mr. Gross, our Co-Chief Executive Officer and President, and Mr. Spohler, our Co-Chief Executive Officer and Chief Operating Officer, through their ownership interest in SLR Capital Partners, our investment adviser, are entitled to a portion of any profits earned by SLR Capital Partners, which includes any fees payable by us to SLR Capital Partners under the terms of the Advisory Agreement, less expenses incurred by SLR Capital Partners in performing its services under the Advisory Agreement. Messrs. Gross and Spohler do not receive any additional compensation from SLR Capital Partners in connection with the management of our portfolio.
Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary and, through Foreside Consulting Services, LLC, Guy Talarico, our Chief Compliance Officer, are paid by SLR Capital Management, our administrator, subject to reimbursement by us of an allocable portion of such compensation for services rendered by such persons to the Company. To the extent that SLR Capital Management outsources any of its functions, we will pay the fees associated with such functions on a direct basis without profit to SLR Capital Management.
134
Compensation of Directors
The following table sets forth compensation of the Companys directors, for the year ended December 31, 2021.
Name |
Fees Earned or Paid in Cash (1) |
Stock Awards (2) |
All Other Compensation |
Total | ||||||||||||
Interested Directors |
||||||||||||||||
Michael S. Gross |
| | | | ||||||||||||
Bruce Spohler |
| | | | ||||||||||||
Independent Directors |
||||||||||||||||
Steven Hochberg |
$ | 63,500 | | | $ | 63,500 | ||||||||||
David S. Wachter |
$ | 61,000 | | | $ | 61,000 | ||||||||||
Leonard A. Potter |
$ | 61,000 | | | $ | 61,000 |
(1) | For a discussion of the independent directors compensation, see below. |
(2) | We do not maintain a stock or option plan, non-equity incentive plan or pension plan for our directors. However, our independent directors have the option to receive all or a portion of the directors fees to which they would otherwise be entitled in the form of shares of our common stock issued at a price per share equal to the greater of our then current net asset value per share or the market price at the time of payment. No shares were issued to any of our independent directors in lieu of cash during 2021. |
Our independent directors annual fee is $50,000. The independent directors also receive $1,250 ($500 if participating telephonically) plus reimbursement of reasonable out-of-pocket expenses incurred in connection with attending each board meeting and $500 plus reimbursement of reasonable out-of-pocket expenses incurred in connection with each committee meeting attended. In addition, the Chairman of the Audit Committee receives an annual fee of $3,750, the Chairman of the Nominating and Corporate Governance Committee receives an annual fee of $1,250 and the Chairman of the Compensation Committee receives an annual fee of $1,250. Further, we purchase directors and officers liability insurance on behalf of our directors and officers. In addition, no compensation was paid to directors who are interested persons of the Company as defined in the 1940 Act.
Compensation Committee
The Compensation Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at http://www.slrseniorinvestmentcorp.com. The charter sets forth the responsibilities of the Compensation Committee. The Compensation Committee is responsible for reviewing and recommending for approval to our board of directors the Advisory Agreement and the Administration Agreement. In addition, although we do not directly compensate our executive officers currently, to the extent that we do so in the future, the Compensation Committee would also be responsible for reviewing and evaluating their compensation and making recommendations to the board of directors regarding their compensation. Lastly, the Compensation Committee would produce a report on our executive compensation practices and policies for inclusion in our proxy statement if required by applicable proxy rules and regulations and, if applicable, make recommendations to the board of directors with matters related to compensation generally. The Compensation Committee has the authority to engage compensation consultants and to delegate their duties and responsibilities to a member or to a subcommittee of the Compensation Committee. The members of the Compensation Committee are Messrs. Hochberg, Wachter and Potter, all of whom are considered independent under the rules of the NASDAQ Stock Market and are not interested persons of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Potter serves as Chairman of the Compensation Committee.
Compensation Committee Interlocks and Insider Participation
During fiscal year 2021 none of the Companys executive officers served on the board of directors (or a compensation committee thereof or other board committee performing equivalent functions) of any entities that
135
had one or more executive officers serve on the Compensation Committee of the Company or on the Board of Directors of the Company. No member of the Compensation Committee had any relationship requiring disclosure under any paragraph of Item 404 of Regulation S-K.
Compensation Committee Report
Currently, none of our executive officers are compensated by the Company, and as such the Company is not required to produce a report on executive officer compensation for inclusion in our annual report on Form 10-K.
Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
The following table sets forth, as of February 25, 2022, the beneficial ownership of each current director, the nominees for directors, the Companys executive officers, each person known to us to beneficially own 5% or more of the outstanding shares of our common stock, and the executive officers and directors as a group.
Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission (SEC) and includes voting or investment power with respect to the securities. Ownership information for those persons who beneficially own 5% or more of our shares of common stock is based upon reports filed by such persons with the SEC and other information obtained from such persons, if available.
Unless otherwise indicated, the Company believes that each beneficial owner set forth in the table has voting and investment power and has the same address as the Company. Our address is 500 Park Avenue, New York, New York 10022.
Name and Address of Beneficial Owner |
Number of Shares Owned Beneficially (1) |
Percentage of Class (2) |
||||||
Interested Directors |
||||||||
Michael S. Gross(3)(4) |
905,122 | 5.6 | % | |||||
Bruce Spohler(3) |
781,671 | 4.9 | % | |||||
Independent Directors |
||||||||
Steven Hochberg |
20,000 | 0.1 | % | |||||
Leonard A. Potter |
6,250 | * | ||||||
David S. Wachter |
9,110 | 0.1 | % | |||||
Executive Officers |
||||||||
Richard L. Peteka |
6,250 | * | ||||||
Guy Talarico |
| | ||||||
All executive officers and directors as a group (7 persons) |
1,184,929 | 7.4 | % | |||||
John W. Jordan II(5) |
1,428,904 | 8.9 | % | |||||
JPMorgan Chase & Co.(6) |
816,250 | 5.0 | % |
* | Represents less than one percent. |
(1) | Beneficial ownership has been determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). Assumes no other purchases or sales of our common stock since the most recently available SEC filings. This assumption has been made under the rules and regulations of the SEC and does not reflect any knowledge that we have with respect to the present intent of the beneficial owners of our common stock listed in this table. |
(2) | Based on a total of 16,049,034 shares of the Companys common stock issued and outstanding as of February 25, 2022. |
(3) | Includes 455,500 shares held by Solar Senior Capital Investors, LLC and 100 shares held by SLR Capital Management, LLC, a portion of both of which may be deemed to be indirectly beneficially owned by |
136
Michael S. Gross and by Bruce Spohler by virtue of their collective ownership interests therein. Also includes 87,874 shares held by Solar Capital Partners Employee Stock Plan LLC, which is controlled by SLR Capital Partners, LLC. Mr. Gross and Mr. Spohler may be deemed to indirectly beneficially own a portion of the shares held by Solar Capital Partners Employee Stock Plan LLC by virtue of their collective ownership interest in SLR Capital Partners, LLC. Each of Mr. Gross and Mr. Spohler disclaim beneficial ownership of any shares of our common stock directly held by Solar Capital Partners Employee Stock Plan LLC, Solar Senior Capital Investors, LLC or SLR Capital Management, LLC, except to the extent of their respective pecuniary interest therein. Also includes 100,000 shares held in a trust of which Bruce Spohler became co-trustee in which he and certain members of his immediate family are beneficiaries (the Spohler Trust) and 130,697 shares held by a limited liability company in which he holds a pro rata interest (the Spohler LLC). Mr. Spohler disclaims beneficial ownership of the shares in the Spohler Trust and the Spohler LLC. |
(4) | Includes (i) 21,844 shares directly held by Michael S. Gross profit sharing plan (the Profit Sharing Plan), which may be deemed to be directly beneficially owned by Mr. Gross as the sole participant in the Profit Sharing Plan, and (ii) 96,717 shares directly held by a grantor retained annuity trust (GRAT) setup by and for Michael S. Gross. As the sole trustee of the GRAT, Mr. Gross may be deemed to directly beneficially own all of the shares held by the GRAT. |
(5) | Based on information contained in Schedule 13G filed on February 21, 2020 by John W. Jordan II. Includes 1,015,726 shares held by The John W. Jordan II Revocable Trust, a trust formed under the laws of Illinois (the JWJ Trust) and 124,701 shares held by The GSJ 2003 Trust. Mr. Jordan is the trustee of the JWJ Trust and the GSJ 2003 Trust and may be deemed to have voting and dispositive power with respect to the shares of our common stock held by these trusts. The address for Mr. Jordan is 875 North Michigan Avenue, Suite 4020, Chicago, Illinois 60611. |
(6) | Based on information contained in Schedule 13G filed on January 28, 2022 by JPMorgan Chase & Co. Such securities are held by certain investment vehicles controlled and/or managed by JPMorgan Chase & Co. or its affiliates. The address for JPMorgan Chase & Co. is 383 Madison Avenue, New York, NY 10179. |
Set forth below is the dollar range of equity securities beneficially owned by each of our directors as of February 25, 2022. We are not part of a family of investment companies, as that term is defined in the 1940 Act.
Name of Director |
Dollar Range of Equity Securities Beneficially Owned (1)(2) |
|||||||
Interested Directors |
||||||||
Michael S. Gross |
Over | $ | 100,000 | |||||
Bruce Spohler |
Over | $ | 100,000 | |||||
Independent Directors |
||||||||
Steven Hochberg |
Over | $ | 100,000 | |||||
Leonard A. Potter |
$ | 50,001 $100,000 | ||||||
David S. Wachter |
Over | $ | 100,000 |
(1) | The dollar ranges are: None, $1-$10,000, $10,001-$50,000, $50,001-$100,000, or Over $100,000. |
(2) | The dollar range of equity securities beneficially owned in us is based on the closing price for our common stock of $13.63 on February 25, 2022 on the NASDAQ Global Select Market. Beneficial ownership has been determined in accordance with Rule 16a-1(a)(2) of the Exchange Act. |
Item 13. | Certain Relationships and Related Transactions, and Director Independence |
We have entered into the Advisory Agreement with SLR Capital Partners. Mr. Gross, our Chairman, Co-Chief Executive Officer and President, and Mr. Spohler, our Co-Chief Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary, serves as the Chief Financial Officer for SLR Capital Partners.
137
SLR Capital Partners and its affiliates may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, SLR Capital Partners presently serves as investment adviser to private funds and managed accounts as well as to SLR Investment Corp., a publicly traded BDC, which focuses on investing primarily in senior secured loans, unsecured loans and equity securities, SCP Private Credit Income BDC LLC, an unlisted BDC, which focuses on investing primarily in senior secured loans, including non-traditional asset-based loans and first lien loans and SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry. In addition, Michael S. Gross, our Chairman and Co-Chief Executive Officer, Bruce Spohler, our Co-Chief Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SLR Investment Corp., SCP Private Credit Income BDC LLC and SLR HC BDC LLC.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we should invest side-by-side with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners allocation procedures.
Related party transactions may occur among SLR Senior Investment Corp., SLR Healthcare ABL and SLR Business Credit. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Healthcare ABL or SLR Business Credit.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
Regulatory restrictions limit our ability to invest in any portfolio company in which any affiliate currently has an investment. The Company obtained its most recent exemptive order from the SEC on June 13, 2017 (the Exemptive Order). The Exemptive Order permits us to participate in negotiated co-investment transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. We believe that it will be advantageous for us to co-invest with funds managed by SLR Capital Partners where such investment is consistent with the investment objectives, investment positions, investment policies, investment strategy, investment restrictions, regulatory requirements and other pertinent factors applicable to us.
We have entered into a license agreement with SLR Capital Partners, pursuant to which SLR Capital Partners has agreed to grant us a non-exclusive, royalty-free license to use the names SLR Senior and SOLAR In addition, pursuant to the terms of the Administration Agreement, SLR Capital Management provides us with the office facilities and administrative services necessary to conduct our day-to-day operations.
Board Consideration of the Investment Advisory and Management Agreement
Our board of directors determined, at a virtual meeting held on November 3, 2021, to approve the Advisory Agreement between the Company and SLR Capital Partners. In reliance on certain exemptive relief provided by the SEC in connection with the global COVID-19 pandemic, our board undertook to ratify the Advisory Agreement at its next in-person meeting. In its consideration of the approval of the Advisory Agreement, the board of directors focused on information it had received relating to, among other things:
| the nature, extent and quality of advisory and other services provided by SLR Capital Partners, including information about the investment performance of the Company relative to its stated |
138
objectives and in comparison to the performance of the Companys peer group and relevant market indices, and concluded that such advisory and other services are satisfactory and the Companys investment performance is reasonable; |
| the experience and qualifications of the personnel providing such advisory and other services, including information about the backgrounds of the investment personnel, the allocation of responsibilities among such personnel and the process by which investment decisions are made, and concluded that the investment personnel of SLR Capital Partners have extensive experience and are well qualified to provide advisory and other services to the Company; |
| the current fee structure, the existence of any fee waivers, and the Companys anticipated expense ratios in relation to those of other investment companies having comparable investment policies and limitations, and concluded that the current fee structure is reasonable; |
| the advisory fees charged by SLR Capital Partners to the Company, to SLR Investment Corp. and to SCP Private Credit Income BDC LLC, the advisory fees that will be charged by SLR Capital Partners to SLR HC BDC LLC, and comparative data regarding the advisory fees charged by other investment advisers to business development companies with similar investment objectives, and concluded that the advisory fees charged by SLR Capital Partners to the Company are reasonable; |
| the direct and indirect costs, including for personnel and office facilities, that are incurred by SLR Capital Partners and its affiliates in performing services for the Company and the basis of determining and allocating these costs, and concluded that the direct and indirect costs, including the allocation of such costs, are reasonable; |
| possible economies of scale arising from the Companys size and/or anticipated growth, and the extent to which such economies of scale are reflected in the advisory fees charged by SLR Capital Partners to the Company, and concluded that some economies of scale may be possible in the future; |
| other possible benefits to SLR Capital Partners and its affiliates arising from their relationships with the Company, and concluded that all such other benefits were not material to SLR Capital Partners and its affiliates; and |
| possible alternative fee structures or bases for determining fees, and concluded that the Companys current fee structure and bases for determining fees are satisfactory. |
Based on the information reviewed and the discussions detailed above, the board of directors, including a majority of the directors who are not interested persons as defined in the 1940 Act, concluded that the fees payable to SLR Capital Partners pursuant to the Advisory Agreement were reasonable, and comparable to the fees paid by other management investment companies with similar investment objectives, in relation to the services to be provided. The board of directors did not assign relative weights to the above factors or the other factors considered by it. Individual members of the board of directors may have given different weights to different factors.
Director Independence
In accordance with rules of the NASDAQ Stock Market, our board of directors annually determines each directors independence. We do not consider a director independent unless the board of directors has determined that he has no material relationship with us. We monitor the relationships of our directors and officers through a questionnaire each director completes no less frequently than annually and updates periodically as information provided in the most recent questionnaire changes.
Our governance guidelines require any director who has previously been determined to be independent to inform the Chairman of the board of directors, the Chairman of the Nominating and Corporate Governance
139
Committee and our Secretary of any change in circumstance that may cause his status as an independent director to change. The board of directors limits membership on the Audit Committee, the Nominating and Corporate Governance Committee and the Compensation Committee to independent directors.
In order to evaluate the materiality of any such relationship, the board of directors uses the definition of director independence set forth in the rules promulgated by the NASDAQ Stock Market. Rule 5605(a)(2) provides that a director of a BDC, shall be considered to be independent if he or she is not an interested person of such BDC, as defined in Section 2(a)(19) of the 1940 Act.
The board of directors has determined that each of the directors is independent and has no relationship with us, except as a director and stockholder, with the exception of Michael S. Gross, as a result of his positions as the Co-Chief Executive Officer and President of the Company and a Managing Member of SLR Capital Partners, and Bruce Spohler, as a result of his positions as the Co-Chief Executive Officer and Chief Operating Officer of the Company and a Managing Member of SLR Capital Partners.
Indemnification Agreements
We have entered into indemnification agreements with our directors. The indemnification agreements are intended to provide our directors the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that SLR Senior shall indemnify the director who is a party to the agreement (an Indemnitee), including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.
Item 14. | Principal Accountant Fees and Services |
KPMG LLP has advised us that neither the firm nor any present member or associate of it has any material financial interest, direct or indirect, in the Company or its affiliates.
Table below in thousands
Fiscal Year Ended December 31, 2021 |
Fiscal Year Ended December 31, 2020 |
|||||||
Audit Fees |
$ | 294.9 | $ | 271.7 | ||||
Audit-Related Fees |
| | ||||||
Tax Fees |
49.7 | 48.3 | ||||||
All Other Fees |
43.0 | | ||||||
Total Fees: |
$ | 387.6 | $ | 320.0 |
Audit Fees: Audit fees consist of fees billed for professional services rendered for the audit of our year-end financial statements and quarterly reviews and services that are normally provided by KPMG LLP in connection with statutory and regulatory filings.
Audit-Related Fees: Audit-related services consist of fees billed for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under Audit Fees. These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.
Tax Services Fees: Tax services fees consist of fees billed for professional tax services. These services also include assistance regarding federal, state, and local tax compliance.
All Other Fees: Other fees would include fees for products and services other than the services reported above.
140
Pre-Approval Policy
The Audit Committee has established a pre-approval policy that describes the permitted audit, audit-related, tax and other services to be provided by KPMG LLP, the Companys independent registered public accounting firm (KPMG). The policy requires that the Audit Committee pre-approve the audit and non-audit services performed by the independent auditor in order to assure that the provision of such service does not impair the auditors independence.
Any requests for audit, audit-related, tax and other services that have not received general pre-approval must be submitted to the Audit Committee for specific pre-approval, irrespective of the amount, and cannot commence until such approval has been granted. Normally, pre-approval is provided at regularly scheduled meetings of the Audit Committee. However, the Audit Committee may delegate pre-approval authority to one or more of its members. The member or members to whom such authority is delegated shall report any pre-approval decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to pre-approve services performed by the independent registered public accounting firm to management. During the fiscal year ended December 31, 2021, the Audit Committee pre-approved 100% of services described in this policy.
141
PART IV
Item 15. | Exhibit and Financial Statement Schedules |
a. Documents Filed as Part of this Report
The following reports and consolidated financial statements are set forth in Item 8:
b. Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:
142
(1) | Previously filed in connection with SLR Senior Investment Corp.s registration statement on Form N-2 (File No. 333-171330) filed on February 14, 2011. |
(2) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 10-K filed on February 22, 2012. |
(3) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 8-K filed on August 31, 2011. |
(4) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 10-K filed on February 25, 2014. |
(5) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 10-Q filed on August 2, 2016. |
143
(6) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 10-Q filed on August 6, 2018. |
(7) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 10-K filed on February 24, 2021. |
(8) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 8-K filed on February 25, 2021. |
(9) | Previously filed in connection with SLR Senior Investment Corp.s report on Form 8-K filed on December 1, 2021. |
* | Filed herewith. |
c. Consolidated Financial Statement Schedules
Separate Financial Statements of Subsidiaries Not Consolidated:
Consolidated Financial Statements for Gemino Healthcare Finance, LLC and Subsidiary year ended December 31, 2021 and December 31, 2020 are attached as Exhibit 99.1 hereto. Consolidated Financial Statements for North Mill Holdco LLC year ended December 31, 2021 and December 31, 2020 are attached as Exhibit 99.2 hereto.
Item 16. | Form 10-K Summary |
None.
144
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SLR SENIOR INVESTMENT CORP. | ||||
/s/ MICHAEL S. GROSS |
/s/ BRUCE J. SPOHLER | |||
Michael S. Gross Co-Chief Executive Officer, President, Chairman of the Board and Director Date: March 1, 2022 |
Bruce J. Spohler Co-Chief Executive Officer, Chief Operating Officer and Director Date: March 1, 2022 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.
Date |
Signature |
Title | ||
March 1, 2022 | /s/ MICHAEL S. GROSS Michael S. Gross |
Co-Chief Executive Officer, President, Chairman of the Board and Director (Principal Executive Officer) | ||
March 1, 2022 | /s/ BRUCE J. SPOHLER Bruce J. Spohler |
Co-Chief Executive Officer, Chief Operating Officer and Director (Principal Executive Officer) | ||
March 1, 2022 | /s/ STEVEN HOCHBERG Steven Hochberg |
Director | ||
March 1, 2022 | /s/ DAVID S. WACHTER David S. Wachter |
Director | ||
March 1, 2022 | /s/ LEONARD A. POTTER Leonard A. Potter |
Director | ||
March 1, 2022 | /s/ RICHARD L. PETEKA Richard L. Peteka |
Chief Financial Officer (Principal Financial Officer) and Secretary |
145
Exhibit 4.2
DESCRIPTION OF SECURITIES
The following is a brief description of the securities of SLR Senior Investment Corp. (the Company, we, our or us), registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the Exchange Act). This description of the terms of our stock does not purport to be complete and is subject to and qualified in its entirety by reference to the applicable provisions of Maryland General Corporation Law, and the full text of our charter and bylaws. As of December 31, 2021 and the date hereof, our common stock is the only class of our securities registered under Section 12 of the Exchange Act.
Common Stock
As of December 31, 2021, our authorized stock consisted of 200,000,000 shares of stock, par value $0.01 per share, all of which are initially designated as common stock. Our common stock is listed on the NASDAQ Global Select Market under the ticker symbol SUNS. There are no outstanding options or warrants to purchase our stock. No stock has been authorized for issuance under any equity compensation plans. Under the Maryland General Corporation Law, our stockholders generally are not personally liable for our debts or obligations.
Under our charter, our board of directors is authorized to classify and reclassify any unissued shares of stock into other classes or series of stock without obtaining stockholder approval. As permitted by the Maryland General Corporation Law, our charter provides that the board of directors, without any action by our stockholders, may amend the charter from time to time to increase or decrease the aggregate number of shares of stock or the number of shares of stock of any class or series that we have authority to issue.
All shares of our common stock have equal rights as to earnings, assets, voting, and distributions and, when they are issued, will be duly authorized, validly issued, fully paid and nonassessable. Distributions may be paid to the holders of our common stock if, as and when authorized by our board of directors and declared by us out of assets legally available therefor. Shares of our common stock have no preemptive, conversion or redemption rights and are freely transferable, except where their transfer is restricted by federal and state securities laws or by contract. In the event of our liquidation, dissolution or winding up, each share of our common stock would be entitled to share ratably in all of our assets that are legally available for distribution after we pay all debts and other liabilities and subject to any preferential rights of holders of our preferred stock, if any preferred stock is outstanding at such time. Each share of our common stock is entitled to one vote on all matters submitted to a vote of stockholders, including the election of directors. Except as provided with respect to any other class or series of stock, the holders of our common stock will possess exclusive voting power. There is no cumulative voting in the election of directors, which means that holders of a majority of the outstanding shares of common stock can elect all of our directors, and holders of less than a majority of such shares will be unable to elect any director.
Certain Provisions of the Maryland General Corporation Law and Our Charter and Bylaws
The Maryland General Corporation Law and our charter and bylaws contain provisions that could make it more difficult for a potential acquiror to acquire us by means of a tender offer, proxy contest or otherwise. These provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of such proposals may improve their terms.
Classified Board of Directors
Our board of directors is into three classes of directors serving staggered three-year terms. The current terms of the first, second and third classes expire at the annual meeting of stockholders in 2024, 2022 and 2023, respectively, and in each case, those directors will serve until their successors are duly elected and qualify. Upon expiration of their current terms, directors of each class will be elected to serve for three-year terms and until their successors are duly elected and qualify and each year one class of directors will be elected by the stockholders. A classified board may render a change in control of us or removal of our incumbent management more difficult. We believe, however, that the longer time required to elect a majority of a classified board of directors will help to ensure the continuity and stability of our management and policies.
Election of Directors
Under our charter and bylaws, the affirmative vote of the holders of a plurality of all the votes cast in the election of directors at a meeting of stockholders duly called and at which a quorum is present will be required to elect a director. Pursuant to our charter and bylaws our board of directors may amend the bylaws to alter the vote required to elect directors.
Number of Directors; Vacancies; Removal
Our charter provides that the number of directors will be set only by the board of directors in accordance with our bylaws. Our bylaws provide that a majority of our entire board of directors may at any time increase or decrease the number of directors. However, the number of directors may never be less than one nor more than twelve unless our bylaws are amended in which case we may have more than twelve directors but never less than one. Our charter provides that, at such time as we have at least three independent directors and our common stock is registered under the Exchange Act, we elect to be subject to the provision of Subtitle 8 of Title 3 of the Maryland General Corporation Law regarding the filling of vacancies on the board of directors. Accordingly, except as may be provided by the board of directors in setting the terms of any class or series of preferred stock, any and all vacancies on the board of directors may be filled only by the affirmative vote of a majority of the remaining directors in office, even if the remaining directors do not constitute a quorum, and any director elected to fill a vacancy will serve for the remainder of the full term of the directorship in which the vacancy occurred and until a successor is duly elected and qualifies, subject to any applicable requirements of the Investment Company Act of 1940, as amended (the 1940 Act).
Our charter provides that, subject to the rights of holders of one or more classes or series of preferred stock to elect or remove one or more directors, a director may be removed only for cause, as defined in our charter, and then only by the affirmative vote of at least two-thirds of the votes entitled to be cast in the election of directors.
Action by Stockholders
Under the Maryland General Corporation Law, stockholder action can be taken only at an annual or special meeting of stockholders or (with respect to the holders of common stock, unless the charter provides for stockholder action by less than unanimous written consent, which our charter does not) by unanimous written consent in lieu of a meeting. These provisions, combined with the requirements of our bylaws regarding the calling of a stockholder-requested special meeting of stockholders discussed below, may have the effect of delaying consideration of a stockholder proposal until the next annual meeting.
Advance Notice Provisions for Stockholder Nominations and Stockholder Proposals
Our bylaws provide that with respect to an annual meeting of stockholders, nominations of persons for election to the board of directors and the proposal of business to be considered by stockholders may be made only (1) pursuant to our notice of the meeting, (2) by the board of directors or (3) by a stockholder who was a stockholder of record both at the time of giving notice and at the time of the meeting who is entitled to vote at the meeting and who has complied with the advance notice procedures of our bylaws. With respect to special meetings of stockholders, only the business specified in our notice of the meeting may be brought before the meeting. Nominations of persons for election to the board of directors at a special meeting may be made only (1) by the board of directors or (2) provided that the board of directors has determined that directors will be elected at the meeting, by a stockholder who was a stockholder of record both at the time of giving notice and at the time of the meeting who is entitled to vote at the meeting and who has complied with the advance notice provisions of the bylaws.
The purpose of requiring stockholders to give us advance notice of nominations and other business is to afford our board of directors a meaningful opportunity to consider the qualifications of the proposed nominees and the advisability of any other proposed business and, to the extent deemed necessary or desirable by our board of directors, to inform stockholders and make recommendations about such qualifications or business, as well as to provide a more orderly procedure for conducting meetings of stockholders. Although our bylaws do not give our board of directors any power to disapprove stockholder nominations for the election of directors or proposals recommending certain action, they may have the effect of precluding a contest for the election of directors or the consideration of stockholder proposals if proper procedures are not followed and of discouraging or deterring a third party from conducting a solicitation of proxies to elect its own slate of directors or to approve its own proposal without regard to whether consideration of such nominees or proposals might be harmful or beneficial to us and our stockholders.
Exclusive Forum
Our bylaws provide that, unless we consent in writing to the selection of a different forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on behalf of us, (c) any action asserting a claim of breach of any duty owed by any of our directors or officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors or officers or
other agents arising pursuant to any provision of the MGCL or our charter or our bylaws, or (e) any other action asserting a claim against us or any of our directors or officers or other agents that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, we and our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland Rule 16-308 or any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws does not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act of 1933, as amended (the Securities Act), the Exchange Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the Exchange Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Calling of Special Meetings of Stockholders
Our bylaws provide that special meetings of stockholders may be called by our board of directors and certain of our officers. Additionally, our bylaws provide that, subject to the satisfaction of certain procedural and informational requirements by the stockholders requesting the meeting, a special meeting of stockholders will be called by the secretary of the corporation upon the written request of stockholders entitled to cast not less than a majority of all the votes entitled to be cast at such meeting.
Approval of Extraordinary Corporate Action; Amendment of Charter and Bylaws
Under Maryland law, a Maryland corporation generally cannot dissolve, amend its charter, merge, convert, sell all or substantially all of its assets, engage in a share exchange or engage in similar transactions outside the ordinary course of business, unless approved by the affirmative vote of stockholders entitled to cast at least two-thirds of the votes entitled to be cast on the matter. However, a Maryland corporation may provide in its charter for approval of these matters by a lesser percentage, but not less than a majority of all of the votes entitled to be cast on the matter. Our charter generally provides for approval of charter amendments and extraordinary transactions by the stockholders entitled to cast at least a majority of the votes entitled to be cast on the matter. Our charter also provides that the following matters require the approval of stockholders entitled to cast at least 80% of the votes entitled to be cast: (i) certain charter amendments; (ii) any proposal for our conversion, whether by merger or otherwise, from a closed-end company to an open-end company; (iii) any proposal for our liquidation or dissolution; (iv) any proposal regarding a merger, consolidation, share exchange or sale or exchange of all or substantially all of our assets that the Maryland General Corporation Law requires to be approved by our stockholders; or (v) any transaction between us and a person, or group of persons acting together (including, without limitation, a group for purposes of Section 13(d) of the Exchange Act), and any person controlling, controlled by or under common control with any such person or member of such group, that is entitled to exercise or direct the exercise, or acquire the right to exercise or direct the exercise, directly or indirectly, other than solely by virtue of a revocable proxy, of one-tenth or more of the voting power in the election of directors generally. However, if such amendment or proposal is approved by a majority of our continuing directors (in addition to approval by our board of directors), such amendment or proposal may be approved by a majority of the votes entitled to be cast on such a matter, provided that with respect to any transaction referred to in (v) above, if such transaction is approved by the continuing directors, by a vote of at least two-thirds of such continuing directors, no stockholder approval of such transaction is required unless the Maryland General Corporation Law or another provision of our charter or bylaws otherwise requires such approval. The continuing directors are defined in our charter as (1) our current directors, (2) those directors whose nomination for election by the stockholders or whose election by the directors to fill vacancies is approved by a majority of our current directors then on the board of directors or (3) any successor directors whose nomination for election by the stockholders or whose election by the directors to fill vacancies is approved by a majority of continuing directors or the successor continuing directors then in office.
Our charter and bylaws provide that the board of directors will have the exclusive power to make, alter, amend or repeal any provision of our bylaws.
No Appraisal Rights
Except with respect to appraisal rights arising in connection with the Control Share Act (defined and discussed below), as permitted by the Maryland General Corporation Law, our charter provides that stockholders will not be entitled to exercise appraisal rights unless a majority of the board of directors shall determine such rights apply.
Control Share Acquisitions
The Maryland General Corporation Law provides that a holder of control shares of a Maryland corporation acquired in a control share acquisition has no voting rights with respect to those shares except to the extent approved by a vote of two-thirds of the votes entitled to be cast on the matter, or the Control Share Act. Shares owned by the acquiror, by officers or by directors who are employees of the corporation are excluded from shares entitled to vote on the matter. Control shares are voting shares of stock which, if aggregated with all other shares of stock owned by the acquiror or in respect of which the acquiror is able to exercise or direct the exercise of voting power (except solely by virtue of a revocable proxy), would entitle the acquiror to exercise voting power in electing directors within one of the following ranges of voting power:
| one-tenth or more but less than one-third; |
| one-third or more but less than a majority; or |
| a majority or more of all voting power. |
The requisite stockholder approval must be obtained each time an acquiror crosses one of the thresholds of voting power set forth above. Control shares do not include shares the acquiring person is then entitled to vote as a result of having previously obtained stockholder approval. A control share acquisition means the acquisition of issued and outstanding control shares, subject to certain exceptions.
A person who has made or proposes to make a control share acquisition may compel the board of directors of the corporation to call a special meeting of stockholders to be held within 50 days of demand to consider the voting rights of the shares. The right to compel the calling of a special meeting is subject to the satisfaction of certain conditions, including an undertaking to pay the expenses of the meeting. If no request for a meeting is made, the corporation may itself present the question at any stockholders meeting.
If voting rights are not approved at the meeting or if the acquiring person does not deliver an acquiring person statement as required by the statute, then the corporation may redeem for fair value any or all of the control shares, except those for which voting rights have previously been approved. The right of the corporation to redeem control shares is subject to certain conditions and limitations, including, as provided in our bylaws, compliance with the 1940 Act. Fair value is determined, without regard to the absence of voting rights for the control shares, as of the date of the last control share acquisition by the acquiror or of any meeting of stockholders at which the voting rights of the shares are considered and not approved. If voting rights for control shares are approved at a stockholders meeting and the acquiror becomes entitled to vote a majority of the shares entitled to vote, all other stockholders may exercise appraisal rights. The fair value of the shares as determined for purposes of appraisal rights may not be less than the highest price per share paid by the acquiror in the control share acquisition.
The Control Share Act does not apply (a) to shares acquired in a merger, consolidation or share exchange if the corporation is a party to the transaction or (b) to acquisitions approved or exempted by the charter or bylaws of the corporation. Our bylaws contain a provision exempting from the Control Share Act any and all acquisitions by any person of our shares of stock. There can be no assurance that such provision will not be amended or eliminated at any time in the future. However, we will amend our bylaws to be subject to the Control Share Act only if the board of directors determines that it would be in our best interests, including in light of the fiduciary obligations of the board of directors, applicable federal and state laws, and the particular facts and circumstances surrounding the decision of the board of directors.
Business Combinations
Under Maryland law, business combinations between a Maryland corporation and an interested stockholder or an affiliate of an interested stockholder are prohibited for five years after the most recent date on which the interested stockholder becomes an interested stockholder (the Business Combination Act). These business combinations include a merger, consolidation, share exchange or, in circumstances specified in the statute, an asset transfer or issuance or reclassification of equity securities. An interested stockholder is defined as:
| any person who beneficially owns 10% or more of the voting power of the corporations outstanding voting stock; or |
| an affiliate or associate of the corporation who, at any time within the two-year period prior to the date in question, was the beneficial owner of 10% or more of the voting power of the then outstanding voting stock of the corporation. |
A person is not an interested stockholder under this statute if the board of directors approved in advance the transaction by which the stockholder otherwise would have become an interested stockholder. However, in approving a transaction, the board of directors may provide that its approval is subject to compliance, at or after the time of approval, with any terms and conditions determined by the board.
After the five-year prohibition, any business combination between the Maryland corporation and an interested stockholder generally must be recommended by the board of directors of the corporation and approved by the affirmative vote of at least:
| 80% of the votes entitled to be cast by holders of outstanding shares of voting stock of the corporation; and |
| two-thirds of the votes entitled to be cast by holders of voting stock of the corporation other than shares held by the interested stockholder with whom or with whose affiliate the business combination is to be effected or held by an affiliate or associate of the interested stockholder. |
These super-majority vote requirements do not apply if the corporations common stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares.
The statute permits various exemptions from its provisions, including business combinations that are exempted by the board of directors before the time that the interested stockholder becomes an interested stockholder. Our board of directors has adopted a resolution that any business combination between us and any other person is exempted from the provisions of the Business Combination Act, provided that the business combination is first approved by the board of directors, including a majority of the directors who are not interested persons as defined in the 1940 Act. This resolution may be altered or repealed in whole or in part at any time; however, our board of directors will adopt resolutions so as to make us subject to the provisions of the Business Combination Act only if the board of directors determines that it would be in our best interests and if the Securities and Exchange Commission staff does not object to our determination that our being subject to the Business Combination Act does not conflict with the 1940 Act. If this resolution is repealed, or the board of directors does not otherwise approve a business combination, the statute may discourage others from trying to acquire control of us and increase the difficulty of consummating any offer.
Conflict with 1940 Act
Our bylaws provide that, if and to the extent that any provision of the Maryland General Corporation Law, including the Maryland Control Share Acquisition Act (if we amend our bylaws to be subject to such Act) and the Business Combination Act, or any provision of our charter or bylaws conflicts with any provision of the 1940 Act, the applicable provision of the 1940 Act will control.
Exhibit 21.1
Subsidiaries of SLR Senior Investment Corp.
The following list sets forth each of our consolidated subsidiaries, the state or country under whose laws the subsidiary is organized, and the percentage of voting securities or membership interests owned by us in such subsidiary:
ESP SSC Corporation (Delaware) 100%
SUNS SPV LLC (Delaware) 100%
The subsidiaries listed above are consolidated for financial reporting purposes. We may also be deemed to control certain portfolio companies.
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statement on Form N-2 of SLR Senior Investment Corp. of our report dated March 1, 2022, with respect to the consolidated financial statements, which appears in the annual report on Form 10-K of SLR Senior Investment Corp. for the year ended December 31, 2021, and to the use of our report dated March 1, 2022 on the senior securities table included herein as an exhibit to the Form 10-K. We also consent to the reference to our firm under the heading Controls and Procedures in the Form 10-K.
/s/ KPMG LLP
New York, New York
March 1, 2022
Exhibit 23.2
Consent of Independent Auditor
We hereby consent to the incorporation by reference of our report dated February 18, 2022 on the consolidated financial statements of Gemino Healthcare Finance, LLC, which report appears in the annual report on Form 10-K of SLR Senior Investment Corp. dated March 1, 2022, in the Registration Statement on Form N-2 (No. 333-255516) of SLR Senior Investment Corp.
/s/ Baker Tilly US, LLP
Philadelphia, Pennsylvania
March 1, 2022
Exhibit 23.3
Consent of Independent Auditor
We consent to the incorporation by reference in Pre-Effective Amendment No. 1 to the Registration Statement on Form N-2 of SLR Senior Investment Corp. of our report dated February 18, 2022, relating to the financial statements of North Mill HoldCo LLC and Subsidiaries, appearing in this Annual Report on Form 10-K of SLR Senior Investment Corp. for the year ended December 31, 2021.
/s/ RSM US LLP
Philadelphia, Pennsylvania
March 1, 2022
Exhibit 31.1
Certification Pursuant to Section 302
Certification of Co-Chief Executive Officer
I, Michael S. Gross, Co-Chief Executive Officer of SLR Senior Investment Corp., certify that:
1. I have reviewed this annual report on Form 10-K of SLR Senior Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 1, 2022
/S/ MICHAEL S. GROSS |
Michael S. Gross |
Co-Chief Executive Officer |
Exhibit 31.2
Certification Pursuant to Section 302
Certification of Co-Chief Executive Officer
I, Bruce J. Spohler, Co-Chief Executive Officer of SLR Senior Investment Corp., certify that:
1. I have reviewed this annual report on Form 10-K of SLR Senior Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 1, 2022
/s/ BRUCE J. SPOHLER |
Bruce J. Spohler |
Co-Chief Executive Officer |
Exhibit 31.3
Certification Pursuant to Section 302
Certification of Chief Financial Officer
I, Richard L. Peteka, Chief Financial Officer of SLR Senior Investment Corp., certify that:
1. I have reviewed this annual report on Form 10-K of SLR Senior Investment Corp.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and
5. The registrants other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.
Date: March 1, 2022
/s/ RICHARD L. PETEKA |
Richard L. Peteka |
Chief Financial Officer |
Exhibit 32.1
Certification of Co-Chief Executive Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2021 (the Report) of SLR Senior Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Michael S. Gross, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ MICHAEL S. GROSS | ||
Name: | Michael S. Gross | |
Date: | March 1, 2022 |
Exhibit 32.2
Certification of Co-Chief Executive Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2021 (the Report) of SLR Senior Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Bruce J. Spohler, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ BRUCE J. SPOHLER | ||
Name: | Bruce J. Spohler | |
Date: | March 1, 2022 |
Exhibit 32.3
Certification of Chief Financial Officer
Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350)
In connection with the Annual Report on Form 10-K for the year ended December 31, 2021 (the Report) of SLR Senior Investment Corp. (the Registrant), as filed with the Securities and Exchange Commission on the date hereof, I, Richard L. Peteka, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
/s/ RICHARD L. PETEKA | ||
Name: | Richard L. Peteka | |
Date: | March 1, 2022 |
Exhibit 99.1
Gemino Healthcare Finance, LLC
d/b/a SLR Healthcare ABL
Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Table of Contents
Years Ended December 31, 2021 and 2020
Page | ||||
Independent Auditors Report |
1 | |||
Consolidated Financial Statements |
||||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Operations |
4 | |||
Consolidated Statements of Changes in Members Equity |
5 | |||
Consolidated Statements of Cash Flows |
6 | |||
Notes to Consolidated Financial Statements |
7 |
Independent Auditors Report
To the Board of Managers of
Gemino Healthcare Finance, LLC and Subsidiary
Opinion
We have audited the consolidated financial statements of Gemino Healthcare Finance, LLC and Subsidiary d/b/a SLR Healthcare ABL (the Company), which comprise the consolidated balance sheets as of December 31, 2021 and 2020, and the related consolidated statements of operations, changes in members equity and cash flows for the years then ended, and the related notes to the consolidated financial statements.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020 and the results of its operations and its cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America (GAAP).
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Consolidated Financial Statements
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with GAAP, and for the design, implementation and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are available to be issued.
Auditors Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the consolidated financial statements.
Baker Tilly US, LLP, trading as Baker Tilly, is a member of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. © 2020 Baker Tilly US, LLP
1
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the consolidated financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
Philadelphia, Pennsylvania
February 18, 2022
2
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Balance Sheets
December 31, 2021 and 2020
2021 | 2020 | |||||||
Assets | ||||||||
Assets |
||||||||
Cash and cash equivalents |
$ | 3,256,256 | $ | 10,356,890 | ||||
Loans receivable, net |
81,603,569 | 39,340,360 | ||||||
Accrued interest receivable |
664,127 | 627,981 | ||||||
Intangible asset - trade name |
| 2,800,000 | ||||||
Goodwill |
5,663,531 | 5,663,531 | ||||||
Furniture and equipment, net |
14,319 | 21,100 | ||||||
Other assets |
72,954 | 71,327 | ||||||
|
|
|
|
|||||
Total assets |
$ | 91,274,756 | $ | 58,881,189 | ||||
|
|
|
|
|||||
Liabilities and Members Equity | ||||||||
Liabilities |
||||||||
Credit facility, net |
$ | 59,398,378 | $ | 24,201,884 | ||||
Accounts payable and accrued expenses |
2,491,180 | 2,239,801 | ||||||
Dividend payable |
529,058 | 529,029 | ||||||
|
|
|
|
|||||
Total liabilities |
62,418,616 | 26,970,714 | ||||||
|
|
|
|
|||||
Members equity |
||||||||
Units, $1,000 par value, issued and outstanding 35,270 and 35,270, respectively |
32,820,783 | 32,820,783 | ||||||
Accumulated deficit |
(3,964,643 | ) | (910,308 | ) | ||||
|
|
|
|
|||||
Total members equity |
28,856,140 | 31,910,475 | ||||||
|
|
|
|
|||||
Total liabilities and members equity |
$ | 91,274,756 | $ | 58,881,189 | ||||
|
|
|
|
See notes to consolidated financial statements
3
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Operations
Years Ended December 31, 2021 and 2020
2021 | 2020 | |||||||
Interest income: |
||||||||
Interest income |
$ | 5,583,832 | $ | 7,092,079 | ||||
Interest expense |
1,634,855 | 2,305,418 | ||||||
|
|
|
|
|||||
Net interest income |
3,948,977 | 4,786,661 | ||||||
Provision for loan losses |
426,428 | (726,251 | ) | |||||
|
|
|
|
|||||
Net interest income after provision for loan losses |
3,522,549 | 5,512,912 | ||||||
Other income |
4,468,588 | 3,275,372 | ||||||
Operating expenses: |
||||||||
Compensation and benefits |
3,819,816 | 3,823,694 | ||||||
Depreciation and amortization |
2,811,730 | 14,338 | ||||||
General and administrative |
697,811 | 661,336 | ||||||
|
|
|
|
|||||
Total operating expenses |
7,329,357 | 4,499,368 | ||||||
Net income |
$ | 661,780 | $ | 4,288,916 | ||||
|
|
|
|
See notes to consolidated financial statements
4
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Changes in Members Equity
Years Ended December 31, 2021 and 2020
Balance at December 31, 2019 |
$ | 31,339,970 | ||
Capital distributions |
(2,186 | ) | ||
Dividends declared |
(3,716,225 | ) | ||
Net income |
4,288,916 | |||
|
|
|||
Balance at December 31, 2020 |
$ | 31,910,475 | ||
Capital distributions |
| |||
Dividends declared |
(3,716,115 | ) | ||
Net income |
661,780 | |||
|
|
|||
Balance at December 31, 2021 |
$ | 28,856,140 | ||
|
|
See notes to consolidated financial statements
5
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Consolidated Statements of Cash Flows
Years Ended December 31, 2021 and 2020
2021 | 2020 | |||||||
Cash Flows from Operating Activities |
||||||||
Net income |
$ | 661,780 | $ | 4,288,916 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
Depreciation |
11,730 | 14,338 | ||||||
Amortization of intangible asset - trade name |
2,800,000 | | ||||||
Amortization of deferred origination fees and costs |
(590,858 | ) | (346,265 | ) | ||||
Amortization of debt issuance costs |
229,084 | 228,034 | ||||||
Provision for loan losses |
426,428 | (726,251 | ) | |||||
Changes in assets and liabilities: |
||||||||
(Increase) decrease in accrued interest receivable |
(36,146 | ) | 431,123 | |||||
(Increase) decrease in other assets |
(1,627 | ) | 11,986 | |||||
Increase in deferred origination fees and costs |
507,863 | 505,850 | ||||||
Increase (decrease) in accounts payable and accrued expenses |
251,379 | (21,356 | ) | |||||
|
|
|
|
|||||
Net cash provided by operating activities |
4,259,633 | 4,386,375 | ||||||
|
|
|
|
|||||
Cash Flows from Investing Activities |
||||||||
(Increase) decrease in loans receivable, net |
(42,606,642 | ) | 72,193,946 | |||||
Purchase of furniture and equipment |
(4,949 | ) | (6,597 | ) | ||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
(42,611,591 | ) | 72,187,349 | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from (repayments of) credit facility, net |
35,000,000 | (64,000,000 | ) | |||||
Debt issuance costs paid |
(32,590 | ) | (19,618 | ) | ||||
Dividends paid |
(3,716,086 | ) | (3,716,275 | ) | ||||
Capital distributions |
| (2,186 | ) | |||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
31,251,324 | (67,738,079 | ) | |||||
|
|
|
|
|||||
Net (decrease) increase in cash and cash equivalents |
(7,100,634 | ) | 8,835,645 | |||||
Cash and cash equivalents, beginning of the year |
10,356,890 | 1,521,245 | ||||||
|
|
|
|
|||||
Cash and cash equivalents, end of the year |
$ | 3,256,256 | $ | 10,356,890 | ||||
|
|
|
|
|||||
Supplemental Disclosure of Cash Flow Information |
||||||||
Interest paid |
$ | 1,359,195 | $ | 2,265,221 | ||||
|
|
|
|
See notes to consolidated financial statements
6
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
1. | Description of Business |
Gemino Healthcare Finance, LLC is a Delaware limited liability company formed in December 2006. In February 2021, the Company filed a d/b/a in the name of SLR Healthcare ABL (SLR Healthcare). SLR Healthcare is a commercial finance company that originates, underwrites and manages primarily secured, asset-based loans for small and mid-sized companies operating across the U.S. in the healthcare industry. SLR Healthcares loans are primarily in the form of revolving lines of credit, secured by accounts receivable of the borrowers. The accounts receivable serving as collateral are primarily third party obligations from government payers, such as Medicare or Medicaid, and commercial insurers.
In certain cases, SLR Healthcare may provide senior term loan financing, including real estate financing to qualified borrowers in addition to a revolving line of credit. Senior term loans, including real estate loans are typically secured by accounts receivable and all other assets of the borrowers, such as pledges of the stock of the borrowers and real estate.
Gemino Healthcare Funding, LLC (Gemino Funding) is a wholly-owned special purpose limited liability company that purchases and holds certain eligible loans and related property from SLR Healthcare (collectively, the Company).
On September 30, 2013, SLR Senior Investment Corp. formerly known as Solar Senior Capital Ltd. (SLR Senior), a Maryland corporation, acquired a controlling interest in SLR Healthcare. The remaining interest is held by various employees of SLR Healthcare through their investment in Gemino Management Investment, LLC.
On January 30, 2020, the World Health Organization declared a global emergency in the wake of the novel coronavirus (COVID-19) outbreak and in March of 2020 declared the outbreak a global pandemic. The outbreak of COVID-19 and its related negative public health developments have adversely affected workforces, customers, suppliers, economies and financial markets around the world. The Companys ability to execute its business initiatives and strategies, will continue to depend on future developments in the U.S. and globally, which are uncertain and cannot be predicted, including the duration and further spread of the disease, as well as the severity of the economic downturn or any delay or weakness in the economic recovery. This impact will in part be dependent on the U.S. government and other actions taken to lessen the health and economic repercussions, such as additional fiscal stimulus, and the effectiveness of past and any future fiscal, monetary and other governmental actions. While the Company considers these disruptions to be temporary, if they continue, this may have a material adverse effect on the Companys results of future operations.
2. | Summary of Significant Accounting Policies |
Principles of Consolidation
The consolidated financial statements include the accounts of SLR Healthcare and Gemino Funding. All significant intercompany balances have been eliminated in consolidation.
7
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
Use of Estimates
The preparation of consolidated financial statements in conformity with generally accepted accounting principles in the United States of America (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and to report amounts of revenues and expenses during the reporting period. Actual results could differ materially from these estimates. The allowance for loan losses represents an estimate that is particularly susceptible to material change.
Cash and Cash Equivalents
Cash and cash equivalents include funds deposited with financial institutions and short-term, liquid investments in money market accounts with original maturities of three months or less.
Loans Receivable
Loans receivable that management has the intent and ability to hold for the foreseeable future or until maturity or payoff are reported at their outstanding unpaid principal balances less the allowance for loan losses and any deferred fees or costs.
Commitment terms of the Companys financing agreements generally range from two to five years with interest charged on a floating rate basis. Funding under revolving loan commitments is subject to the Companys estimation of the value of the accounts receivable pledged as collateral.
Revenue Recognition
Income on loans receivable is recognized using the simple interest method. Revolving loan origination fees and costs are deferred and amortized on a straight-line basis over the terms of the related loan commitments as an adjustment to interest income on loans. Term loan origination fees and costs are deferred and amortized using either the effective interest method or the straight-line method over the life of the loan as an adjustment to interest income. The straight-line method may be used for term loan facilities when it approximates the effective interest method. Other fees, such as unused balance and collateral monitoring fees, are recognized when the services are provided. Termination fees are recognized when a loan is terminated. These other fees are included in other income.
The accrual of interest on loans is discontinued at the time the loan is 90 days delinquent unless the loan is secured. Typically, loans are placed on non-accrual or charged off at an earlier date if collection of principal or interest is considered doubtful. When a loan is placed on non-accrual status, all interest previously accrued, but not collected, is reversed against current interest income and all future proceeds received will generally be applied against principal or interest, in the judgment of management. Loans are returned to accrual status when all principal and interest amounts contractually due are reasonably assured.
The Company recognizes revenue in accordance with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers. The core principle of the revenue model is for an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services.
8
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
2. | Summary of Significant Accounting Policies continued |
Revenue Recognition continued
ASC 606 is not applicable to financial instruments and, therefore, does not impact the Companys revenues. The Company has evaluated the nature of its contracts with customers and fully satisfies its performance obligations on its contracts as services are rendered and the transaction prices are typically fixed; they are charged either on a periodic basis or based on activity.
Impaired Loans
A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all amounts due in accordance with the contractual terms of the loan agreement. Loans are evaluated for impairment by the Company based on an ongoing analysis of each borrowers repayment capacity, the value of the collateral support and the strength of any guarantees. Loans identified as impaired are further evaluated to determine the estimated extent of impairment.
Allowance for Loan Loss
The allowance for loan loss represents the Companys recognition of the assumed risks of extending credit. The allowance is maintained at a level considered adequate to provide for probable losses inherent in the loan portfolio. Management establishes a general portfolio reserve for unimpaired loans based on various factors including historical loss experience, the overall credit quality of the loan portfolio, economic trends and conditions, and the regulatory environment.
The overall credit quality of the Companys borrowers is reflected in the individual and weighted average credit risk ratings of the loans in the portfolio. Credit risk ratings for each borrower are established based on a number of qualitative and quantitative factors including an assessment of management and strategy, historical and projected repayment capacity, collateral coverage and performance, financial condition and sponsorship, strength of guarantees and any contingencies.
Specific allowances for loan losses on impaired loans are typically measured based on a comparison of the recorded carrying value of the loan to the present value of the loans expected cash flow using the loans effective interest rate, the loans estimated market price or the estimated fair value of the underlying collateral, if the loan is collateral-dependent combined with the strength of any guarantee arrangements. Specific allowances are recorded when the discounted cash flows, collateral value, or aggregate market price of the impaired loan is lower than the carrying value of that loan.
Loans are charged off when collection is questionable and when the Company can no longer justify maintaining the loan as an asset on the consolidated balance sheet. Loans qualify for charge off when, after thorough analysis, all possible sources of collection are determined to be insufficient to repay the loan. These include impairment of potential future cash flow, value of collateral and/or financial strength of guarantors. Recoveries of previous charge-offs are recorded when received. For the years ended December 31, 2021 and 2020, there were no recoveries of previous charge-offs.
9
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
Goodwill and Intangible Asset
Goodwill and intangible asset - trade name arose from the acquisition of the Company on September 30, 2013 (Note 1). Goodwill represents the excess of the purchase price over the fair value of those acquired net assets. Goodwill is not amortized, but instead is reviewed for impairment annually typically in December of each year or more frequently upon the occurrence of certain events or substantive changes in circumstances. The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. The Company has the option to perform a qualitative assessment to determine if an impairment is more likely than not to have occurred. If the conclusion is supported that it is not more likely than not that the fair value is less than its carrying amount, then the Company would not need to perform a quantitative impairment test. If the conclusion cannot be supported, or if the Company does not elect to do the qualitative assessment, then the Company will perform a quantitative assessment. If a quantitative goodwill impairment assessment is performed, the Company utilizes a combination of market and income valuation approaches. No impairment of goodwill resulted for the years ended December 31, 2021 and 2020, respectively.
The Company assessed its indefinite-lived intangible asset trade name for impairment by comparing the carrying value of the asset to its fair value. The fair value of intangible asset - trade name was estimated using the relief from royalty method, which is an income approach based on the present value of royalties the Company would theoretically have had to pay to license the trade name from a third party. During 2021 as part of the rebranding strategy to change its name via the d/b/a filing to SLR Healthcare ABL, the Company evaluated the trade names indefinite-lived position and elected to change the indefinite-lived intangible asset trade name to a finite-lived intangible asset trade name for the period ending December 31, 2021. Accordingly, the carrying value previously ascribed to the intangible asset trade name was fully amortized as of December 31, 2021. For the year ended December 31, 2020, there were no impairments to intangible asset trade name.
Furniture and Equipment
Furniture and equipment are recorded at cost, net of accumulated depreciation, and are depreciated on a straight-line basis over their estimated useful lives ranging from three to five years.
Debt Issuance Costs
The Company reports origination and other costs related to debt issuances as a direct deduction from the carrying amount of the debt liability. These expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life as an adjustment to interest expense. The straight-line method may be used on revolving facilities when it approximates the effective interest method.
10
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
Income Taxes
The Company is not subject to federal or state income taxes. Members of the Company have elected to report the taxable income or loss on their individual tax returns. Accordingly, no provision for income taxes has been recorded in the accompanying consolidated financial statements.
The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more-likely-than-not, based on the technical merits, that the tax position will not be realized or sustained upon examination by the appropriate taxing authority. Management determined there were no tax uncertainties that met the recognition threshold in 2021 and 2020.
The Company files both federal and state income tax returns. The Company remains subject to examination by taxing authorities for the years 2018 and after.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326) to replace the incurred loss model, which is referred to as the current expected credit loss (CECL) model. The CECL model is applicable to the measurement of credit losses on financial assets measured at amortized cost, including loans receivable and held-to maturity debt securities. It also applies to off-balance sheet credit exposures including loan commitments, standby letters of credit, financial guarantees, and other similar instruments. For the assets within the scope of CECL, a cumulative-effect adjustment will be recognized in retained earnings as of the beginning of the first reporting period in which the guidance is effective. This new standard is effective for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact this new standard will have on its consolidated financial statements.
In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases the transparency and comparability of accounting for lease transactions. This ASU requires lessees to recognize liabilities for operating leases and corresponding right-of-use assets on the balance sheet. ASU 2016-02 is effective for the Company for its fiscal year beginning after December 15, 2021. The Company is currently evaluating the impact this new standard will have on its consolidated financial statements.
Basis of Presentation
Certain amounts in the prior year consolidated financial statements have been reclassified whenever necessary to conform with the current year presentation. These reclassifications had no effect on the reported results of operations.
11
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
3. | Loans Receivable |
The following table shows the composition of loans receivable, net as of December 31, 2021 and 2020:
2021 | 2020 | |||||||
Revolving loans receivable |
$ | 82,400,125 | $ | 36,016,783 | ||||
Term loans receivable |
601,137 | 4,377,837 | ||||||
|
|
|
|
|||||
Total loans receivable |
83,001,262 | 40,394,620 | ||||||
Less allowance for loan losses |
(836,654 | ) | (410,226 | ) | ||||
Less deferred origination fees and costs, net |
(561,039 | ) | (644,034 | ) | ||||
|
|
|
|
|||||
Loans receivable, net |
$ | 81,603,569 | $ | 39,340,360 | ||||
|
|
|
|
4. | Allowance for Loan Losses and Recorded Investment in Loans Receivables |
The following table summarizes the activity in the allowance for loan losses by loan class for the respective years ended December 31, 2021 and 2020:
Beginning Balance |
Charge- Offs |
Recoveries | Provisions | Ending Balance |
Ending Balance: Individually Evaluated for Impairment |
Ending Balance: Collectively Evaluated for Impairment |
||||||||||||||||||||||
Allowance for Loan Losses - December 31, 2021 | ||||||||||||||||||||||||||||
Revolving loans |
$ | 366,448 | $ | | $ | | $ | 464,195 | $ | 830,643 | $ | | $ | 830,643 | ||||||||||||||
Term loans |
43,778 | | | (37,767 | ) | 6,011 | 6,011 | | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 410,226 | $ | | $ | | $ | 426,428 | $ | 836,654 | $ | 6,011 | $ | 830,643 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Allowance for Loan Losses - December 31, 2020 | ||||||||||||||||||||||||||||
Revolving loans |
$ | 1,090,200 | $ | | $ | | $ | (723,752 | ) | $ | 366,448 | $ | | $ | 366,448 | |||||||||||||
Term loans |
46,277 | | | (2,499 | ) | 43,778 | 13,778 | 30,000 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total |
$ | 1,136,477 | $ | | $ | | $ | (726,251 | ) | $ | 410,226 | $ | 13,778 | $ | 396,448 | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
4. | Allowance for Loan Losses and Recorded Investment in Loans Receivables continued |
The following table presents loans receivable individually and collectively evaluated for impairment by loan class at December 31, 2021 and 2020:
Ending Balance | Ending Balance Individually Evaluated for Impairment |
Ending Balance Collectively Evaluated for Impairment |
||||||||||
Loans Receivables - December 31, 2021 | ||||||||||||
Revolving loans |
$ | 82,400,125 | $ | | $ | 82,400,125 | ||||||
Term loans |
601,137 | 601,137 | | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 83,001,262 | $ | 601,137 | $ | 82,400,125 | ||||||
|
|
|
|
|
|
|||||||
Loans Receivables - December 31, 2020 | ||||||||||||
Revolving loans |
$ | 36,016,783 | $ | | $ | 36,016,783 | ||||||
Term loans |
4,377,837 | 1,377,837 | 3,000,000 | |||||||||
|
|
|
|
|
|
|||||||
Total |
$ | 40,394,620 | $ | 1,377,837 | $ | 39,016,783 | ||||||
|
|
|
|
|
|
The following table summarizes the non-accrual loans by loan class at December 31, 2021 and 2020.
Recorded Investment |
Unpaid Principal |
Related Allowance |
||||||||||
Loans Receivables - December 31, 2021 | ||||||||||||
Term loans |
$ | 601,137 | $ | 601,137 | $ | 6,011 | ||||||
|
|
|
|
|
|
|||||||
Total |
$ | 601,137 | $ | 601,137 | $ | 6,011 | ||||||
|
|
|
|
|
|
|||||||
Recorded Investment |
Unpaid Principal |
Related Allowance |
||||||||||
Loans Receivables - December 31, 2020 | ||||||||||||
Term loans |
$ | 1,377,837 | $ | 1,377,837 | $ | 13,778 | ||||||
|
|
|
|
|
|
|||||||
Total |
$ | 1,377,837 | $ | 1,377,837 | $ | 13,778 | ||||||
|
|
|
|
|
|
13
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
4. | Allowance for Loan Losses and Recorded Investment in Loans Receivables continued |
Credit Quality Indicators
The following table summarizes the loan portfolio by the Companys internal credit rating (scale: 1 to 7) as of December 31, 2021 and 2020: Loans with a rating of 4 or better generally pose minimal risk to the Company as they exhibit, among other things, one or more of the following attributes: (1) secured collateral position; (2) satisfactory cash flows; and (3) history of timely payment of debt obligations. Loans credit rated below 4 are considered watchlist loans; an overall degree of risk exists with these loans that warrants managements review each quarter.
December 31, 2021 | ||||||||
Revolving Loans |
Term Loans | |||||||
Rated 4 or better |
$ | 82,400,125 | $ | | ||||
Rated 6 |
| 601,137 | ||||||
|
|
|
|
|||||
Total |
$ | 82,400,125 | $ | 601,137 | ||||
|
|
|
|
|||||
December 31, 2020 | ||||||||
Rated 4 or better |
$ | 36,016,783 | $ | 3,000,000 | ||||
Rated 6 |
| 1,377,837 | ||||||
|
|
|
|
|||||
Total |
$ | 36,016,783 | $ | 4,377,837 | ||||
|
|
|
|
5. | Furniture and Equipment |
Furniture and equipment are comprised of the following at December 31, 2021 and 2020:
2021 | 2020 | |||||||
Computer software and equipment |
$ | 93,183 | $ | 88,234 | ||||
Furniture and fixtures |
41,032 | 41,032 | ||||||
Leasehold improvement |
21,551 | 21,551 | ||||||
|
|
|
|
|||||
Total |
155,766 | 150,817 | ||||||
Less accumulated depreciation |
(141,447 | ) | (129,717 | ) | ||||
|
|
|
|
|||||
Furniture and equipment, net |
$ | 14,319 | $ | 21,100 | ||||
|
|
|
|
Depreciation expense was $11,730 and $14,338 for the years ended December 31, 2021 and 2020, respectively.
14
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
6. | Debt |
On May 27, 2016, the Company entered into a four-year, non-recourse $125,000,000 secured revolving credit facility, which is expandable to $200,000,000 under its accordion feature. On June 28, 2019, the credit facility was amended and has a maturity date of June 28, 2023. Under the terms of the credit facility, the Company has made certain customary representations and warranties, and is required to comply with various covenants, including financial and reporting requirements and other customary requirements for similar credit facilities. The credit facility also includes usual and customary events of default for credit facilities of this nature.
Amounts available to borrow under the credit facility are also subject to compliance with a borrowing base that applies different advance rates to different types of assets in the Companys portfolio that are pledged as collateral. As of December 31, 2021 and 2020, there were principal borrowings of $60,000,000 and $25,000,000 outstanding, respectively, under the credit facility. As of December 31, 2021 and 2020, there were approximately $76,107,000 and $38,675,000 of eligible loans and related security pledged as collateral under the credit facility, respectively.
Interest on the credit facility accrues at a variable rate per annum of one-month LIBOR plus 2.25% approximating 2.35% and 2.39% at December 31, 2021 and 2020, respectively. The Company also pays other customary loan fees for the credit facility.
The credit facility is comprised of the following at December 31, 2021 and 2020:
2021 | 2020 | |||||||
Principal borrowings |
$ | 60,000,000 | $ | 25,000,000 | ||||
Unamortized debt issuance costs |
(601,622 | ) | (798,116 | ) | ||||
|
|
|
|
|||||
Credit facility, net |
$ | 59,398,378 | $ | 24,201,884 | ||||
|
|
|
|
7. | Commitments and Concentrations |
At December 31, 2021 and 2020, the Company has committed facilities to its borrowers totaling approximately $183,501,000 and $218,028,000, respectively, of which approximately $100,500,000 and $177,633,000, respectively, was unused. Borrowers may borrow up to the lesser of (i) the committed facility or (ii) the underlying collateral value multiplied by the advance rate. Of the unused committed facility amount at December 31, 2021 and 2020, borrowers could borrow up to approximately $27,414,000 and $71,292,000, respectively. As of December 31, 2021 and 2020, the Company had sufficient cash available and/or availability under its credit facility to fund its commitments.
At December 31, 2021, the Company had two loans approximating 29% and 16% of the total loans receivable and at December 31, 2020, the Company had one loan approximating 29% of the total loans receivable, respectively.
15
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
8. | Lease Commitments |
The Company leases its headquarters, regional sales offices and equipment under non-cancelable operating leases, which expire at various dates through 2024. As of December 31, 2021, future lease payments under non-cancelable operating leases, are as follows:
Years ending December 31: |
||||
2022 & Thereafter |
$ | 63,657 | ||
|
|
|||
Total |
$ | 63,657 | ||
|
|
Total rent expense for all leases amounted to approximately $167,000 and $168,000 for the years ended December 31, 2021 and 2020, respectively.
9. | 401(k) Savings Plan |
The Company has a savings incentive plan covering substantially all employees of the Company. The Companys contribution for the years ended December 31, 2021 and 2020 was approximately $134,000 and $135,000, respectively.
10. | Long-Term Incentive Plan |
The Company has a Long-Term Incentive Plan (LTIP Plan) that provides for an annual bonus pool to employees based on the Company achieving certain performance criteria.
11. | Fair Value Disclosure |
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values:
Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
Level 3: Significant unobservable inputs that reflect a companys own assumptions about the assumptions that market participants would use in pricing an asset or liability.
The following information should not be interpreted as an estimate of the fair value of the entire Company, since a fair value calculation is only provided for a limited portion of the Companys assets and liabilities. Assets and liabilities measured at fair value on a recurring basis are summarized in the table below at December 31, 2021 and 2020.
16
Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL
Notes to Consolidated Financial Statements
Years Ended December 31, 2021 and 2020
11. | Fair Value Disclosure continued |
2021 | ||||||||
Carrying Value | Fair Value | |||||||
Financial assets: |
||||||||
Cash and cash equivalents (Level 1) |
$ | 3,256,256 | $ | 3,256,256 | ||||
Loans receivable, net (Level 3) |
81,603,569 | 82,020,335 | ||||||
Financial liabilities: |
||||||||
Credit facility, net (Level 2) |
59,398,378 | 60,000,000 | ||||||
2020 | ||||||||
Carrying Value | Fair Value | |||||||
Financial assets: |
||||||||
Cash and cash equivalents (Level 1) |
$ | 10,356,890 | $ | 10,356,890 | ||||
Loans receivable, net (Level 3) |
39,340,360 | 39,653,713 | ||||||
Financial liabilities: |
||||||||
Credit facility, net (Level 2) |
24,201,884 | 25,000,000 |
12. | Related Parties |
An employee of an affiliated entity provides marketing and sales services to the Company for which the Company reimburses the affiliated entity. Such reimbursements have been included in compensation and benefits expenses.
The Company had sold a participation in a loan agreement to SLR Investment Corp., an affiliate of SLR Senior. The loan was repaid in February 2021. The participation was sold for a total commitment of $15,000,000 and the amount outstanding at December 31, 2020 was $7,579,174.
13. | Subsequent Events |
The Company evaluated subsequent events for recognition or disclosure through February 18, 2022, which was the date the consolidated financial statements were available to be issued.
17
Exhibit 99.2
North Mill Holdco LLC
and Subsidiaries
Consolidated Financial Report
December 31, 2021
North Mill Holdco LLC and Subsidiaries
Independent Auditors Report |
1-2 | |||
Consolidated Balance Sheets |
3 | |||
Consolidated Statements of Income |
4 | |||
Consolidated Statements of Members Equity |
5 | |||
Consolidated Statements of Cash Flows |
6 | |||
Notes to Consolidated Financial Statements |
7 |
RSM US LLP
Independent Auditors Report
Audit Committee
North Mill Holdco LLC
Opinion
We have audited the consolidated financial statements of North Mill Holdco LLC and its subsidiaries (the Company), which comprise the consolidated balance sheets as of December 31, 2021 and 2020, the related consolidated statements of income, members equity and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements).
In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of their operations and their cash flows for the years then ended in accordance with accounting principles generally accepted in the United States of America.
Basis for Opinion
We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditors Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities, in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.
Responsibilities of Management for the Financial Statements
Management is responsible for the preparation and fair presentation of the financial statements in accordance with accounting principles generally accepted in the United States of America, and for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued, when applicable).
Auditors Responsibilities for the Audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.
1
In performing an audit in accordance with GAAS, we:
| Exercise professional judgment and maintain professional skepticism throughout the audit. |
| Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. |
| Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control. Accordingly, no such opinion is expressed. |
| Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements. |
| Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Companys ability to continue as a going concern for a reasonable period of time. |
We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.
/s/ RSM US LLP
Philadelphia, Pennsylvania
February 18, 2022
2
North Mill Holdco LLC and Subsidiaries
Consolidated Balance Sheets
December 31, 2021 and 2020
2021 | 2020 | |||||||
Assets |
||||||||
Cash |
$ | 5,187,429 | $ | 4,383,512 | ||||
Finance receivables: |
||||||||
Loans receivable |
110,975,999 | 108,069,408 | ||||||
Less: unearned fee income |
35,927 | 18,970 | ||||||
|
|
|
|
|||||
110,940,072 | 108,050,438 | |||||||
Accounts receivable |
137,675,981 | 40,622,065 | ||||||
Less: allowance for uncollectible finance receivables |
1,834,061 | 1,834,061 | ||||||
|
|
|
|
|||||
Finance receivables, net |
246,781,992 | 146,838,442 | ||||||
Goodwill |
36,187,729 | 24,478,018 | ||||||
Accrued interest receivable |
845,561 | 879,774 | ||||||
Other assets |
329,828 | 281,904 | ||||||
Furniture and equipment, net |
282,006 | 212,860 | ||||||
Right of use asset |
1.179,246 | 626,471 | ||||||
|
|
|
|
|||||
Total assets |
$ | 290,793,791 | $ | 177,700,981 | ||||
|
|
|
|
|||||
Liabilities and Members Equity |
||||||||
Liabilities: |
||||||||
Note payable, net of issuance costs (Note 7) |
$ | 182,536,660 | $ | 110,225,882 | ||||
Due to factoring clients |
27,944,605 | 9,723,713 | ||||||
Accounts payable and accrued expenses |
2,030,084 | 2,016,318 | ||||||
Lease liability |
1,179,246 | 626,471 | ||||||
|
|
|
|
|||||
Total liabilities |
213,690,595 | 122,592,384 | ||||||
Commitments (Note 8) |
||||||||
Members equity |
77,103,196 | 55,108,597 | ||||||
|
|
|
|
|||||
Total liabilities and members equity |
$ | 290,793,791 | $ | 177,700,981 | ||||
|
|
|
|
See notes to consolidated financial statements.
3
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Income
Years Ended December 31, 2021 and 2020
Year Ended | Year Ended | |||||||
December 31, 2021 | December 31, 2020 | |||||||
Interest and finance charges |
$ | 20,192,516 | $ | 16,728,493 | ||||
Less: interest expense |
3,921,934 | 3,981,365 | ||||||
|
|
|
|
|||||
Net interest income |
16,270,582 | 12,747,128 | ||||||
Service fees and other finance charges |
3,828,782 | 2,986,756 | ||||||
|
|
|
|
|||||
20,099,364 | 15,733,884 | |||||||
(Credit) provision for uncollectible finance receivables |
| (360,000 | ) | |||||
|
|
|
|
|||||
Net interest and other non-interest income after (credit) provision for uncollectible finance receivables |
20,099,364 | 16,093,884 | ||||||
|
|
|
|
|||||
Expenses: |
||||||||
Personnel |
9,232,239 | 8,509,726 | ||||||
Acquisition expenses |
529,552 | | ||||||
General and administrative |
2,799,572 | 2,680,417 | ||||||
Legal and professional fees |
242,785 | 391,954 | ||||||
|
|
|
|
|||||
12,804,148 | 11,582,097 | |||||||
|
|
|
|
|||||
Net income |
$ | 7,295,216 | $ | 4,511,787 | ||||
|
|
|
|
See notes to consolidated financial statements.
4
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Members Equity
Years Ended December 31, 2021 and 2020
Balance, January 1, 2020 |
$ | 55,776,810 | ||
Net income |
4,511,787 | |||
Distribution to members |
(5,180,000 | ) | ||
|
|
|||
Balance, December 31, 2020 |
55,108,597 | |||
Net income |
7,295,216 | |||
Issuance of equity units |
20,000,000 | |||
Distribution to members |
(5,300,617 | ) | ||
|
|
|||
Balance, December 31, 2021 |
$ | 77,103,196 | ||
|
|
See notes to consolidated financial statements.
5
North Mill Holdco LLC and Subsidiaries
Consolidated Statements of Cash Flows
Years Ended December 31, 2021 and 2020
Year Ended | Year Ended | |||||||
December 31, 2021 | December 31, 2020 | |||||||
Cash flows from operating activities: |
||||||||
Net income |
$ | 7,295,216 | $ | 4,511,787 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
||||||||
Depreciation |
120,067 | 143,913 | ||||||
Amortization of deferred financing costs |
472,437 | 358,855 | ||||||
(Credit) for uncollectible finance receivables |
| (360,000 | ) | |||||
Changes in assets and liabilities: |
||||||||
(Increase) decrease in: |
||||||||
Accrued interest receivable |
34,213 | 102,628 | ||||||
Other assets |
(47,924 | ) | 117,192 | |||||
Increase (decrease) in: |
||||||||
Unearned fee income |
16,957 | (56,046 | ) | |||||
Accounts payable and accrued expenses |
13,766 | 507,387 | ||||||
Due to factoring clients |
6,964,158 | (9,073,459 | ) | |||||
|
|
|
|
|||||
Net cash provided by (used in) operating activities |
14,868,890 | (3,747,743 | ) | |||||
Cash flows from investing activities: |
||||||||
(Increase) decrease in finance receivables, net |
(33,742,591 | ) | 22,457,584 | |||||
Acquisition of business |
(66,670,894 | ) | | |||||
Purchases of furniture and equipment |
(189,212 | ) | (133,542 | ) | ||||
|
|
|
|
|||||
Net cash (used in) provided by investing activities |
(100,602,697 | ) | 22,324,042 | |||||
|
|
|
|
|||||
Cash flows from financing activities: |
||||||||
(Repayments of) net proceeds from note payable |
72,160,557 | (11,459,285 | ) | |||||
Issuance of equity units |
20,000,000 | | ||||||
Payment of debt issuance costs |
(322,215 | ) | (1,038,061 | ) | ||||
Distribution to members |
(5,300,617 | ) | (5,180,000 | ) | ||||
|
|
|
|
|||||
Net cash provided by (used in) financing activities |
86,537,725 | (17,677,346 | ) | |||||
|
|
|
|
|||||
Net increase in cash |
803,917 | 898,953 | ||||||
Cash: |
||||||||
Beginning |
4,383,512 | 3,484,559 | ||||||
|
|
|
|
|||||
Ending |
$ | 5,187,429 | $ | 4,383,512 | ||||
|
|
|
|
|||||
Supplemental disclosure of cash flow information: |
||||||||
Cash paid for interest |
$ | 3,204,430 | $ | 3,672,168 | ||||
|
|
|
|
|||||
Non-Cash Disclosure: |
||||||||
Right of use asset and lease liability |
$ | 877,449 | | |||||
|
|
|
|
|||||
Assets and liabilities acquired in business combination: |
||||||||
Accounts receivable |
$ | 66,217,916 | | |||||
Due to factoring clients |
$ | 11,256,734 | | |||||
|
|
|
|
See notes to consolidated financial statements.
6
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Note 1. Nature of the Business
The operations of North Mill Holdco LLC (Holdco) and Subsidiaries (collectively, the Company) consist primarily of those financial activities common to the commercial asset-based finance industry.
Holdco, a subsidiary of SLR Senior Investment Corp.(SLR), was formed on May 17, 2019 in connection with the acquisition of Summit Financial Resources, LLC (Summit).
North Mill Capital LLC (NMC) was formed as a single-member Delaware limited liability company on August 18, 2010 and commenced operations on October 29, 2010. SLR acquired a controlling interest in NMC on October 20, 2017. SLR contributed its interests in NMC to Holdco on June 28, 2019. NMC is a wholly owned subsidiary of Holdco.
NMC is a specialty finance company engaged in providing asset-based commercial financing to small and medium-sized businesses. The Companys core business is providing and servicing loans ranging from $200,000 to $30,000,000 secured by accounts receivable, inventory, and equipment. Borrowers are located throughout the United States.
PrinSource Capital Companies, LLC, a wholly owned subsidiary of NMC, and their wholly owned subsidiary Partner Plus, LLC (collectively, PrinSource), were acquired by NMC on December 30, 2011. Summit was acquired by Holdco on June 28, 2019. PrinSource, Summit, and Fast Pay Partners LLC (Fast Pay) (Note 2) provide financial services through the funding and financing of working capital assets, primarily accounts receivable and inventory.
Note 2: Acquisition
On June 3, 2021, NMC acquired a 100% equity interest in Fast Pay. The total purchase price was $66,670,894. The acquisition was accounted for as a business combination and the assets acquired and liabilities assumed were recorded at their respective fair values as of the date of the acquisition. The excess of the purchase price over the fair value of assets acquired and liabilities assumed has been recorded as goodwill on the accompanying consolidated balance sheet.
Assets Acquired |
||||
Accounts receivable |
$ | 66,217,916 | ||
|
|
|||
Liabilities Assumed |
||||
Due to factoring clients |
11,256,734 | |||
|
|
|||
Identifiable net assets |
54,961,182 | |||
Goodwill |
11,709,713 | |||
|
|
|||
Purchase price |
$ | 66,670,894 | ||
|
|
Upon allocating the purchase price to the fair value of assets acquired and liabilities assumed, the book value of intangible assets, consisting of goodwill, increased by $11,709,713. The accounts receivable were recorded at fair value with no allowance for loan losses established at the acquisition date.
7
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Acquisition related costs of $529,552, including legal, professional and other expenses, were recorded in the period incurred and not included in the purchase price.
Note 3: Significant Accounting Policies
Significant accounting policies are as follows:
Principles of consolidation: The financial statements include the accounts of NMC and its subsidiaries. All material intercompany accounts and transactions have been eliminated in consolidation.
Revenue recognition: The Company recognizes interest and fee income in accordance with ASC 310, Receivables and ASC 825, Interest. Interest income is recognized as earned based on the terms of the underlying loan agreement. Fees received for the origination of loans are deferred and amortized into income over the contractual lives of the loans and annual fees received for loans are deferred and amortized into income over a twelve-month period using the straight-line method, which approximates the effective interest rate method. Unamortized amounts are recognized as income at the time that loans are paid in full. Interest income on loans receivable is recognized using the interest method. Interest and fee income are accrued based on the outstanding loan balance and charged monthly to the loan balance as earned, except in instances that a reasonable doubt exists as to the collectability of interest, in which case the accrual of income may be suspended.
The Company recognizes and measures revenue recognition on other fee income in accordance with ASC 606, Revenue from Contracts With Customers. Other fee income, which includes wire transfers, field examination charges, late reporting fees and other items charged to borrowers, is recognized as charged.
Cash: The Company maintains its cash balances at several financial institutions which at various times during the year have exceeded the threshold for insurance provided by the Federal Deposit Insurance Corporation.
Loans and accounts receivable: The Company provides asset-based financing primarily in the form of revolving credit facilities collateralized by the borrowers assets, including, but not limited to, accounts receivable, inventory, equipment and general intangibles. The loan term is generally two years and management has the intention and ability to hold until maturity or payoff. Provisions for credit losses for loans receivable are charged to operations in amounts sufficient to maintain the allowance for credit losses at an amount considered adequate to cover the estimated losses of principal and accrued interest in the existing loan portfolio. The Companys charge -off policy is based on a loan-by-loan review for all receivables. Management periodically evaluates the adequacy of the allowance for credit losses by reviewing credit loss experience, change in size and character of credit risks, the value of collateral and general economic conditions. Loans are charged off against the allowance when management determines the loan to be permanently impaired.
8
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Specific allowances for loan losses are generally applied to impaired loans and are typically measured based on a comparison of the recorded value of the loan to the present value of the loans expected future cash flows from the liquidation of the underlying collateral.
Finance receivables are stated at cost, net of an allowance for credit losses. The allowance for credit losses is based on managements assessment of the collectability of specific customer accounts, the aging of the accounts receivable, historical experience and other currently available evidence. If there is a deterioration of a major customers credit worthiness or actual defaults are higher than the historical experience, managements estimates of the recoverability of amounts due to the Company could be adversely affected.
When the Company determines there is insufficient collateral to support an outstanding loan or accounts receivable balance and believes it is no longer probable that principal and/or interest payments will be collected, the Company will place the loan on non-accrual status. Such non-accrual loans may be restored to accrual status if past due principal and interest are paid in cash, and, in managements judgment, are likely to continue.
Participation funding: The Company enters into participation funding and servicing arrangements with other lending institutions whereby the other institutions pay the Company a processing fee for servicing financing arrangements that the other institutions have entered into with their customers. Under these arrangements, the Company, as the participant, assumes the risk related to their percentage share of the arrangement. The Company pays the lending institutions a pro rata percentage of the fee income earned. The arrangements are presented in accounts receivable in the accompanying consolidated balance sheet net of the amount due to the institution.
The Company enters into participation funding arrangements with third-party lending institutions, whereby those institutions participate in loans originated by the Company. These arrangements are used by the Company to manage risk associated with loans and accounts receivable that may potentially exceed funding limits. Transfers of financial assets are accounted for as sales, when control over the assets has been surrendered. Control over transferred assets is deemed to be surrendered when: the assets have been isolated from the Company put presumptively beyond the reach of the transferor and its creditors, even in bankruptcy or other receivership; the transferee obtains the right (free of conditions that constrain it from taking advantage of that right) to pledge or exchange the transferred assets; and the Company does not maintain effective control over the transferred assets through an agreement to repurchase them before their maturity or the ability to unilaterally cause the holder to return specific assets, other than through a cleanup call.
Furniture and Equipment: Property and equipment acquired in acquisitions is recorded at fair value. Additions are recorded at cost and stated net of accumulated depreciation. Depreciation and amortization are provided using the straight-line method over the estimated lives of the assets, which is generally three to five years for equipment and ten years for furniture and fixtures.
Debt issuance costs: Costs incurred in connection with the placement of the revolving credit facility have been capitalized and recorded as a reduction to the note payable on the balance sheets. These costs are amortized as interest expense over the life of the facility using the effective interest method or straight line method if it approximates the effective interest method.
9
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Impairment of long-lived assets: The Company reviews long-lived assets, including furniture and equipment and intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. An impairment loss would be recognized when undiscounted future cash flows expected to result from the use of the asset and its eventual disposition is less than the carrying amount. No impairments have occurred to date.
Goodwill: Goodwill represents the excess of consideration paid for an acquired business over the fair value of the related assets acquired and liabilities assumed. Goodwill arose from the acquisition of the Company on October 20, 2017, Summit, and Fast Pay (Note 2). The Company is required to assess its goodwill for impairment annually, or more frequently if events or changes in circumstances indicate impairment may have occurred.
The Company assesses goodwill for impairment by comparing the carrying value of the Company to its fair value. If the fair value were less than the carrying value, an impairment loss would be recorded for the difference between the fair value and carrying value. For the years ended December 31, 2021 and 2020, there was no impairment.
Income taxes: No provision has been made for income taxes, if any, as these are the obligation of the members. The Company files income tax returns as a partnership in the U.S. federal jurisdiction and in various state jurisdictions.
The Company applies authoritative guidance relating to the accounting for uncertain tax positions. Accordingly, a provision for uncertain tax positions and related penalties and interest is recognized when it is more likely-than-not, based on the technical merits, that the tax position will be realized or sustained upon examination. The term more-likely-than-not means a likelihood or more than 50%. A tax position that meets the more-likely-than-not recognition threshold is initially and subsequently measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon settlement with a taxing authority that has full knowledge of all relevant information. The determination of whether or not a tax position has met the more-likely-than-not recognition threshold considers the facts, circumstances, and information available at the reporting date and is subject to managements judgment.
Interest rate risk: Inherent in the Companys principal business activities is the potential for the Company to assume interest rate risks that result from differences in the maturities and re-pricing characteristics of certain assets and liabilities.
Use of estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.
10
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Leases: The Company recognizes and measures its leases in accordance with FASB ASC 842, Leases. The Company is a lessee in several non-cancellable operating leases for office space. The Company determines if an arrangement is a lease, or contains a lease, at inception of a contract and when the terms of an existing contract are changed. The Company recognizes a right of use (ROU) asset and a lease liability asset, initially and subsequently, based on the present value of its future lease payments. The discount rate is the implicit rate, if it is readily determinable, or otherwise the Company uses its incremental borrowing rate. The implicit rates of the Companys leases are not readily determinable and accordingly, the Company uses an incremental borrowing rate based on the information available at the commencement date for all leases. The Companys incremental borrowing rate for a lease is the rate of interest it would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms and in a similar economic environment. The Company used a weighted average discount rate of 2.84% and the weighted average remaining lease terms is 2.1 years. The ROU asset is subsequently measured throughout the lease term at the amount of the remeasured lease liability (i.e., present value of the remaining lease payments), plus unamortized initial direct costs, plus (minus) any prepared (accrued) lease payments, less the unamortized balance of lease incentives received, and any impairment recognized.
Subsequent events: The Company has evaluated its subsequent events (events occurring after December 31, 2021) through February 18, 2022, which represents the date the financial statements were available to be issued, and determined that there were no material subsequent events requiring adjustment to, or disclosure in the consolidated financial statements for the year ended December 31, 2021, except for the execution of a lease agreement in January 2022 for additional office space. This lease is an operating lease that provides for lease payments in 2022 of $154,770 and annual increases of 3.5% through the expiration date in September 2027.
Recent Accounting Pronouncement: In June 2016, the FASB issued ASU 2016-13, Financial InstrumentsCredit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which creates a new credit impairment standard for financial assets measured at amortized cost and available-for-sale debt securities. The ASU requires financial assets measured at amortized cost (including loans, trade receivables and held-to-maturity debt securities) to be presented at the net amount expected to be collected, through an allowance for credit losses that are expected to occur over the remaining life of the asset, rather than incurred losses. The ASU requires that credit losses on available-for-sale debt securities be presented as an allowance rather than as a direct write-down. The measurement of credit losses for newly recognized financial assets (other than certain purchased assets) and subsequent changes in the allowance for credit losses are recorded in the statements of operations as the amounts expected to be collected change. In October 2019, the FASB voted to defer the effective date of ASU 2016-13 for public business entities not considered an accelerated filer to fiscal years beginning after December 15, 2022. The Company continues to evaluate the impact the new standard will have on the accounting for credit losses, but the Company may recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective, consistent with regulatory expectations set forth in interagency guidance issued at the end of 2016. The Company cannot yet determine the magnitude of any such one-time cumulative adjustment or of the overall impact of the new standard on its consolidated financial statements.
11
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350), which simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. ASU 2017-04 is effective for annual or any interim goodwill impairment tests in fiscal year 2023, with early adoption permitted for annual or interim tests performed on testing dates after January 1, 2017. The amendments included in this ASU are to be applied prospectively. The Company does not expect implementation of this new standard to have a material impact on its consolidated financial statements.
In January 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020, to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as the Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. The Company is currently evaluating the impact the adoption of the standard will have on the Companys financial position and results of operations.
Note 4. Fair Value of Financial Instruments
FASB ASC 820, Fair Value Measurements (ASC 820), establishes a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect managements market assumptions.
These two types of inputs create the following fair value hierarchy:
Level 1 Quoted prices for identical instruments in active markets.
Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, such as interest rates and foreign exchange rates that are observable at commonly quoted intervals. Financial assets utilizing Level 2 inputs include currency swaps and interest rate caps.
Level 3 Unobservable inputs.
ASC 820 also requires that the Company disclose estimated fair values for its financial instruments. No quoted market exists for the Companys financial instruments. Therefore, fair market estimates are based on judgments, risk characteristics of various financial instruments and other factors. Changes in these assumptions could significantly affect the estimates.
The Company estimates the carrying amounts of cash approximated its fair value as of December 31, 2021 and 2020. Since there is no liquid secondary market for the Companys financing receivables, the Company estimated the fair value of its secured loans by comparing the average yield of the portfolio to recent issuances of similar loans. The Company has determined that the secured loans and note payable are considered level three under the fair value hierarchy described above.
12
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
The carrying amount and estimated fair values of the Companys financial instruments at December 31, 2021 and 2020 were as follows:
December 31, 2021 | December 31, 2020 | |||||||||||||||
Carrying Amount | Estimated Fair Value |
Carrying Amount |
Estimated Fair Value |
|||||||||||||
Financial assets: |
||||||||||||||||
Cash |
$ | 5,187,429 | $ | 5,187,429 | $ | 4,383,512 | $ | 4,383,512 | ||||||||
Finance receivables: |
||||||||||||||||
Net of allowance |
246,781,991 | 246,781,991 | 146,838,442 | 146,838,442 | ||||||||||||
Liabilities: |
||||||||||||||||
Note Payable |
$ | 182,536,660 | $ | 182,536,660 | $ | 110,225,882 | $ | 110,225,882 |
Note 5. Loans and Accounts Receivable and Allowance for Credit Losses
Loans receivable at December 31, 2021 and 2020 consist of revolving lines of credit to commercial customers that range from one to three years and are secured by accounts receivable, inventory and equipment. There are commitments to borrowers that are dependent on the borrowing base. The commitments are generally limited to 85% of the collateral being presented.
Changes in the allowance for credit losses for loans receivable and accounts receivable are as follows:
Balance, January 1, 2020 |
$ | 2,189,341 | ||
Credit for uncollectible finance receivables |
(360,000 | ) | ||
Recoveries |
4,720 | |||
|
|
|||
Balance, December 31, 2020 |
1,834,061 | |||
Provision for uncollectible finance receivables |
| |||
|
|
|||
Balance, December 31, 2021 |
$ | 1,834,061 | ||
|
|
All balances were individually evaluated for impairment.
The Company has implemented and adheres to an internal review system and credit loss allowance methodology designed to provide for the detection of problem receivables and an adequate allowance to cover credit losses. At least quarterly, a risk rating is assigned to individual balances. Management assigns a higher risk rating when they determine that their credit exposure has increased. Management assigns these risk ratings based on a number of factors including, but not limited to, the profitability, cash flow position, tangible net worth, strength of collateral performance and coverage, the probability of a loss being realized and results of internal audits and verifications related to each specific receivable.
The Company typically classifies all loans as held to maturity. Any acquired loans are recorded at their estimated Acquisition Date fair values. The estimated fair values include consideration of discounted cash flows as well as various other factors including the type of loan and related
13
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
collateral, estimated future cash flows, as well as a discount rate that reflects the Companys assessment of risk inherent in the cash flow estimates. The fair value of the loans acquired effectively remove the Companys allowance for loan losses for such acquired loans. Loans funded subsequent to an acquisition are recorded at the amount of unpaid principal, net of unearned fees, discounts and includes an allowance for loan losses.
A loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments in accordance with the contractual terms of the loan. Factors considered in determining impairment include payment status, collateral value and the probability of collecting payments when due. The significance of payment delays and/or shortfalls is determined on a case-by-case basis. All circumstances surrounding the loan are taken into account. Such factors include the length of the delinquency, the underlying reasons and the borrowers prior payment record. Impairment is measured on these loans on a loan -by-loan basis. Impaired loans include non-accrual loans and other loans deemed to be impaired based on the aforementioned factors.
NMC did not have any loans or accounts receivable that are non-performing, impaired, modified or past due as of December 31, 2021 and December 31, 2020.
Note 6. Furniture and Equipment
Furniture and equipment consists of the following at December 31, 2021 and 2020:
2021 | 2020 | |||||||
Furniture and fixtures |
$ | 275,011 | $ | 275,011 | ||||
Equipment |
1,907,774 | 1,718,561 | ||||||
|
|
|
|
|||||
2,182,785 | 1,993,572 | |||||||
Accumulated depreciation |
1,900,779 | 1,780,712 | ||||||
|
|
|
|
|||||
$ | 282,006 | $ | 212,860 | |||||
|
|
|
|
Depreciation expense was $120,067 for the year ended December 31, 2021 and $143,913 for the year ended December 31, 2020.
Note 7. Note Payable
The Company has entered into a $225,000,000 credit facility which expires November 13, 2024. Borrowings are secured by substantially all of the Companys assets. Interest on borrowings under the facility is payable monthly and is based on the LIBOR plus an applicable margin, as defined. The interest rate is 2.10 percent as of December 31, 2021. Outstanding borrowings under the credit facility are generally limited to 85 percent of eligible receivables, less any reserves established by the bank, as defined. The Company is required to maintain specified financial ratios and to comply with other covenants. The balance outstanding under this credit facility was $183,251,870 at December 31, 2021 and $111,091,313 at December 31, 2020. Note payable as of December 31, 2021 and 2020 consist of the following:
2021 | 2020 | |||||||
Outstanding principal balance |
$ | 183,251,870 | $ | 111,091,313 | ||||
Less: debt issuance costs, net of accumulated amortization of $1,364,587 and $892,151, respectively |
715,210 | 865,431 | ||||||
|
|
|
|
|||||
$ | 182,536,660 | $ | 110,225,882 | |||||
|
|
|
|
14
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Total interest expense related to note payable was $3,310,394 and $3,475,422 for the years ended December 31, 2021 and 2020, respectively. Amortization of deferred costs of $472,437 and $358,855 for the years ended December 31, 2021 and 2020, respectively, is included in interest expense in the Consolidated Statements of Income.
Note 8. Commitments
Employment agreements: The Company has entered into service agreements with certain members of management. Annual base compensation due under these agreements is included in personnel expenses in the consolidated statements of income. The annual base compensation is subject to review and adjustment by the Company. The employees are also eligible to receive bonus compensation at the discretion of the Board of Managers. The agreements can be terminated by either the Company or the employees at any time upon written notice. Certain additional amounts may be paid to the employees, contingent upon the circumstances surrounding the termination, as defined in the service agreements.
Operating lease: The Company rents its office space under non-cancelable operating leases that expire through October 2026. Base rents due under the leases escalate throughout the term of the leases. These leases generally contain renewal options but the Company is not reasonably certain to exercise these options. The optionable periods are not included in determining the lease term and the associated payments under the renewal options are excluded from lease payments.
The total minimum rental commitment at December 31, 2021, is due as follows:
Years ending December 31: |
||||
2022 |
$ | 366,080 | ||
2023 |
287,426 | |||
2024 |
242,581 | |||
2025 |
196,640 | |||
2026 |
166,175 | |||
|
|
|||
Total lease commitments |
1,258,902 | |||
Less: interest |
(79,656 | ) | ||
|
|
|||
Present value of lease liability |
$ | 1,179,246 | ||
|
|
Rent expense was $499,517 and $501,800 for the years ended December 31, 2021 and 2020, respectively.
15
North Mill Holdco LLC and Subsidiaries
Notes to Consolidated Financial Statements
Note 9. Related Party Transactions
An employee of NMC provides marketing and sales services to an affiliated entity for which NMC was reimbursed. Such reimbursements have been recorded in the Companys Statement of Income as a reduction of Personnel expenses.
NMC has sold a participation in a loan agreement to SLR Investment Corp., an affiliate of SLR Senior Investment Corp. The participation was sold for a total commitment of $7.5 million and the amount outstanding at December 31, 2021 was $1.0 million.
Note 10. Risk and Uncertainties
Coronavirus pandemic: On January 30, 2020, the World Health Organization declared the coronavirus outbreak a Public Health Emergency of International Concern, and, on March 11, 2020, declared it to be a pandemic. Actions taken around the world to help mitigate the spread of coronavirus include restrictions on travel, quarantines in certain areas and forced closures for certain types of public places and businesses. The coronavirus and actions taken to mitigate it have had, and are expected to continue to have, an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Organizations operates.
It is unknown how long the adverse conditions associated with the coronavirus will last and what the complete financial effect will be to the Organizations. Additionally, it is reasonably possible that accounting estimates made in the preparation of the Organizations financial statements could be materially and adversely impacted in the near-term future as a result of those conditions.
16
Exhibit 99.3
Report of Independent Registered Public Accounting Firm on Supplemental Information
To the Stockholders and Board of Directors
SLR Senior Investment Corp. (formerly, Solar Senior Capital Ltd.):
We have audited and reported separately herein on the consolidated financial statements of SLR Senior Investment Corp. (and subsidiaries) (the Company) as of December 31, 2021 and 2020 and for each of the years in the three-year period ended December 31, 2021.
We have also previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statements of assets and liabilities of the Company, including the consolidated schedules of investments, as of December 31, 2019, 2018, 2017, 2016, 2015, 2014, 2013, and 2012, and the related consolidated statements of operations, changes in net assets, and cash flows for the years ended December 31, 2018, 2017, 2016, 2015, 2014, 2013, and 2012 (none of which is presented herein), and we expressed unqualified opinions on those consolidated financial statements.
The senior securities table included in Part II, Item 7 of the Annual Report on Form 10-K of the Company for the year ended December 31, 2021, under the caption Senior Securities (the Senior Securities Table) has been subjected to audit procedures performed in conjunction with the audit of the Companys respective consolidated financial statements. The Senior Securities Table is the responsibility of the Companys management. Our audit procedures included determining whether the Senior Securities Table reconciles to the respective consolidated financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the Senior Securities Table. In forming our opinion on the Senior Securities Table, we evaluated whether the Senior Securities Table, including its form and content, is presented in conformity with the instructions to Form N-2. In our opinion, the Senior Securities Table is fairly stated, in all material respects, in relation to the respective consolidated financial statements as a whole.
/s/ KPMG LLP
New York, NY
March 1, 2022